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The existence and functional importance of RNA secondary structure in the
replication of positive-stranded RNA viruses is increasingly recognised. In this
thesis several computational methods to detect RNA secondary structure in the
coding regions of hepatitis C virus (HCV), hepatitis G virus (HGV)/GB virus C
(GBV-C) and related viruses have been used. These include thermodynamic
prediction of folding free energies (FFEs), evolutionary conservation of minimum
energy structures between virus genotypes, suppression of synonymous variability
and analysis of covariant and semi covariant substitutions in thermodynamically
favoured structures. Each of the predictive methods provided evidence for conserved
RNA secondary structure in the core and NS5B encoding regions of HCV and
throughout the entire coding region ofHGV/GBV-C.
Positions in the HCV genome with predicted RNA structure localise precisely to
regions of marked suppression of variability at synonymous sites, indicating that
RNA structure constrains sequence change at what are generally regarded as
phenotypically neutral sites. Combining these methods, the computational data
obtained in this thesis demonstrates the existence of at least ten conserved stem loop
structures within the NS5B coding region and three in that coding for the core
protein both within the coding region of HCV. Analysis of the NS5B coding region
and 3' untranslated region (3'UTR) ofHGV/GBV-C indicates an even greater degree
of RNA secondary structure. Remarkably, it appears from analysis of FFEs that
extensive RNA secondary structure may exist along the entire length of both the
X
HCV and HGV/GBV-C genomes, a finding with considerable implications for future
functional studies.
The existence of predicted RNA structures in the HCV genome was determined
using controlled nuclease mapping of RNA transcripts from the core and NS5B
regions under conditions which retained potential long-range RNA interactions. The
pattern of cleavage sites of nucleases specific for single and double stranded RNA
provided strong experimental support for structures previously predicted in this
study. Electron microscopy was also used to directly visualise the RNA folding
structure of HGV/GBV-C and provided some evidence for at least four structures
within the NS5B coding region and long range RNA folding across the length of the
virus genome.
The degree of structural conservation between diverse HCV and HGV/GBV-C
genotypes and related viruses suggests roles in virus replication, and/or RNA
packaging for the discrete structures identified in this thesis. Whilst this role and that
of the genome wide structure identified is currently not understood the structures
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1.1 DISCOVERY OF HEPATITIS C VIRUS
Viral hepatitis is a major public health issue throughout the world. Initially, the
two major aetiological viral agents of transfusion-associated hepatitis (TAH) were
believed to be hepatitis A virus (HAV) and hepatitis B virus (HBV). HAV is single
stranded RNA virus which was originally classified as a member of the enterovirus
genera (enterovirus 72) and is a major cause of hepatitis epidemics via the faecal-oral
route (Melnick 1982). HAV has since been reclassified into the hepatovirus genus
within the family Picornaviridae. HBV is a double stranded, circular DNA virus,
with a circular genome, and is classified in the Hepadnaviridae family. In the 1970s
serological tests were developed for both viruses, such as anti-core protein antibody
or surface antigen (HBsAg) tests for HBV and immunoglobulin M antibody to HAV.
After screening of patients it became evident that many cases of hepatitis associated
with blood transfusions were not due to either HAV or HBV and were thus described
as non-A, non-B hepatitis (NANBH). The acute phase ofNANBH is a mild disease
resulting in jaundice in less than half of cases. In at least 50% of cases it leads to a
chronic infection (compared with 5% in HBV infection) which may result in
progression to cirrhosis of the liver and hepatocellular carcinoma (HCC) after a long
incubation period.
Both cytomegalovirus (CMV) and Epstein-Barr virus (EBV) are known to cause
liver damage and can be transmitted by blood transfusion. However, in a number of
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studies both these viruses were discounted by serological testing of TAH patients
who were also shown to be negative for both HAV and HBV (Feinstone at al..
1975). Consequently a diagnosis of NANBH was made by excluding HAV, HBV,
herpesviruses such as CMV and EBV and other infectious causes of hepatitis.
NANBH was documented as representing over 90% of TAH cases in the United
States and up to 10% of transfusions were estimated to result in NANBH (Alter at al.
1975; Aach at al. 1981).
Progress towards identifying the cause ofNANBH was hampered by the difficulty
in culturing the agent in either organ or cell culture. However, evidence of a viral
aetiology was provided in epidemiological studies which suggested that NANBH
hepatitis was transmissible between humans (Prince at al. 1974; Alter at al. 1978).
After successful transmission to chimpanzees (Alter at al. 1978), experimental
evidence from filtration and chloroform inactivation studies was obtained suggesting
that the infectious agent was an enveloped particle between 30 and 60 nm in
diameter (Bradley at al. 1983; Feinstone at al. 1983; Bradley at al. 1985).
DNA recombinant technology was finally used to create a cDNA clone based on
the genome of what would subsequently be known as hepatitis C virus (HCV) (Choo
at al. 1989). Nucleic acid (both DNA and RNA) was extracted from experimentally
infected chimpanzees following ultracentrifugation of large volumes of relatively
high infectious titre plasma. The total nucleic acid was then reverse transcribed
using random primers and the resulting cDNA fragments cloned in to bacteriophage
kgtll (cDNA library). Recombinant proteins were then expressed as fusion proteins
in Escherichia coli (E. coli) colonies during bacteriophage replication. Sera from
patients with chronic NANBH was then used to screen large numbers of colonies;
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leading to the eventual identification of cDNA clone 5-1-1. Hybridisation studies
showed that the clone was not derived from the genomes of either human or
chimpanzee hosts. Further, total nucleic acid derived from NANBH chimpanzee
plasma hybridised to clone 5-1-1 after treatment with deoxyribonucleases, but not
after digestion with ribonucleases, and only one of the cDNA strands was found to
hybridise to the RNA extracted from plasma. These results indicated that the virus
has a single stranded RNA genome (Choo at al. 1989).
The 5-1-1 clone was subsequently used as a hybridisation probe against the
original cDNA library to identify three overlapping clones which were used to
reconstruct a single open reading frame (ORF) which was expressed in yeast as a
fusion protein (CI00-3) (Kuo at al. 1989). CI00-3 was 363 viral amino acids in
length and was used as the basis of serological screening studies, in which purified
protein was used to coat the wells ofmicrotiter plates, so that circulating antibody in
patient blood samples could be assayed. Detection of bound antibody was achieved
by challenge with a radioactive second antibody. The recombinant protein was
shown to be consistently recognised by sera derived from NANBH patients but not
from control individuals or those with hepatitis of different aetiology. It was also
shown that approximately 80% of patients with chronic, post-transfusion NANBH in
Italy and Japan had antibodies to HCV, compared to 15% in those cases where
hepatitis was observed in acute, resolving infections. In addition, 58% of NANBH
patients in the United States, with no known source of parenteral exposure to the
virus, were shown to be positive for the HCV antibody (Kuo at al. 1989).
Retrospective studies of 16 patients with chronic transfusion associated NANBH, in
which linked donor and recipient samples were available, showed that 88% of the
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recipients had received transfusions from donor plasma in which HCV antibody was
detectable (Alter at al. 1989). From such data, it became clear that HCV was the
causative agent of the majority on transfusion associated NANBH.
Comparative analysis of the genomes of several strains of HCV, reconstructed
from overlapping cDNA clones, was used to determine the structure and organisation
of the virus (Choo at al. 1991; Takamizawa at al. 1991; Okamoto at al. 1991). It
was shown that the virus genome is approximately 9500 nucleotides in length with a
single ORF which is flanked by both 5 'and 3' untranslated regions (5' and 3'
UTRs). The ORF encodes a single polyprotein approximately 3000 amino acids in
length which and is co- and post-translationally cleaved by host and viral proteases
into individual mature proteins. The polyprotein itself can be divided into upstream
and downstream domains. The upstream domain codes for three main structural
proteins core (C), El and E2 (envelope proteins) and P7. The downstream domain
codes for the non structural proteins NS2, NS3, NS4A, NS4B, NS5A and NS5B.
Based on nucleotide and amino acid sequence comparisons and similarities in
polyprotein organisation and hydrophobicity profiles, HCV was shown to group
phylogenetically with pestiviruses and flaviviruses (Millera and Purcell 1990;
Koonin 1991; Choo at al. 1991; Takamizawa at al. 1991). For example, comparative
analysis of the amino acid sequences from single stranded positive sense RNA
viruses showed that the RNA dependent RNA polymerase protein (RdRp) (NS5B)
contained conserved motifs either side of the active site which grouped into three
large subgroups (Koonin 1991). HCV clustered in subgroup II which also included
carmoviruses, tombusvirus, luteiviruses, pestiviruses, flaviviruses and unexpectedly,
single stranded RNA bacteriophages (Koonin 1991).
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It has since been shown by comparative analysis of nucleotide sequences that the
genome of HCV is relatively heterogeneous. This has led to the classification of the
virus into six major genotypes whose distribution varies both geographically and
between risk groups. The genotypes have been numbered 1 to 6 and are equally
divergent from each other, differing by 31% to 34% at the nucleotide level and
exhibiting approximately 30% amino acid divergence (Fig. 1.1) (Simmonds at al.
1994a). The six main genotypes comprise several more closely related subtypes with
approximately 20% nucleotide divergence, while within the subtypes variation is less
than 10% (Simmonds and Smith 1999a). Different regions of the genome exhibit
varying levels of sequence diversity. In particular the non-structural and core coding
regions exhibit lower levels of divergence between genotypes than has been observed
within the El and E2 coding regions. For example, 49% nucleotide sequence
divergence has been observed for the El protein coding region, between genotypes 1
and 2, as compared to approximately 20% for the core gene (Minutello at al. 1993;
Bukh at al. 1994). However, it has been shown that congruent phylogenetic
relationships are observed irrespective of whether the complete genome or discrete
regions are analysed (Chamberlain at al. 1997).
1.2 SEARCH FOR VIRAL AGENTS OF NON-A,B,C,D HEPATITIS
With the advent of specific serological testing HAV, HBV and HCV molecular
cloning techniques led to the isolation of a cDNA clone believed to be a further
human hepatitis virus, which was designated hepatitis E virus (HEV) (Reyes at al.
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Figure 1.1. Phylogenetic analysis of HCV diversity based on analysis of NS5B
sequences. Major genotype groupings are labelled in bold type (1-6).
Approximately 32% sequence divergence between genotypes is observed with
approximately 20 % diversity within genotypes (Reproduced with permission of
Peter Simmonds, adapted from Simmonds et al. 1999b).
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1990). HEV was shown to be a non-enveloped, positive sense, single stranded RNA
virus sharing a number of features including sedimentation coefficient and sensitivity
to CsCl with caliciviruses (Reyes at al. 1990). HEV has since been shown to be a
major causative agent ofwater born epidemics of acute hepatitis.
In 1994 it was reported that novel 27-37 nm particles were observed by electron
microscopy in the stool sample of a patient with sporadic NANBH, which when
serially inoculated into rhesus monkeys, produced hepatopthic lesions (Deka at al.
1994). After inoculation with infectious plasma 27-37 nm particles were
subsequently isolated from the infected rhesus monkey livers. The putative
infectious agent was reported to possess a double stranded DNA genome,
approximately 20 kb in length and was provisionally named hepatitis F virus (HFV)
(Deka at al. 1994). Subsequent research has failed to confirm these findings.
With the advent of reliable assays for the detection ofHAV, HBV, HCV and HEV
it became increasingly evident that the aetiology of a substantial fraction ofNANBH
cases remained undefined, suggesting the existence of additional causative agents
(Alter at al. 1989) (Simons at al. 1995a). For example, in a five year prospective
study of 182 adult patients with NANBH in Greece only 47% were shown to be of a
non A-D aetiology (Tassopoulos at al. 1992). Of these 29.1% acquired the infection
after parenteral exposure and 71.9% were community acquired cases, associated with
HEV (Tassopoulos at al. 1992) (Tassopoulos at al. 1994). Further evidence of the
existence of an unknown aetiological agent of TAH was provided in a number of
studies which reported levels of non-A, non-E chronic hepatitis between 1.5 and 5%
(Aach at al. 1991) (Hammel at al. 1994; Peters at al. 1993).
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1.3 DISCOVERY OF GB VIRUSES
In 1967 attempts to isolate HAV led to the first report of a "GB hepatitis agent"
following experimental inoculation of tamarins {Saguinus sp.) with patient sera
(Deinhardt at al. 1967). The serum was obtained from a 34 year old surgeon (initials
GB) from Chicago in the third day of jaundice with an acute mild form of hepatitis
and was used to set up a series of five serial marmoset to marmoset passages.
Animals directly inoculated with this serum developed hepatitis, as did animals
inoculated with serum from tamarins with acute-phase hepatitis after subsequent
passage. Hepatitis was assessed by elevated liver enzyme levels in serum and
histological abnormalities in the tamarin livers, following biopsy. Based on cross-
challenge and differential neutralisation data it was demonstrated that the GB agent
was distinct from HAV. Immune electron microscopy was used to directly visualise
the infectious agent, from a high dose serum sample (tamarin passage 11) (Almeida
at al. 1976). The GB agent was observed to have a particle diameter ranging
between 20-22 nm as opposed to HAV which has an average diameter of 27 nm.
Further evidence for the novel nature of the GB agent was presented in 1989 after
further passage and cross-challenge experiments (Karayiannis at al. 1989). Three
tamarins {Saguinus labiatus), two of which had previously been infected with and
were immune to HAV, were inoculated intravenously with plasma containing the GB
agent. All three animals developed acute hepatitis within two weeks post
inoculation, based on increased levels of serum alanine aminotransferase (ALT) and
biopsies showing liver abnormalities. These results further indicated that the GB
agent was unique from HAV, as infection was induced in animals with prior
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immunity to HAV. In the same study it was shown that faecal specimens taken from
acutely infected animals were non-infectious; indicating that the virus was unlikely
to be an enterovirus and was distinct from enterically transmitted NANBH hepatitis
virus such as HEV.
In 1995 a system of representational difference analysis (RDA) was used to
provide a more detailed molecular characterisation of the GB agent genome (Simons
at al. 1995b). RDA was developed by Lisitsyn and Wigler in order to amplify
unique DNA sequences present in one complex source but absent in a highly related
one (Lisitsyn at al. 1993). Plasma was taken from two tamarins; pre-inoculation
with GB agent sera and post inoculation during the acute phase of hepatitis, as
measured by increased levels of serum ALT. Reverse transcription followed by
second strand synthesis was performed on total extracted nucleic acid using random
hexamer primers. The DNA fragments were digested with Sau2A\ and ligated to a
compatible primer set (Lisitsyn at al. 1993). Using RDA, 76 sequences present in
the post inoculation, but not the pre-inoculation samples, unique sequences were
identified and cloned.
Following cross hybridisation eleven clones were identified which were shown by
Southern blot analysis to be absent in pre-inoculation tamarin, human,
Saccharomyses cerevisiae (S. cerevisiae) and E. coll genomic DNA indicating an
exogenous source. Of these, seven were selected for further investigation all of
which could be detected by RT-PCR, but not PCR, in infectious tamarin plasma;
suggesting an RNA genome. Sequence analysis of the seven clones, followed by
comparison with the GenBank and Swiss-prot nucleotide and protein databases,
revealed that 5 had limited amino acid sequence identity to the non structural
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proteins of HCV. Extension of the cloned sequences followed by further sequence
analysis demonstrated the presence of two distinct virus RNA molecules within the
infected tamarin plasma. Both viruses had limited sequence identity to flaviruses and
were designated GB virus B (GBV-B) and GB virus A (GBV-A) (Simons at al.
1995b).
The genomes of both GBV-A and GBV-B were reconstructed from overlapping
cDNA clones, isolated from infectious tamarin serum and liver samples (Muerhoff at
al. 1995). GBV-A was observed to have a genome 9493 nucleotides in length,
encoding a potential polyprotein of 2972 amino acids. The genome of GBV-B was
found to be 9143 nucleotides long, encoding a potential polyprotein of 2864 amino
acids. Based on a comparison of hydrophobicity profiles the genomes of the two
viruses were shown to be organised in a similar way to those of pestiviruses
(BVDV), flaviviruses (YFV) and HCV, with predicted structural genes located
towards the 5' of the genome upstream of the predicted non structural protein coding
region (Muerhoff at al. 1995). Amino acid alignments and subsequent phylogenetic
analysis of the predicted RdRp and helicase encoding regions showed that they
clustered within supergroup II (Koonin 1991), although they could not be considered
the same virus or genotypes of HCV and represent a subgenus within the
hepaciviruses of the Flaviviridae family.
In order to investigate the seroprevalence of antibodies to HCV, GBV-A and
GBV-B and epidemiological links of the GB viruses to non A-E hepatitis, serum
samples from a large number of individuals were screened using GBV-A and GBV-
B specific ELISAs (Simons at al. 1995a). The ELISAs used recombinant proteins
coded for by the putative core and non structural genes of GBV-B and the non
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structural genes of GBV-A. The screened samples were obtained from three diverse
sources; a low risk group of United States volunteer blood donors which had
previously tested negative for antibodies to HCV, and HBV surface (HBsAG) and
core antigens (anti-HBc); intravenous drug users (IVDUs) with a high prevalence of
HCV (99%) and HBV (76%) infection and a group of West African samples from
where infection with hepatitis agents is considered relatively common. The United
States blood donors exhibited a seroprevalence of 3% to GBV-A and 1.2% to GBV-
B. In contrast the IVDUs showed a prevalence of 14% to both viruses and the West
African subset 8.4% to GBV-A and 14.6% to GBV-B (Simons at al. 1995a).
The immunoreactive sera was tested for the presence of virus RNA with
degenerate primers, designed to amplify the putative helicase coding regions (NS3)
from HBV-A, GBV-B or HCV genomes. A novel amplification product was
generated from the West African sample set whose sequence identity was 59.0%,
53.7%, 47.9% at the nucleotide level and 64.2%, 57.3% and 50.4% at the amino acid
level to GBV-A, GBV-C and HCV respectively. BLAST homology comparisons of
the nucleotide and amino acid sequences did not detect any significant similarity to
any further published sequences. After alignment of the amino acid sequence with
those of the flaviviridae family it was proposed that the sequence was amplified from
a novel virus. Due to the relatively high sequence identity with GBV-A the virus
was named GB virus C (GBV-C). No amplification product was detected when the
RT step was omitted and RT-PCR failed to detect GBV-C sequences in human,
Rhesus monkey, S. cerevisiae or E. coli DNA samples, confirming that the GBV-C
sequence was exogenously derived from an RNA virus. Analysis of the near
complete genome of the virus through reconstruction of overlapping clones revealed
11
a sequence approximately 9125 nucleotides in length with a single ORF coding for a
putative polyprotein of 2906 amino acids (Leary at al. 1996). Comparative analysis
of hydrophobicity plots predicted a similar genome organisation to GBV-A and other
members of the Flaviviridae family, with the structural proteins located towards the
N-terminal of a single polyprotein and the non structural proteins downstream
towards the C-terminus (Leary at al. 1996).
1.4 DISCOVERY OF HEPATITIS G VIRUS
A novel virus, designated Hepatitis G virus (HGV), was identified and
characterised by a different group in a parallel search for unidentified aetiological
agents associated with non-A-E hepatitis (Linnen at al. 1996). The virus was
isolated from a patient with chronic NANBH. Initially the patient was believed to be
negative for HCV infection, based on the first generation immunoassay but was later
shown to be positive by the second generation immunoassay and RT-PCR for the
5'UTR (Linnen at al. 1996).
RNA was extracted from the plasma and reverse transcribed using sequence
independent single primer amplification. The RNA products were cloned into a X
gtl 1 library and patient plasma used to screen for immunoreactive clones. Analysis
of the immunoreactive clones revealed HCV-related sequences as well as a number
which did not match any sequences in the GenBank database, from which primers
were designed. PCR was performed on various sequences such as genomic human
DNA, E. coli and S. cerevisiae. No amplification products were obtained, suggesting
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an exogenous source for the sequence contained in the immunoreactive clone. No
PCR product was obtained from the patient plasma when the RT step of the reaction
was omitted, demonstrating that the exogenous sequence was RNA derived.
The initial exogenous sequence was extended using anchored PCR to produce
multiple overlapping cDNA clones whose combined sequence length was 9392
nucleotides, with a single ORF encoding a putative polyprotein of 2873 amino acids
(Linnen at al. 1996). The genome organisation of HGV resembles that of HCV and
the GB viruses, with the structural and non-structural proteins coded by the 5' and 3'
regions of the ORF and 5' and 3' UTRs. Comparison of the amino acid sequence
with members of the Flaviviridae family revealed 43.8% sequence identity to GBV-
A, 28.4% to GBV-B and 26.8% to HCV. Higher levels of sequence identity were
observed when only the RdRp and helicase domains were analysed, although the
same trend was maintained. A comparison of the putative NS3 domain with that of
GBV-C showed 85.5% nucleotide sequence identity and 100% amino acid identity.
Further analysis of complete genome sequences of HGV and GBV-C revealed 85%
nucleotide and 95% amino acid sequence identity (Zuckerman 1996). Consequently
it was shown that GBV-C and HGV are isolates of the same virus. The terminology
HGV/GBV-C will be used throughout this study.
Unlike HCV, variants of HGV/GBV-C show somewhat limited sequence
variability. In an analysis of 33 epidemiologically and geographically diverse
isolates the most extreme variants of HGV/GBV-C exhibited only 14% sequence
divergence across the complete genome sequence (Smith at al. 2000). Initial
attempts to define genotype groupings relied on analysis of subgenomic fragments
such as the NS3 or NS5B encoding regions (Katayama at al. 1997; Viazov at al.
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1997). However, analysis of complete genome sequences failed to reproduce the
observed phylogenetic relationships observed between subgenomic fragments (Smith
at al. 1997a). It was later shown, after analysis of 33 epidemiologically unlinked
isolates, that HGV/GBV-C clusters into four major phylogenetic groupings which are
geographically distinct and equally divergent from a recently isolated chimpanzee
isolate GBV-Ccpz (Fig. 1.2) (Smith at al. 2000). These four groupings are not
reproducible by analysis of individual genes or subgenomic fragments, with the
exception of the E2 coding region (Smith at al. 2000).
1.5 HCV GENOMIC ORGANISATION
The genome of HCV is a single stranded positive sense RNA molecule of
approximately 9600 nucleotides. The genome carries a single long ORF flanked by
both 5' and 3'UTRs and encodes a single polyprotein that is both co- and post-
translationally cleaved by viral and cellular proteases (Fig. 1.4). Translation of the
polyprotein is directed in a cap independent manner via an internal ribosome entry
site (IRES) in the 5'UTR, which acts as a landing pad for the 40S ribosomal subunit,
permitting direct binding of the translation initiation complex in close proximity to
the start codon of the ORF (Tsukiyama Kohara at al. 1992; Wang at al. 1993).
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Figure 1.2. Phylogenetic analysis of HGV/GBV-C diversity based on analysis of
complete genome sequences, rooted with HGV/GBV-Ccpz (GBV-tro). Genotype
groupings are labelled in bold type (1-4). Divergence between genotypes is far less
than that observed for HCV (approximately 32% for HCV compared to greatest
divergence of 13% for HGV/GBV-C) (Reproduced with permission of Peter









































Following characterisation of the 5'UTR region it was shown that polyprotein
synthesis is initiated from an AUG start codon at nucleotide 342 (Han at al. 1991).
The 5'UTR, is predicted to form a stable RNA structures in a similar way to the
previously characterised IRESs of picornaviruses (Tsukiyama Kohara at al. 1992;
Brown at al. 1992). The 5'UTR sequence was observed to contain a further four or
five (depending on the genotype) potential alternative AUG start codons upstream of
position 342 which are believed to be non-functional. The nucleotide sequence of
the 5'UTR has been shown to be highly conserved between divergent genotypes
(Bukh at al. 1992), to such an extent that the primers for the region have been used
as the basis of qualitative and quantitative RT-PCR screening between divergent
genotypes (1-6) (Smith at al. 1995).
The RNA secondary structure of the HCV IRES was modelled by thermodynamic
and comparative sequence analysis (Brown at al. 1992; Smith at al. 1995), and
subsequently supported by mutational analysis and ribonuclease mapping (Fig. 1.3)
(Honda at al. 1996a; Honda at al. 1999). The HCV 5'UTR IRES is proposed to be
composed of 4 main structural domains (I-IV). The AUG start codon appears to be
located in a single stranded loop of the most down stream structure (domain IV),
which includes approximately nine nucleotides of the core gene. Mutations which
enhance the stability of this structure have been shown to inhibit internally initiated
translation (Honda at al. 1996a). Some controversy exists as to the exact 3'
boundary of the IRES. For example, using a chimeric poliovirus construct that
contained the HCV IRES, it was shown that the first 21 nucleotides of the core gene
16
Figure 1.3. Proposed secondary structure of the
highlighted in black. Domain names labelled in bold type and start codon
highlighted by shaded box. Regions of tertiary interactions highlighted in bold type
and by connecting lines. (Adapted from Honda et al 1999).
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were required for efficient viral replication ( Reynolds et al. 1995; Lu and Wimmer
1996). However, efficient HCV IRES function has been observed in dicistronic
reporter constructs containing only the first AUG start codon of the core gene
(Rijnbrand at al. 1995; Rijnbrand at al. 1996). It has also been proposed that a long
range interaction between a region of the core gene sequence and nucleotides 23-38
of the 3'UTR may down-regulate IRES translational efficiency (Kim at al 2003).
The larger upstream structures (domains II and III) have been shown to be absolutely
required for translational activity (Kew 1998; Honda at al. 1996b; Rijnbrand at al.
1995). The most 5' of the stem loops (domain I) has been observed to have an
inhibitory affect on IRES activity, as its deletion appears to up-regulate translation
both in vivo and in vitro (Honda at al. 1996b; Reynolds et al. 1995; Rijnbrand at al.
1995).
1.5.2 CODING REGION
Like other members of the Flaviviridae family the nascent viral polyprotein is
processed both co- and post-translationally from the N-terminal region by host cell
signal peptidases and two viral proteinases. The structural proteins are located in the
N-terminal third and non-structural proteins within the C-terminal two thirds of the
polyprotein (Fig. 1.4). The structural domain is cleaved by host cell peptidases at the
Core/El/E2/p7/NS2 junction (Grakoui at al. 1993b; Mizushima at al. 1994; Lin at
al. 1994; Hijikata at al. 1991b; Ralston at al. 1993). However, the production of
processing intermediates, such as E2-p7-NS2 indicates that not all cleavage of
18
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structural proteins is co-translational. Further processing intermediates and truncated
protein products have been observed for the structural proteins. For example, the
core protein is cleaved from the polyprotein at amino acid 191 (Hijikata at al. 1991b;
Ralston at al. 1993). However, at least 3 truncated core proteins have been detected
including a product generated by a secondary cleavage at amino acid 173 which has
been isolated from the sera of infected patients, suggesting that the truncated core
protein is a component of native viral particles (Yasui at al. 1998).
Immunoelectron microscopy and RNA binding assays have been used to confirm
the nucleocapsid nature of the core protein. It was shown to form a close association
with detergent stripped virion particles recovered from infected hosts and bind RNA
encoding the virus structural proteins through a cluster of four basic amino acids at
the N-terminus (Takahashi at al. 1992) (Santolini at al. 1994). A specific interaction
between the core protein and the 5'UTR with a resulting suppression of IRES
activity has also been reported (Shimoike at al. 1999). However, this has been
disputed by further research in which no specific interaction was observed (Wang at
al. 2000). Further putative core protein functions include regulation of cellular
transcription, the modulation of cellular transcription, cellular transformation and
immunosuppression (Shimoike at al. 1999; Wang at al. 2000).
The El and E2 structural proteins are type 1 membrane proteins which have been
shown to contain five/six and eleven N-linked glycosylation sites respectively, in the
same relative position as the envelope proteins of flaviviruses and pestiviruses (Choo
at al. 1991) (Grakoui at al. 1993b). The E2 protein has been observed in expression
systems extended at its C-terminus to include the small p7 protein (Mizushima at al.
1994). Cleavage of E2/p7 and p7/NS2 appears to be a post translational process; the
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p7 protein has been implicated in ion channel function (Clarke 1997). The El and
E2 proteins localise in the endoplasmic reticulum (ER) where they undergo
glycosylation and form both non-covalent and di-sulphide bound E1-E2 heterodimers
(Flint and McKeating 1999); it is believed that the non-covalently bound dimers
represent the mature pre-budding complex (Deleersnyder at al. 1997). The cellular
attachment and entry mechanism of HCV is still poorly understood. However, E2 is
believed to be the main virus receptor mediating virion attachment, as pre-incubation
with antisera raised against the E2 protein has been shown to block the attachment
process (Flint at al. 1999). CD81 was recently identified as a putative cell surface
receptor for the E2 protein (Piled at al. 1998), although it has also been speculated
that virion entry is via low-density lipoprotein (LDL) receptors. The role of El is
less clear, although similarities to the envelope fusion proteins of flaviviruses and
paramyxoviruses suggest it may play a similar role in HCV membrane fusion.
The El and E2 genes are the most genetically divergent regions of the HCV
genome. Within E2 there exist hypervariable domains (HVR), including HVR-1,
representing the amino-terminal 34 amino acids of the E2 protein (nucleotides 383-
414), which is the most variable region of the HCV genome (Kato at al. 1992;
Weiner at al. 1991; Hijikata at al. 1991a). The extreme variability of the HVR-1 is
believed to play a role in HCV persistence through the development of
immunological escape mutations (section 1.8.1) Antibodies raised against this
region have been shown to block infection in tissue culture and chimpanzee
challenge experiments (Shimizu at al. 1996; Farci at al. 1996), whilst variability was
not observed in a patient with agammaglobulinaemia over a 2.5 year period;
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suggesting that the diversity observed in the HVR domains is a result of evolutionary
pressure exerted by the host immune system (Kumar at al. 1993).
The putative non structural proteins are processed by two virally encoded
proteases and as a whole are not expected to be constituents of the mature virion
particle but are required for replication of the viral RNA. Processing between the
NS2/NS3 boundary is a rapid autolytic event dependant on a NS2-NS3 protease
(Silini at al. 1993). The proteolytic domain for this activity has been mapped to the
C-terminus of NS2 and N-terminus of NS3 (Hijikata at al. 1993). It has been
proposed that the NS2-NS3 proteolytic domain is a zinc dependant metalloprotease,
based upon inhibition with chelating agents such as EDTA (Hijikata at al. 1993).
NS3 is also involved in the proteolytic processing of all the downstream proteins
NS3/4A, NS4A/NS4B, NS4B/NS5A and NS5A/NS5B from a separate serine
protease mapped within the C-terminal third of the protein (Grakoui at al. 1993a).
Analysis of the NS3 protease activity through an in vitro transcription-translation
system identified a catalytic triad of His (residue 1083), Asp (residue 1107) and Ser
(residue 1165) (Bartenschlager at al. 1993; Grakoui at al. 1993a). In recombinant
protein assays, such as vaccinia virus expression systems, substitution of the serine
residue was observed to block down-stream polyprotein processing but had no affect
on cleavage accoss the NS2/NS3 boundary; further indicating the separate nature of
the proteolytic activity at the N-terminal ofNS3 (Bartenschlager at al. 1993; Grakoui
at al. 1993a).
NS3 on its own is able to catalyse the proteolytic cleavage of all downstream
proteins. However, it was observed that its action is greatly increased in transient
and vaccinia virus recombinant expression systems by co-expression of NS4A,
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which forms a complex with the N-terminus domain of NS3 and acts as a cofactor;
stabilising and localising NS3 to the ER membrane where down-stream proteolytic
cleavage is believed to take place (Tanji at al. 1995; Failla at al. 1995; Wolk at al.
2000). The complex crystal formation of the NS3 protease domain and synthetic
NS4A cofactor has since been further elucidated by X-ray crystallography (Kim at
al. 1996).
NS3 is believed to be a multifunctional protein in which amino acid motifs
resembling both NTPase and helicase domains have been recognised within the C-
terminus of the protein. The NTPase and helicase activity of the NS3 C-terminal
domain has been confirmed in recombinant expression systems (Jin,Peterson 1995),
and the unwinding properties of the helicase domain have been shown to be optimal
in a 3' to 5' orientation. The C-terminus of the protein has also been observed to
preferentially bind to both the sense and antisense 3'UTR sequences. Binding to the
sense sequence was observed to be dependent on the presence of both the 3' and 5'
extremes of the UTR and binding to the negative sense orientation was greatly
enhanced by a 3' terminus RNA stem loop structure (Banerjee and Dasgupta 2001).
The NS5B domain of the polyprotein is cleaved into functional domains NS5A and
NS5B. The role of NS5A, which is a highly phosphorylated protein, has yet to be
fully elucidated although it has been implicated in the modulation of cell cycle genes
and resistance of infected cells to the antiviral activity of interferon (IFN). NS5A has
been observed in yeast expression systems to bind and inactivate the active site of
IFN induced protein kinase (PKR) (Gale at al. 1997). The NS5B protein is the most
downstream domain of the virus polyprotein and has been shown to possess close
sequence identity to the RdRp sequences of many positive stranded RNA viruses,
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including other members of the Flaviviridae family (Koonin 1991). In particular the
glycine-aspartate-aspartate (GDD) motif, associated with the active site of virus
RdRp was observed to be very highly conserved. A number of studies have
suggested the HCV RdRp shows little template specificity. However, electrophoretic
mobility shift and competition assays have also revealed that recombinant NS5B
protein preferentially binds the 3' end of the NS5B protein coding region, between
positions 8922 and 9121 (Cheng at al. 1999).
1.5.3 3'UTR
The full extent of the HCV 3'UTR has only recently been elucidated. It has a
tripartite structure composed of a hetrologous sequence following the ORF stop
codon, a poly(U) tract (of variable length) and a highly conserved downstream
sequence of approximately 98 nucleotides, known as the 3X' tail (Kolykhalov at al.
1996; Tanaka at al. 1995; Tanaka at al. 1996; Ferri at al. 1996). The 3'X tail has
since been shown to possess highly conserved RNA stem loop structures which form
a terminal "clover-leaf' structure and is essential for virus replication in vivo
(Kolykhalov at al. 1996; Blight and Rice 1997; Smith at al. 2002; Yanagi at al.
1999; Tanaka at al. 1996). It has been shown to bind a number of both viral and
cellular proteins, such as NS3 and polypyrimidine tract-binding protein (PTB), which
are associated with the viral replication complex (Ito and Lai 1997; Wood at al.
2001). It has also been shown, in a recombinant virus expression system, that
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inclusion of the 3'X tail of the 3'UTR can result in a three to five fold increase in
translation of viral proteins (Ito at al. 1998).
1.6 HGV /GBV-C GENOME ORGANISATION
The genome of HGV/GBV-C is a single stranded positive sense RNA molecule
approximately 9400 nucleotides in length. The genome and polyprotein organisation
of HGV/GBV-C is very similar to that of HCV and other members of the
Flaviviridae family; with a single ORF, flanked by both 5' and 3'UTRs, which is
translated as a polyprotein in a cap independent manner, via an IRES structure
situated in the 5'UTR (Simons at al. 1996). Although, the genomes of both HCV
and HGV/GBV-C are very similar there are several major differences between the
two.
1.6.1 5'UTR
The 5'UTR of HGV/GBV-C is longer then that ofHCV (524 nt versus 342 nt) and
shows limited sequence homology to GBV-A but not HCV or GBV-B (Simons at al.
1996). Site specific mutagenesis and protein product sequencing of the translation
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products from a mono-cistronic construct, composed of the 5' region of HGV/GBV-
C linked in frame to chloramphenicol acetyltranferase (CAT), indicated that the
authentic HGV/GBV-C AUG start codon is located at nucleotide 524; directly
upstream of the polyprotein El gene (Simons at al. 1996). Although a number of
other potential AUG start codons exist upstream of this site they have not been
observed to be transcriptionally active (Simons at al. 1996). Translation of a bi-
cistronic construct, containing the HGV/GBV-C 5'UTR, was indicative of the
presence of an IRES (Simons at al. 1996). However, the activity of the HGV/GBV-
C IRES was observed to be much lower (2% to 5%) than that of HCV IRES driven
translation.
Based on thermodynamic and phylogenetic analysis the RNA structure of the
HGV/GBV-C IRES is predicted to be quite different from that previously modelled
for HCV but similar to that of GBV-A (Fig. 1.5) (Brown at al. 1992; Smith at al.
1995; Simons at al. 1996). The IRES is composed of 5 major domains (as opposed
to four in HCV) and unlike HCV the AUG start codon is not internal to a stem loop
structure but is down stream of a highly conserved oligopyrimidine tract, similar to
that critical for IRES driven translation in poliovirus (Simons at al. 1996).
1.6.2 CODING REGION
As with HCV, HGV/GBV-C encodes two glyoproteins which are predicted to
compose the virus envelope proteins El and E2 (Fig. 1.4). Based on putative signal
domains it is believed that the El and E2 proteins are cleaved from the polyprotein in
26
Figure 1.5. Proposed secondary structure of the HGV/GBV-C IRES. AUG start
codon is highlighted in red. Domain names labelled in bold type (Adapted from





















































































































a co-translational manner by host cell peptidases, in a similar manner to those of
HCV (Linnen at al. 1996; Leary at al. 1996). However, several major differences
have been recognised between the structure and organisation of the HCV and
HGV/GBV-C genomes. Only one potential N-linked glycosylation site has been
noted in the El protein of HGV/GBV-C and three in the E2 region, which compares
to five/six and eleven respectively in HCV (Leary at al. 1996; Okamoto at al. 1997).
A further difference between the viruses are the hypervariable domains such as
HVR-1 which are observed in the E2 protein ofHCV and are believed to play a role
in viral persistence (Kato at al. 1992; Weiner at al. 1991; Hijikata at al. 1991a).
Analysis of HGV/GBV-C has shown that, although the E2 encoding region is the
most variable across the ORF, the rate of nucleotide and amino acid substitution is
much lower than that noted for HCV and no hypervariable regions are present
(Katayama at al. 1998; Nakao at al. 1997). For example, in a study of a patient
infected with HGV/GBV-C through a contaminated blood transfusion, approximately
the same rate of nucleotide change (0.35%) and only a single amino acid conversion
was noted in both the El and E2 genes as was observed across the rest of the
polyprotein coding region (0.33%) (Nakao at al. 1997). In a further study of
geographically variant isolates 80% sequence identity was observed across the El-
E2-NS2 region as compared to 50% for HCV (Katayama at al. 1998).
A further difference between the genome organisation of HCV and HGV/GBV-C
is that HGV/GBV-C does not appear to code for a core or nucleocapsid protein
(Linnen at al. 1996b; Leary at al. 1996) . A number of alternative AUG start codons
exist upstream of the recognised start codon at nucleotide 524. However, all have
been shown to encode truncated products of variable composition and length or to be
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completely absent in many isolates (Okamoto at al. 1997). Further, in vitro
translation experiments using 5'UTR sequences fused in frame with CAT, showed
that enzyme activity was abolished when the AUG start codon at position 524 was
rendered inactive (Simons at al. 1996). In contrast biophysical and electron
microscopic characterisations have indicated that the virus may possess a
nucleocapsid type structure (Xiang at al. 1998). These observations have led to the
suggestion that HGV/GBV-C may assemble in a nucleocapsid free virion structure or
sequester or utilise host cellular proteins.
The non-structural domains of HGV/GBV-V polyprotein show greater sequence
identity to those of HCV. Based on conserved His and Cys residues a zinc
dependant metalloprotease has been predicted between the adjacent C-terminal of
NS2 and N-terminal of NS3, which is predicted to be responsible for the autolytic
cleavage of the NS2/NS3 boundary in a similar mechanism to that of HCV (Linnen
at al. 1996; Muerhoff at al. 1995; Leary at al. 1996). Conservation of the amino
acid triad His, Asp and Ser, also suggests the presence of a serine protease within the
N-terminus of NS3 (Linnen at al. 1996; Leary at al. 1996). The proteolytic domains
and active sites of both enzymes have now been confirmed through site-directed
mutagenesis and deletion mapping of the putative motifs, followed by analysis in a
baculovirus expression system (Belyaev at al. 1998; Khudyakov at al. 1997). In this
analysis it was shown that the NS3 serine protease is responsible for all downstream
cleavages between NS3/NS4A, NS4A/NS4B, NS4B/NS5B and NS5B/NS4B. It was
also shown that NS4A was absolutely required as a cofactor for cleavage of
NS4B/NS5A and increased the efficiency of the other cleavage events, in a similar
way to that observed in HCV (Belyaev at al. 1998).
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The similarity between the two viruses extends downstream throughout the NS5A
and NS5B polyprotein domains, where a number of amino acid sequence motifs have
been identified which show close homology to those observed in other viruses of the
Flaviviridae family. In particular the amino acid motif Gly-Asp-Asp has been
identified within the NS5B encoding region, which is indicative of the active site of
RdRp. Consequently is it believed that NS5B encodes the HGV/GBV-C polymerase
(Linnen at al. 1996b; Leary at al. 1996).
1.6.3 3'UTR
The sequence of 3'UTR of HGV/GBV-C is highly conserved (Okamoto at al.
1997; Katayama at al. 1998), with mean pairwise distances of 3.8% to 6.6% between
genotypes which is in contrast to 12.8% to 13.4% across the entire genome (Cuceanu
at al. 2001). Unlike HCV the 3'UTR of HGV/GBV-C is not composed of a tripartite
structure and no poly(U) tract has been identified (Okamoto at al. 1997; Katayama at
al. 1998; Cuceanu at al. 2001; Xiang at al. 2000). Conserved RNA stem loop
structures have been observed at the end the 3'UTR ofHGV/GBV-C which resemble
those predicted in HCV and GBV-B (Okamoto at al. 1997; Xiang at al. 2000).
However, there is no evidence of a conserved third stem loop which makes up the
terminal "clover-leaf' structure observed in the other two viruses (Cuceanu at al.
2001).
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1.7 EPIDEMIOLOGY AND GEOGRAPHICAL DISTRIBUTION
1.7.1 HCV EPIDEMIOLOGY
HCV has been detected at varying levels in populations throughout the world. The
main route of transmission for HCV is parenteral exposure to blood. Rates of active
infection in healthy blood donors have been estimated to be 0.25% in Australia
(Crofts at al. 1997); 1.8% in the USA (Alter at al. 1999; Alter 1997); 0.69% in
France (Aymard at al. 1993); 0.66% in Saudi Arabia (Bernvil at al. 1994) and 2.8%
in the rural Bantu population of the Central African Republic (Fretz at al. 1995).
Prior to the development of serological screening assays the main route of
transmission was through transfusion of blood and non-inactivated blood products
such as factor VIII and IX concentrates. In a study of haemophiliacs who had
received factor VIII, prepared from commercial and volunteer plasma, 96.4% (54/56)
were later shown to be viraemic for HCV infection by RT-PCR (Jarvis at al. 1996).
In a further group who, received factor IX, viraemia was observed in 88% (15/17) of
individuals (Jarvis at al. 1996). All the haemophiliacs who tested negative by RT-
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PCR for viraemia were shown to be antibody positive for HCV, indicating past
resolved infection.
The risk of exposure through blood transfusion or blood products has been
dramatically reduced since the advent of serological screening (Schreiber at al.
1996), and the main risk of infection in industrialised countries is now associated
with intravenous drug users (IVDUs). Current seroprevalence rates within this risk
group are extremely high, ranging from 30% to 90% (Hope at al. 2001; Macdonald
at al. 2000; Taylor at al. 2000; Trepo and Pradat 1999). In non-industrialised
countries transmission routes are less clear, although the use of non-sterilised
medical equipment appears to be a major risk factor (Sanchez at al. 2000).
Unusually high seroprevalence has been observed in Egypt of between 20% to
30% in the general population and as high as 50% around the Nile Delta, of which
approximately 70% correspond to subtype 4a (Saeed at al. 1991; Ray at al. 2000;
McOmish at al. 1994; Simmonds at al. 1993). Based on the high predominance of a
single subtype, in contrast to the wide diversity of subtypes found in low endemic
populations, it is suggested that these high rates of infection are due to a recent
spread within Egypt; possibly during a mass campaign, from the 1960s to 70s, to
treat schistosomiasis with parenteral treatment (Frank at al. 2000).
The frequency of vertical transmission of HCV is comparatively low. For
example, in a study of 170 anti-HCV positive women a vertical transmission rate of
2.7% was observed, although a higher rate of 5.4% (2/37) was observed for women
co-infected with HIV than in HIV-negative women (3/151) (Ferrero at al. 2003).
However, all infected children were born to mothers with high levels of viraemia,
which is suggestive that many cases may result from unrecognised parenteral
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exposure (Ferrero at al. 2003). There is evidence that HCV can be sexually
transmitted (Kao at al. 2000). For example, in a study of 38 spouses of HCV
infected patients 7 were found to be viraemic for HCV (Benezra 1993), although the
efficiency of sexual transmission is believed to be poor, which was shown in a report
that none of 50 partners ofHCV viraemic patients had detectable levels of anti-HCV
antibody (Bresters at al. 1993).
1.7.2 HCV GEOGRAPHICAL DISTRIBUTION
HCV has been shown to group in six major genotypes which exhibit
approximately 30% divergence between each other (Simmonds at al. 1994a). In
Japan and other countries of the Far East, infection is mainly restricted to genotypes
lb, 2a and 2b (Hara at al. 1996), whilst in Western Europe and the USA genotypes
la, lb, 2b, 2c and 3a predominate although relative frequencies of infection vary. In
North and Western Europe the main genotypes are la and 3 (Harris at al. 1999;
Westin at al. 1999), in contrast to Eastern Europe where lb predominates (Naoumov
1999; Stamenkovic at al. 2000), and southern Europe where lb and 2c are most
common (Nousbaum at al. 1995; Tisminetzky at al. 1994; Maggi at al. 1999).
In Africa, South East Asia and India the distribution and diversity of genotypes is
markedly different from that observed in other regions. Genotypes 3 and 6
predominate in India and South East Asia where numerous divergent subtypes are
observed (Simmonds at al. 1996). In Western Africa infection is predominantly
confined to highly divergent subtypes of genotypes 1 and 2 (Ruggieri at al. 1996). In
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Central Africa the majority of infection has been shown to be due to highly divergent
subtypes of genotype 4 (Fretz at al. 1995; Xu at al. 1994).
It is believed that areas of high genetic diversity such as West and Central Africa
indicate long term evolution of the virus in the host population. The widespread
dispersal of a limited number of subtypes amongst specific risk groups in
industrialised nations suggest relatively recent introduction of the virus, from areas
of endemic infection, into new and efficient transmission networks such as blood
transfusion and IVDUs (Nousbaum at al. 1995; Westin at al. 1999; Yu at al. 2001;
Tisminetzky at al. 1994).
1.7.3 HGV/GBV-C EPIDEMIOLOGY
HGV/GBV-C has been shown to be more prevalent worldwide in healthy
population groups than HCV. Levels of active viraemia measured by RT-PCR have
been measured in Scotland at 3.2% (Jarvis at al. 1996); France 3.4% (Mercier at al.
1999); Japan 1% to 2.9% (Zhang at al. 1998) and 5% in Thailand (Poovorawan at
al. 1998). However, these figures underestimate rates of past exposure to
HGV/GBV-C as measured by the presence of anti-HGV/GBV-C antibody, which is
rarely observed in viraemic patients. Based on combined serological and RT-PCR
analysis past and present exposure has been shown to be remarkably high in healthy
blood donor populations with rates of 12.9% in France (Mercier at al. 1999); 16% in
Spain (Tacke at al. 1997); 9% in Sao Paulo Brazil (Bassit at al. 1998), 13.3% in
Australia and 10.4% in Germany (Nubling at al. 1997).
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As with HCV, parenteral exposure from contaminated blood or blood products and
intravenous drug use, is a main risk factor associated with transmission of
HGV/GBV-C. For example, present or past exposure in IVDUs in Germany has
been shown to be as high as 74.4% (Nubling at al. 1997); 88.6% in Australia
(Hyland at al. 1998) and 52% to 73% in Spain (Tacke at al. 1997). Viraemia in
multiply transfused patents has been observed at increased frequencies of 30% (Chen
at al. 1997) and 32.6% (Poovorawan at al. 1998). High rates of viraemia have also
been observed in patients who have received non-virus inactivated blood products.
In a study of 95 Scottish haemophiliacs, 14% where shown to be positive for
HGV/GBV-C viraeimia (Jarvis at al. 1996). However, this compares with 83% who
where shown to be positive for HCV replication, despite similarly high levels of
contamination of blood products, suggesting that infection which HGV is less likely
to establish a chronic infection than HCV (Jarvis at al. 1996).
Unlike HCV, high numbers of sexual partners and vertical transmission from
mother to baby have been shown to be associated with a high risk of HGV/GBV-C
transmission. A study of homosexuals in Germany showed a frequency of 30.2%
past exposure to the virus (Nubling at al. 1997) and past and present exposure has
been measured at approximately 45% in homosexual men and prostitutes (Scallan at
al. 1998). A number of studies have presented results consistent with vertical
transmission which has been shown to be more frequent for HGV/GBV-C than HCV
and HIV (Feucht at al. 1996; Zanetti at al. 1998).
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1.7.4 HGV/GBV-C GEOGRAPHICAL DISTRIBUTION
HGV/GBV-C has been divided into four main genotypes based on comparison of
complete genome sequence (Smith at al. 2000). The maximum divergence between
genotypes is approximately 13% at the nucleotide levels and 4% of amino acid
residues, compared to over 30% nucleotide divergence across the length of the HCV
genome. The four genotypes show a distinct geographical distribution (Smith at al.
2000; Kondo at al. 1997); genotype 2 is predominant in Western Europe, America,
India and Northern Africa, genotype 4 in South East Asia and genotype 1 in Sub-
Saharan Africa which also exhibits the greatest observed diversity, particularly in the
5'UTR (Tucker at al. 1999; Sathar at al. 1999). Genotype 3 predominates in
Northern Asia and the native inhabitants of North and South America (Konomi at al.
1999; GonzalezPerez at al. 1997; Tanaka at al. 1998b; Konomi at al. 1999). It has
been proposed that the major observed geographical distribution ofHGV/GBV-C is a
consequence of early Homo sapien sapiens migration (Smith at al. 2000).
1.8 DISEASE ASSOCIATIONS
1.8.1 HCV
Acute or primary HCV infection is generally asymptomatic, or associated with a
mild illness. However, in at least 50% of infected individuals, HCV establishes a
persistent infection of the hepatocytes which is associated with chronic inflammation
36
of the liver (Alter at al. 1992). The average period of incubation from exposure to
the onset of acute symptoms is approximately 6 to 8 weeks, with the appearance of
anti-HCV antibodies, detectible by ELISA, between weeks 8 and 9. The time
between infection and detectible levels of anti-HCV antibodies has been termed the
"window period" during which serological screening of blood donors is ineffective.
However, viraemia has been detected within 1 week of experimental infection or
transfusion (Shimizu at al. 1990; Farci at al. 1991). Consequently RT-PCR may be
used to detect HCV RNA in blood donors, reducing the risk from window period
blood donations. Acute HCV infection is generally subclinical. When symptoms are
observed they are commonly indistinguishable from those due to other forms of
acute viral hepatitis and include jaundice, fatigue, anorexia and abdominal
discomfort. Unique to HCV infection is the extreme likelihood of the virus causing a
chronic infection and the rarity of progression to fulminant liver failure (Alter at al.
1992), although such progression has been documented in a few cases (Yoshiba at al.
1994).
Most of the serious chronic liver diseases associated with HCV infection are due to
cytopathic infection of hepatocytes and the associated inflammatory response.
However, there is also evidence that many of the pathological aspects of HCV
infection are due to a host autoimmune response, which is also believed to be
responsible for a number of extrahepatic symptoms including cryoglobulinaemia
(Ballardini at al. 1995; Johnson at al. 1993). Progression to clinically significant
liver disease is generally slow and insidious, with symptoms commonly absent or
non-specific over long periods of time. Intermittent elevated ALT levels are
observed in approximately 70% of patients reflecting the damage suffered by
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hepatocytes (Di Bisceglie 1998). Histological characteristics of chronic infection
include the appearance of aggregates in the portal tract, inflammatory infiltrates in
the parenchyma, fibrosis, necrosis in periportal regions and the accumulation of lipid
vacuoles in the cytoplasm of infected hepatocytes Over a period of years to decades
the inflammatory process may progress to cirrhosis followed by hepatocellular
carcinoma (HCC) in a further 20% to 25% of patients (Benvegnu at al. 1997;
Tsukuma at al. 1993). In order to make an assessment of a chronically infected
patient's likely disease progression, hepatitis activity is graded over time based on
the levels of necroinflammatory activity and fibrosis.
A number of factors have been implicated in the rate and likelihood of chronic
HCV infection progressing to cirrhosis and/or HCC. These include a history of
alcohol abuse (Ostapowicz at al. 1998), infection with other hepatitis viruses such as
HBV or HAV (Chiaramonte at al. 1999), route of inoculation, host age and infecting
virus genotypes. For example, infection with genotype lb has been documented to
result in a more aggressive disease course resulting in higher incidences of cirrhosis
and HCC (Seeff 1998), although more recent studies have failed to confirm this.
Infection with HCV elicits both T-cell mediated and humoral immune responses
and may be responsible for clearance of the virus in individuals in which virus
infection does not progress to chronicity. For example, in two recent studies a strong
association between a vigorous and sustained CD4+ T-cell response and a self
limiting course of acute infection was observed (Diepolder at al. 1995; Missale at al.
1996). The observed T-cell responses were directed against a number of viral
antigens (Core, E2, NS3, NS4 and NS5), although in the majority of individuals in
which viral clearance was observed the response against NS3 was strongest and
38
detected most consistently (Diepolder at al. 1995; Missale at al. 1996; Diepolder at
al. 1997).
Despite both humoral and cellular immune responses, spontaneous clearance of
virus during chronic infection is rare and the majority of acutely infected patients
progress to chronic infection. It has also been shown that HCV infection does not
illicit a protective immune response (Farci at al. 1992); highlighted by the fact that
following a self limiting infection or during chronic disease re-infection with a
homologous or heterologous serotype is possible. HCV is believed to escape
immune surveillance and clearance through a number of mechanisms. A major
factor is believed to be viral heterogeneity, in which the host immune system exerts
evolutionary pressure leading to an increasingly complex population that can elude
the immune attack and result in a persistent infection (Chang at al. 1997; Wang and
Eckels 1999). For example, in a recent study of acutely infected post transfusion
patients those which resolved the infection exhibited relatively little diversity in
hypervariable region 1 (HVR1), of the envelope protein E2, compared to those with
chronic infection in which increasing levels of sequence diversity were observed
(Farci and Purcell 2000)
Further mechanisms of immune evasion are believed to include association of
virion particles with plasma lipoproteins (Thomssen at al. 1993); impairment of
dendritic antigen presenting cell function (Bain at al. 2001) and a direct interaction
between viral proteins and the host immune response. The NS5A viral protein has
been shown to directly interact with and inactivate an interferon (IFN) induced
protein kinase, PKR, which is a mediator of IFN-induced antiviral resistance
(Enomoto at al. 1995; Gale at al. 1997). Viral amino acid substitutions within NS5A
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have also been implicated in a reduced response to treatment of chronic genotype lb
infection with IFN-a, which is the most widely accepted form of therapy for chronic
HCV infection (Fukuda at al. 1998; Gale at al. 1998; Murashima at al. 1999).
1.8.2 HGV/GBV-C
The detection of HGV/GBV-C in sera from patients with non A-E hepatitis
aetiology initially suggested that HGV/GBV-C might be responsible for some cases
of non A-E hepatitis (Linnen at al. 1996; Yoshiba at al. 1995). However,
subsequent investigations of HGV/GBV-C viraemia and acute or chronic hepatitis
have failed to provide convincing causal evidence that HGV/GBV-C infection is
associated with any pathological process. In the United States HGV/GBV-C RNA
was found in 9% of patients with acute non A-E hepatitis, none of which developed
chronic hepatitis over a follow up period of nine years, despite persistent viraemia in
75% of patients (Alter at al. 1997b). HGV/GBV-C infection has also been
implicated in the occurrence of fulminant hepatitis (Yoshiba at al. 1995; Heringlake
at al. 1996). A strain of HGV/GBV-C with a specific sequence motif domain within
the NS3 region was isolated from eleven patients with fulminant hepatic failure
(Heringlake at al. 1996). However, patients with fulminant hepatitis receive multiple
transfusions so it was not possible to assess the role of HGV/GBV-C in the disease
aetiology of the patients. In a further study fourteen patients undergoing liver
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transplant operations, due to unexplained fulminant hepatitis, were tested for
HGV/GBV-C RNA (Moaven at al. 1997). All fourteen patients tested negative for
HGV/GBV-C RNA pre-operation, three patients died waiting for a suitable donor
and eight of the eleven surviving patients tested positive for viral RNA post-
operation. This was compared to a control group of twenty one post transplant
patients, five ofwhich were positive for viral RNA. These results and others suggest
that the high rates of HGV/GBV-C infection observed in fulminant hepatitis are not
the aetiological agent but are more likely due to multiple transfusions.
A number of studies have reported that the rate of HGV/GBV-C viraemia is
independent of patient serum ALT levels and shows no correlation to chronic
hepatitis (Linnen at al. 1996; Bosmans at al. 1997; Sarrazin at al. 1997). Further, no
significant correlation has been observed between HGV/GBV-C infection and
histological features of chronic hepatitis, such as fibrosis or inflammation (Haagsma
at al. 1997; Sarrazin at al. 1997; Bralet at al. 1997). No link has been observed
between co-infection of HCV infected patients with HGV/GBV-C and the severity or
occurrence of clinical progression (Alter at al. 1997b; Alter at al. 1997a; Bralet at al.
1997; Sarrazin at al. 1997). For example in a study of 105 HCV viraemic patients,
no statistical difference was observed in the incidence of cirrhosis or level of hepatic
fibrosis, between those solely infected with HCV and those co-infected with
HGV/GBV-C (Bralet at al. 1997).
Based on the presence of antisense RNA replication intermediates HGV/GBV-C
replication has been detected in hepatocytes of the liver (Saito at al. 1997; Fan at al.
1999). However, this has not been widely reproducible and most groups have
observed higher levels of replication in plasma, peripheral blood mononuclear cells
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(PBMCs), bone marrow and spleen tissue; suggesting that HGV/GBV-C is
predominantly a lymphotropic virus (Pessoa at al. 1998; Laras at al. 1999; Laskus at
al. 1998; Fan at al. 1999; Kao at al. 1999; Tucker at al. 2000).
As with HCV, HGV/GBV-C is able to setup a long term persistent infection.
However, levels of HGV/GBV-C persistence are lower (approximately 20%) than
those observed for HCV. This difference may be due to the presence of protective
antibody against the E2 envelope protein, which is usually associated with past
exposure and clearance of the virus and is rarely observed in viraemic patients
(Feucht at al. 1997; Thomas at al. 1998). This contrast to HCV may be due to
higher levels of sequence homogeneity observed in HGV/GBV-C, in particular the
envelope proteins of HGV/GBV-C do not contain hypervariable regions (Katayama
at al. 1998; Nakao at al. 1997), which are believed to play a role in the immune
escape of HCV. Based on structural homology the NS5A protein of HGV/GBV-C
may play an analogous role to that of HCV, in which an interaction with host kinase
PKR modulates the host antiviral IFN response.
In summary, no apparent disease burden has been associated with HGV/GBV-C
infection, hepatic or non-hepatic and it is currently believed that the main site of
virus replication is outside the liver and may be related to PBMCs. Also the
mechanism by which HGV/GBV-C persistent infection is maintained is poorly
understood and requires further characterisation.
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1.9 STRUCTURAL CONSTRAINTS ON HCV AND HGV/GBV-C VIRUS
EVOLUTION
1.9.1 HCV
HCV can be divided into at least six major genotypes differing from one another
by approximately 30% at the nucleotide level (Simmonds at al. 1994a). A number of
studies have attempted to reconstruct the origin of this sequence diversity based on
longitudinal studies of infection in one or more individuals with known times of
infection (Ogata at al. 1991; Okamoto at al. 1992; Abe at al. 1992). Sequence
analysis of virus isolated from a patient infected in 1977 was compared with that
isolated from the same patient thirteen years later in 1990 (Ogata at al. 1991). The
two isolates differed at 2.5% of nucleotides across the complete genome resulting in
a rate of nucleotide substitution of 1.92xl0~3 per site per year. In a further study
HCV nucleotide variability was assessed between two viruses, isolated 8.2 years
apart, from an experimentally infected chimpanzee (Okamoto at al. 1992). Across
the complete genome a 1.18% difference in nucleotide sequence was observed giving
a rate of substitution of 1.44* 10"3 per site per year. In a further study a slower rate of
nucleotide substitution (0.9x 10"3 per site per year), was observed within the
structural region of a virus isolated 9 years post experimental inoculation in a
chimpanzee and that of the original virus sequence (Abe at al. 1992b). Extrapolation
of the average substitution rates from these studies results in an estimated time of
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origin for the virus subtypes of 135-286 years ago and genotypes of 230-480 years
ago (Simmonds and Smith 1999a).
However, in both the Ogata and Okamoto studies differing degrees of sequence
variation were observed between different subgenomic regions (Abe at al. 1992;
Ogata at al. 1991). For example, 0.7% sequence divergence was observed between
the sequences of the 5'UTR regions, isolated from the same patient thirteen years
apart, compared to a 28.2% nucleotide divergence between the envelope genes
(Ogata at al. 1991). Such inconsistencies in the frequency of nucleotide substitutions
across the genome mean that divergence in highly variable regions may become
saturated over a relatively short time span, leading to inconsistencies when
determining overall rates of substitution.
A further compounding factor, which may result in false estimates of rates and
times of sequence divergence, is uncertainty within longitudinal studies over the
relationship of compared sequences (Simmonds and Smith 1999a). For example,
primary infection may be initiated with many virus particles, thus a divergent virus
sequence detected after some time may have been present but undetected in the
initial inoculum, leading to an overestimation of the rate of sequence change. In a
previously described study (Okamoto at al. 1992), a chimpanzee was infected with
serum pooled from other chimpanzees originally infected from a chronically infected
blood donor nine years previously. On analysis a third as much variation was
observed in sequences cloned from the initial patient sera as was observed over time.
Further, equal levels of diversity were observed between different clones isolated
from the final chimpanzee infection as was noted between the initial patient and
chimpanzee sequences, which were isolated several years apart (Okamoto at al.
44
1992). Consequently, some of the variation observed over time, in this and other
studies, may represent turnover of sequences present at the initial time of
transmission and so actual rates of nucleotide substitution may be lower than
previously estimated (Smith at al. 1997b).
In order to overcome this apparent sampling bias a further investigation was
undertaken in which the rates of substitution in both the El and NS5B coding regions
were measured in multiple recipients from the same infectious source (Smith at al.
1997b). The infectious source had been identified as anti-D immunoglobulin and
diversity was measured in 26 individuals, 17 years post infection. After analysis
approximately half as much sequence divergence was observed between recipients
compared to between recipients and sequence isolated from the infectious serum, for
both the El and NS5B genes. This is consistent with the shorter period of
divergence from the source (17 years) than between recipients (34 years). In order to
further account for potential sampling bias, individual virus genomes were sequenced
from the initial infectious serum after obtaining PCR product through limiting
dilution PCR. The overall rate of substitution between the recipient samples was
calculated to be 0.41 x 10"3 per nucleotide per year for NS5B and 0.74 x io~3 for El
(Smith at al. 1997b). Using these lower rates of substitution times of origin of 260-
280 years ago for virus subtypes and 400-570 years ago for virus genotypes has been
estimated (Simmonds and Smith 1999a).
Comparison of complete genome sequences for different virus genotypes has
revealed that variability at synonymous sites, which are presumed to be
evolutionarily neutral, is not constant across the genome (Ina at al. 1994; Smith at
al. 1997b; Smith and Simmonds 1997). A study of approximately 100
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epidemiologically unlinked complete genome sequences (genotypes la to 6a),
revealed suppression of synonymous variability towards both the 3' and 5' ends of
the polyprotein encoding sequence (Tuplin at al. 2002). The greatest constraints in
synonymous variability were observed across the core gene and NS5B region, in
which an approximately three fold reduction in variability compared to the rest of the
genome, was observed (Tuplin at al. 2002). Several different explanations can be
advanced for this bias.
Suppression of synonymous variability could be due to the presence of alternative
overlapping reading frames, although this has been shown to be unlikely. For
example, an alternative reading frame has been proposed within the core gene from
the observation that the +1 reading frame is open between codons 124 to 163 (Ina at
al. 1994). However, no AUG start codon is present and further analysis has shown
that in approximately 10% of sequences this short ORF contains at least one stop
codon (Bukh at al. 1994). In a recent study expression of the +1 ORF from a
vaccinia virus construct was shown to require mutations within the core gene to
allow ribosomal frame shifting and the recombinant protein was observed to be
extremely unstable (Roussel at al. 2003). Further, in a set of 52 unlinked sequences
only 23% of amino acid positions are conserved between positions 2 to 160 in the +1
reading frame with a similar proportion in the +2 reading frame (Smith and
Simmonds 1997). The +2 reading frame also contains numerous stop codons and the
longest ORF is only 33 codons in length, between codons 121 to 154. All three
antisense reading frames also encode numerous stop codons and few AUG start
codons. Similar results have been observed for the NS5B encoding region (Smith
and Simmonds 1997).
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A further possibility is that suppression of synonymous variability results from
biased codon usage within these regions. However, base composition in the first,
second and third codon positions has been shown to be consistent across the genome
of HCV, with no evidence of differing codon usage within regions in which
synonymous variability is constrained (Tuplin at al. 2002). Suppression on
synonymous variability may also result from biased dinucleotide frequencies which
limit codon choice. However, this has been discounted as for 14 of the possible 16
dinucleotides little or no difference from expected frequencies has been observed.
The dinucleotide CG is slightly under represented and UG overrepresented, although
no correlation has been observed between frequencies of either dinucleotide and
regions in which synonymous variability is constrained (Tuplin at al. 2002).
Reduction in sequence diversity at synonymous sites may result from constraints
on sequence change that arise from the formation of RNA stem loop structures that
influence virus phenotype. It has been shown that the first eight nucleotides of the
core gene take part in base pairing with upstream nucleotides at the 3' end of 5'UTR,
forming the terminal domain of the HCV IRES (Brown at al. 1992; Smith at al.
1995). At least two further stem loop structures have been predicted downstream of
this structure by thermodynamic minimisation between nucleotides 47-84 and 87-
167. Two RNA structures have also been predicted towards the 3' extreme of the
NS5B coding regions between nucleotide positions 8979-9011 and 8917-8976 (Han
and Houghton 1992; Smith and Simmonds 1997; Kolykhalov at al. 1996; Tanaka at
al. 1996).
The presence of functionally important RNA structure would be expected to confer
constraints on nucleotide variation at synonymous sites due to the requirement to
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maintain base pairing. However, reduction in synonymous variability is observed
across the complete length of the core gene and across approximately the final 2000
nucleotides of the polyprotein coding region (Tuplin at al. 2002). Although, the
RNA structures discussed above may account for a proportion of the observed
synonymous bias they are not extensive enough to account for the scale of sequence
constraint observed. A further indication that RNA structure may be more extensive,
is the observation that covariant substitutions have been shown to cluster in regions
of extreme synonymous bias within HCV (Tuplin at al. 2002; Smith and Simmonds
1997). Although, a number of these clusters are accounted for by the structures
discussed most are not. In particular at least seven clusters of covariant sites have
been observed across the NS5B region whilst only two limited structures were
predicted in this region. Consequently, phylogenetic evidence is suggestive of
extensive evolutionarily conserved RNA structures within both the core gene and
NS5B region ofHCV.
1.9.2 HGV/GBV-C
Based on analysis of complete genome sequences HGV/GBV-C has been divided
into four major genotypes with distinct geographical locations and 11% nucleotide
difference between the most divergent genotypes (Smith at al. 2000). However,
these genotypes are not consistently reproduced by analysis of the 5'UTR (Smith at
al. 1997a), or subgenomic regions (Khudyakov at al. 1997), with the exception of the
E2 gene (Smith at al. 2000). The inconsistent phylogenetic relationships observed
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between HGV/GBV-C subgenomic regions is in sharp contrast to HCV, in which
phylogenetic analysis of a number of subgenomic regions has been shown to
reconstruct the relationship observed between complete genome sequences
(Simmonds at al. 1994b).
In order to reconstruct the relationship between genotypes of HGV/GBV-C and
estimate times of divergence a number of studies have attempted to define rates of
sequence change for the virus. For example, in a study of a patient on maintenance
haemodialysis who had been infected with HGV/GBV-C through transfusion the
sequence of virus isolated from the patient at seroconversion was compared with that
isolated 8.4 years later (Nakao at al. 1997). The two isolates differed at 0.33% of
nucleotide sites and 0.18% of amino acid residues giving a rate of nucleotide
sequence change of 0.4x10"3 per site per year. In a further study sequence
divergence was measured across nucleotides of the NS4/NS5 region over 2.5 years in
an individual with community acquired HGV/GBV-C (Khudyakov at al. 1997). A
higher rate of substitution over time was noted in this study, with a 1 % nucleotide
difference between the two isolates giving a rate of sequence change of 1.7xl0"3 per
site per year. These observed rates of evolution are consistent with those observed
for HCV during chronic infection (0.4-1.9xl0~3 (Ogata at al. 1991; Okamoto at al.
1992; Abe at al. 1992). Based on these rates of annual substitution it has been
estimated that the current diversity observed between the most divergent HGV/GBV-
C genomes would have required between 120 and 500 years to develop (Simmonds
and Smith 1999a).
Rates of short term sequence change equivalent to HCV and a recent divergence of
genotypes is inconsistent with several other lines of evidence which suggest that
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HGV/GBV-C may have always infected the human population through coevolution
with its primate hosts (Simmonds and Smith 1999b). The virus is widely
geographically distributed with rates of active or past infection ranging from 5% to
15% and distinct phylogenetic groupings found in Africa, Asia, and North
America/Europe (Smith at al. 2000; Katayama at al. 1998). Viruses within these
groupings have been found in isolated populations in Africa, Papua New Guinea and
South and Central America as well as highly populated urban areas, which is
consistent with long term endemic infection. Although, HGV/GBV-C infection is
often chronic and associated with high levels of viraemia no hepatic or non-hepatic
disease association has been identified, which is consistent with long term co-
evolution with its host. The geographical distribution of HGV/GBV-C genotypes is
also consistent with ancient human migrations. For example, genotype 3 has been
isolated, almost solely, from populations in the Far East and native inhabitants of
North and South America, which is consistent with infection in the human population
prior to migration across the Bering land bridge and subsequent colonisation of the
Americas, between approximately 15-35 000 years ago. In contrast sequences
isolated in Europe, Western India and North Africa are usually genotype 2. Greatest
sequence diversity is observed in genotype 1, which is confined to sub-Saharan
Africa and exhibits the most extreme variation observed in 15 sequences isolated
from Pygmies and Bantu in Central Africa (Tanaka at al. 1998a).
Recently a virus closely related to HGV/GBV-C has been isolated from non-
captive chimpanzee populations {Pan troglodytes, troglodytes and verus subspecies)
from the Central and Eastern African countries of Cameroon and Nigeria. The
isolate has been described as HGV/GBV-Ccpz and based on analysis of the 5'UTR,
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NS5 and NS3 regions was shown to be less divergent from human sequences (27%
nucleotide divergence; 15% amino acid divergence) than those recovered from GBV-
A infection in new world primates (Adams at al. 1998). HGV/GBV-Ccpz sequences
recovered from different subspecies of chimpanzee were shown to be more diverse
than variants of HGV/GBV-C isolated from the human population. 25% nucleotide
sequence divergence in the 5'UTR and 20% divergence in the NS5 region (9.5%
amino acid) between virus isolates recovered from the troglodytes and verus
subspecies compared with 7.4% and 10.4% (1.9% amino acid) divergence between
HGV/GBV-C isolated from the human population (Adams at al. 1998). The greater
divergence observed within the chimpanzee subtype is consistent with the greater
nuclear genetic diversity of chimpanzees when compared to humans. This is
presumed to be due to the maintenance of chimpanzee population sizes in the past
and the relatively recent expansion of limited numbers of modern humans from
Africa. Even greater divergence is observed within the HGV/GBV-C homologue
(GBV-A) isolated from New World primates, with 42% nucleotide sequence (38%
amino acid) divergence within the NS5 and 25% divergence within GBV-A
sequences isolated from different New World primates, which again mirrors the host
evolutionary relationships divergence times (Simmonds and Smith 1999b; Charrel at
al. 1999). These observations are consistent with coevolution of the virus with its
primate host. A comparison of the phylogenetic relationships observed among
HGV/GBV-C and GBV-A isolates and the phylogeny of their primate hosts reveals
striking similarities between the branching pattern of the viruses and those of the
primates. From this comparative study a rate of sequence change of 3><10~7 per site
per year has been inferred (Charrel at al. 1999). Comparable results were obtained
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in a similar study, in which rates of sequence divergence of 5.6><10"6 and 3.2x10"6
nucleotide and synonymous nucleotide substitutions per site per year respectively,
were inferred (Simmonds and Smith 1999b).
In the studies of chronically infected individuals discussed previously, HGV/GBV-
C was shown to have a short term rate of sequence divergence, over 8.4 years,
comparable to that of other RNA viruses such as HCV (Nakao at al. 1997), which is
incongruent both with early infection of the human population, before the migration
of modern humans out of Africa, and the lack of diversity observed. The short term
rate of sequence change is also inconsistent with the relationship between related
viruses and cospeciation with primate hosts. If the virus did not coevolve with its
host then the geographical spread would have to be due to recent zoonotic events,
which is inconsistent with the geographical spread if the virus genotypes and the
relationship between related viruses and their hosts. This suggests that constraints on
sequence variability exist, which restrict the accumulation on nucleotide substitutions
in HGV/GBV-C, limiting diversity over time (Simmonds and Smith 1999b).
Further evidence for this has been highlighted by the analysis of the rate of
synonymous substitutions, which are not limited by constraints on the encoded
amino acid sequence. In a study of 17 epidemiologically unlinked HGV/GBV-C
complete genome sequences (genotypes 1-3) 23% (622) of codons were invariable at
their synonymous sites; in a second dataset of 17 genotype 3 sequences the bias was
even greater with 30% of codons invariable at their synonymous sites (Simmonds
and Smith 1999b). As with HCV the possibility that these rates were due to unequal
codon usage or base compositions biases was discounted and there was no evidence
of overlapping reading frames in either the sense or antisense orientation (Simmonds
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and Smith 1999b). However, the degree of bias in synonymous substitutions was
more extreme than that observed for HCV and observed along the length of the
HGV/GBV-C genome; not restricted to the 5' and 3' regions as was observed in
HCV.
In the same study multiple covariant substitutions were observed along the length
of the genome, with greater clustering in regions which were spatially associated
with extreme reductions in synonymous variability, such as the NS5, NS3 and E2
protein encoding regions (Simmonds and Smith 1999b) (Cuceanu at al. 2001).
Consequently it was suggested that the genome of HGV/GBV-C may contain
evolutionarily conserved stem loop structures which would limit the rate of
synonymous and non-synonymous sequence variability, due to the need to maintain
internal base pairing. Based on covariant substitutions a number of RNA structures
were predicted along the length of the genome and were again shown to align which
regions of synonymous nucleotide bias (Simmonds and Smith 1999b). One of these
structures, which was located in the El gene, was shown to be thermodynamically
stable and was mapped.
1.9.3 COMPARISONS BETWEEN HCV AND HGV/GBV-C
An intriguing finding from these comparisons is the extent to which the
characteristics of sequence evolution differ so markedly between HCV and
HGV/GBV-C. Although, both sequences show comparable short term rates of
sequence change the long term rate of divergence is severely restricted in
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HGV/GBV-C. Both viruses exhibit constraints in the rate of substitution at
synonymous sites and show geographically distinct genotypes. However, reductions
in synonymous variability are more pronounced and divergence between genotypes
far more restricted in HGV/GBV-C. These biases and differences may be accounted
for by the presence of evolutionarily constrained RNA structure in both viruses
which is more extensive in HGV/GBV-C than HCV.
Whilst the reason for this difference, given the close relationship of the two
viruses, is not understood it may account for the lack of sequence divergence
between genotypes of HGV/GBV-C. These findings may also account for the fact
that genotypes of HCV can be resolved by subgenomic fragments as short as 222
nucleotides whilst complete genomes are generally required for HGV/GBV-C.
A further difference between the viruses is the extent of sequence conservation
within the 5'UTR regions. The 5'UTR of HCV is the most strongly conserved
region across the genome with divergence between genotypes of between 2.5 and
11%. In HGV/GBV-C the 5'UTR exhibits approximately the same level of
conservation (10%) between genotypes as the rest of the genome (11-13%) (Smith at
al. 1997a). This difference is surprising given that both viruses are believed to
replicate using a highly structured IRES, located in the 5'UTR. The IRES would be
expected to be under the same structural constraints as base paired synonymous
nucleotides within the ORF. There is no obvious reason why the 5'UTR of HCV
should be under greater evolutionary constraint than that of HGV/GBV-C.
Consequently, as the short term rates of sequence change for the two viruses have
been shown to be comparable, the greater divergence of the HGV/GBV-C 5'UTR is
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further evidence of an earlier time of origin for HGV/GBV-C than the major
genotypes of HCV (Simmonds and Smith 1999a).
1.10 QUESTIONS TO BE ANSWERED
A number of previous studies have shown that constraints on sequence variation
exist within the polyprotein coding region of HCV and to an even greater degree
HGV/GBV-C (Smith and Simmonds 1997; Simmonds and Smith 1999b) In
particular, restrictions on variation at synonymous codon sites and clustering of
covariant substitutions have been documented within the ORFs of both HCV and
HGV/GBV-C. It has been suggested that such biases are due to the presence of
functionally important and evolutionarily conserved RNA structure. Although, such
structure has been demonstrated within the 5' and 3' UTRs of both viruses, little
progress has been made toward llir identification and characterisation of strucluies
residing within the coding regions ofRNA viruses.
In order to fully define the existence, position and confirmation of RNA structure
within the coding regions of HCV, HGV/GBV-C and related viruses their genomes
were analysed with a combination of thermodynamic prediction of folding free
energies (FFEs), evolutionary conservation of minimum energy structures between
virus genotypes, suppression of synonymous variability and analysis of covariant and
semi covariant substitutions in thermodynamically favoured structures (Chapters 3
and 4). Each of the predictive methods has provided evidence for conserved RNA
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secondary structures in the core gene and NS5B coding region of HCV and
throughout the entire genome ofGBV-C (Cuceanu at al. 2001; Tuplin at al. 2002).
The existence of predicted RNA structures in the core gene and NS5B coding
regions of HCV were determined using a process of controlled nuclease mapping, in
which RNA transcripts were analysed under conditions which maintain potential
long-range RNA interactions (Chapter 6). Electron microscopy was used to directly
visualise the RNA folding structure of HGV/GBV-C RNA transcripts including the
RNA folding conformation of the complete virus genome (chapter 5).
Whilst the role of the RNA structures identified in this study is not currently





2. MATERIALS AND METHODS
2.1 POLYMERASE CHAIN REACTION
2.1.1 EXTRACTION OF VIRAL RNA FROM SERUM SAMPLES
Viral RNA was extracted through incubating 100 pi of serum sample with 400 pi
of lysis buffer (50 mM Tris-HCl pH 8.0, 0.1 M NaCl, 0.5% SDS, 1 mM EDTA, 40
pg/ml polyadenylic acid, 1 mM proteinase K) at 37 °C for 90 min. 450 pi of phenol
(Rathburn Chemicals Ltd.), was then added to each extraction tube and vortexed
thoroughly. After centrifugation at 12,000 g for 10 min the aqueous layer was
transferred to a new Eppendorf tube containing 450 pi of chloroform: isoamylalcohol
(50:1). This mixture was again vortexed thoroughly and centrifuged at 12,000 g for
10 min. The aqueous layer was transferred to a new Eppendorf tube. The nucleic
acid was precipitated overnight at -20°C, after the addition of 2.5 volumes of ice-cold
100% ethanol and 0.1 volumes of sodium acetate (pH 5.2). The nucleic acid was
collected by centrifugation at 12,000 g at 0°C for 15 min. The pellet was then
washed in 80% ethanol and air dried at 42° for approximately 15 min. The dried
pellet was resuspended in 30 pi of nuclease free water (Ambion). During the process
known samples of positive and negative serum samples were extracted in parallel in
order to act as negative and positive controls to ensure that no contamination was
present.
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2.1.2 REVERSE TRANSCRIPTION OF VIRAL RNA
Complementary DNA (cDNA) can be synthesised from single-stranded RNA
using a reverse transcriptase reaction. Synthesis of cDNA was carried out using 5 pi
of extracted RNA, 10 Units of AMV reverse transcriptase (Promega), 40 Units of
RNasin Ribonuclease inhibitor (Promega), 1 mM each of dGTP, dATP, dTTP and
dCTP (Promega) and 0.5 pM of the antisense primer (also used in corresponding
PCR reaction) in a reaction buffer containing 50 mM Tris-HCl, pH 8.3, 50 mM KC1,
10 mM MgCl2,10 mM DTT and 2.5 mM spermidine. Each sample was covered with
a drop of liquid paraffin oil and incubated on a hot block at 48°C for 30 min followed
by 98°C for 2 min in order to inactivate the reverse transcriptase.
2.1.3 PCR AMPLIFICATION
The polymerase chain reaction (PCR) is a technique for the in vitro amplification
of specific DNA sequences by the simultaneous primer extension of complementary
strands of DNA. The sensitivity of PCR can be reduced when using low copy
number DNA template in which case nested, or hemi-nested, PCR can be used. In
this method the PCR is repeated using a pair of primers internal to the original
primers, or in the case of hemi-nested PCR, one new internal primer and the
opposing primer from the first PCR reaction. Hemi nested PCR was used to amplify
HGV/GBV-C 3'UTR and NS5B regions from the reverse transcribed cDNA product
of human serum (section 2.12). Single round PCR amplification was used to amplify
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subgenomic regions of both HGV/GBV-C and HCV from purified cloned cDNA as
the template copy number was higher (section 2.2.6). Internal primers were used for
single round PCR amplification of HGV/GBV-C and outer primers for HCV (Table
2.1).
The primary or single round PCR reaction was carried out in a 50 pi volume
containing 5 pi of cDNA template (section 2.1.2), 0.5 U of DNA Taq polymerase
(Promega), 0.3 mM each of dGTP, dATP, dTTP and dCTP and 0.25 pM of each
outer primer (sense and antisense primers) in PCR reaction buffer containing 50 mM
KC1, 10 mM Tris-HCl (pH 9.0), 0.1% Triton X-100 and 1.5 mM MgCl2. Each
sample was covered with a drop of liquid paraffin oil and transferred to a Techne
Genius thermal cycler.
The secondary PCR reaction was carried out in a 20 pi volume, using 1 pi of the
primary PCR reaction as the DNA template. 0.2 pM of each inner primer was used
and the reaction set up as previously for the primary PCR conditions.
Known positive and negative controls were included to check the integrity of the
reaction and to ensure that there was no contamination. A complete list of primer
sequences and annealing positions for each subgenomic region amplified is shown in
Table 2.1.
The template denaturation, primer annealing and strand elongation conditions for
the PCR amplification reaction were as follows. 30 cycles were performed in each
case:
HGV/GBV-C NS5B region and 3'UTR (first round): 94°C for 18 s; 58 °C for 21 s:
72 °C for 90 s
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HGV/GBV-C NS5B region (second and single round): 94°C for 18 s: 58 °C for 21
s: 72 °C for 90 s
HGV/GBV-C 3'UTR (second and single round): 94°C for 18 s: 55 °C for 21s: 72
°C for 90 s
HCV core gene and NS5B region (single round): 94°C for 18 s: 55 °C for 21s: 72
°C for 120 s
2.1.4 ANALYSIS OF PCR PRODUCT
The amplified DNA was visualised under UV light after electrophoresis through a
1% agarose gel in 1XTAE buffer stained with 0.07 pg/ml ethidium bromide (EtBr).
The gel was run for 30 min at 150V. Amplified DNA was detected due to the
presence of ethidium bromide, which intercalates into the DNA and exhibits
fluorescence under UV light.
2.2 CLONING OF PCR PRODUCT
2.2.1 USING pGEM-T EASY VECTOR
A number of thermostable polymerases, such as Taq DNA polymerase, add a
single deoxyadenosine (A), in a template independent manner, to the 3'-ends of PCR
amplified fragments. The pGEM-T EASY vector (Promega) is supplied pre-cut with
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EcoR V restriction enzyme and with the addition of deoxythymidine (T) to the 3'
terminus at both ends. This reduces the likelihood of vector re-ligation and provides
a compatible overhang for the terminal A produced by Taq polymerase.
The pGEM-T EASY vector contains the promoter and a small region of the (3-
galactosidase (P-gal) gene, known as the a-domain, into which the multiple cloning
site (MCS) is inserted. The competent cells produce P-gal peptide, which is
truncated at the N-terminus. The truncated peptide combines with the a-domain to
produce a functional P-gal protein. The cells are supplied with 5-bromo-4-chloro-3-
indolyl-P-D-galactsidase (X-Gal) (plus an inducer of the enzyme such as isopropyl-
thiogalactoside (IPTG)) which, as a substrate of the P-gal protein, is hydrolysed to
produce a precipitate that colours the colonies blue. When an insert is ligated into
the MCS of the vector the P-gal sequence is disrupted. This prevents the formation
of the functional peptide and white colonies are normally produced.
2.2.2 PREPARATION OF PCR PRODUCT FOR CLONING
The amplified DNA band was excised from the 1 % (w/v) agarose gel after
electrophoresis and purified using a QIAquick Gel Extraction Kit (QIAGEN),
following the manufacturers instructions. After excision the gel fragment was
weighed in a 1.5 ml microcentrifuge tube. 300 pi of solubilisation buffer QG were
added for every 100 mg of gel slice in order to dissolve the gel fragment and to
achieve an optimum pH for binding DNA to the silica-gel membrane. This was then
mixed vigorously by vortexing and the reaction incubated at 50°C for 10 min, or until
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the gel slice had completely dissolved. The DNA was then precipitated from
solution by the addition of 100 pi of isopropan-2-ol for every 100 mg of gel slice.
This was then added to a QIAquick spin column in a 2 ml collection tube and the
DNA bound to the silica-gel membrane by centrifugation at 12,000 g for 60 sec. The
flow through was discarded and any remaining traces of agarose were removed by
the addition of 500 pi of solubilisation buffer QG followed by centrifugation at
12,000 g for 60 sec. The flow through was again discarded and excess salts removed
by the addition of 0.75 ml of ethanol containing buffer PE, followed by
centrifugation at 12,000 g for 60 sec. The flow through was discarded and a final 60
sec centrifugation at 12,000 g removed any residual buffer. The column was placed
in a clean 1.5 ml microcentrifuge tube and 30 pi of nuclease free water was added to
the centre of the QIAquick spin column. After a 1 min incubation the DNA was
eluted by centrifugation at 12,000 g for 60 sec.
2.2.3 LIGATION OF INSERT USING pGEM-T EASY VECTOR
Each ligation was setup in a 0.75 ml microcentrifuge tube with 2pl of purified
HGV/GBV-C NS5B or 3'UTR PCR product (section 2.1.3), 5 pi of 2x rapid ligation
buffer (Promega), 1 pi of pGEM-T Easy vector (lpg/pl) (Promega), 1 pi of T4 DNA
ligase (3U/pl) (Promega) and made up to 10 pi with nuclease free water. This was
mixed by pipetting and incubated overnight at 4°C. A ligation control was setup
substituting the PCR product for 2 pi of control DNA (4ng/pl) supplied with the kit.
A background control was also set up, to test the integrity of the pGEM-T Easy
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vector T overhangs, in which the ligation was carried out with no insert DNA but the
total volume made up with nuclease free water.
2.2.4 TRANSFORMATION REACTION
JM109 competent cells (Promega) with the following genotype were used for the
transformation: endAl, recA 1, gyrA96, thi, hsdR17 (rk~,mk+), re/A 1, supE44, A(lac-
proAB), [F', traD36, proAB, /nglqZAM15].
The ligation mix was centrifuged briefly to collect the reaction mix at the bottom
of the tube, 2 pi of which was transferred to a 1.5 ml microcentrifuge tube on ice.
Competent cells were thawed on ice for about 5 min and mixed by gently flicking the
tube. 50 pi of the competent cells were transferred to the aliquoted ligation reaction,
mixed by flicking the tube and incubated on ice for 20 min. The tube was then heat
shocked for 45 s at 42°C and returned to the ice for 2 min. 950 pi of SOC medium
was then added and the tube incubated at 37°C for 1.5 h in an orbital incubator at
12,000 g.
Luria Broth (LB) agar plates, containing 100 pg/ml ampicillin, 0.5 mM (IPTG) and
80 pg/ml X-Gal were prepared. Ampicillin (Sigma) was used for selection to ensure
the presence only of those transformants with the plasmid containing the ampicillin
resistance gene (P-lactamase).
After incubation 100 pi of the transformed cells were plated out on the LB agar
selective plates and incubated overnight at 37°C.
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2.2.5 SCREENING OF TRANSFORMANTS FOR DNA INSERTS
Successful cloning of an insert into the pGEM-T Easy vector leads to the
disruption of the fi-gal gene, which usually results in white colonies on an LB
selective plate. White colonies were screened for the presence and orientation of
HGV/GBV-C NS5B and 3'UTR cDNA inserts by single round PCR amplification
(section 2.1.3).
A sterile toothpick was used to transfer the edge of a white colony into a 0.5 ml
PCR tube containing 20 pi of PCR mix (0.3 U of DNA Taq polymerase (Promega),
0.3 mM each of dGTP, dATP, dTTP, and dCTP and 0.25 pM of each primer (sense
and antisense primers). In order to determine the insert orientation primers were
designed to amplify across the MCS boundary; with one designed to hybridize to the
vector and the other to the cDNA insert itself (primer sequences and annealing
positions are shown in table 2.1). PCR amplification was performed across both the
T7 (5') and SP6 (3') boundary of the pGEM-T Easy vector construct so that each
colony was checked twice, for both positive and negative PCR amplification. Each
solution was covered with a drop of liquid paraffin oil and placed on a Techne
Genius thermal cycler for 30 cycles of 94°C for 30 s, 50°C for 90 s and 72°C for 120
s. The samples were then analysed by electrophoresis through a 1% agarose/TAE
gel (w/v) containing 0.07 pg/ml EtBr next to a molecular weight marker for
reference (2.1.4). Recombinant transformants of the appropriate size and orientation
were identified and the corresponding colonies on the agar plate selected.
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2.2.6 PREPARATION OF PLASMID DNA
A sterile toothpick was dabbed on the edge of selected recombinant transformant
colonies. This was then used to inoculate 3 ml of LB broth containing 100 pg/ml
ampicillin. The inoculated culture media was incubated at 37 °C overnight in an
orbital incubator at 150 g.
The plasmid DNA was collected and purified from the overnight culture using a
QIAprep miniprep (QIAGEN) following the manufacturers instructions and using the
buffers provided. The bacterial cells were harvested from the overnight culture by
centrifugation at 9,000 g for 5 min, after which the pelleted cells were retained and
the supernatant discarded. The bacterial pellet was resuspended in 250 pi of buffer
PI, containing RNase A. The cells were lysed using an alkaline lysis method by the
addition of 250 pi of buffer P2 following which the tube was inverted a number of
times. After 5 min the lysis reaction was terminated by the addition of 350 pi of
buffer N3, this buffer also increases the salt concentration of the suspension,
optimising the conditions for DNA adsorption to silica gel within a spin column.
The lysate was then cleared by centrifugation at 12,000 g for 10 min and the
supernatant applied to a QIAprep spin column. The plasmid DNA was bound to the
silica gel by centrifugation at 12,000 g for 1 min and the flow through discarded.
The bound plasmid DNA was washed by the addition of 0.5 ml of buffer PB
followed by centrifugation at 12,000 g for 1 min, which removed any endonucleases
that may have been released during cell lysis. After the flow though was discarded,
salt was removed from the plasmid DNA by the addition of 0.75 ml of ethanol
containing buffer PE followed by centrifugation at 12,000 g for 1 min. The flow
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through was discarded and the columns were again by centrifugation at 12,000 g for
1 min to remove any residual wash buffer. The spin column was placed in a clean
1.5 ml collection tube and 50 pi of nuclease free water was added to the centre of the
QIAquick gel. After 1 min incubation the plasmid DNA was eluted by
centrifugation at 12,000 g for 1 min.
2.2.7 DNA SEQUENCING
The nucleotide sequence of each cDNA insert within the purified plasmid DNA
constructs was determined by cycle sequencing, which also further confirmed the
orientation of the cDNA insert. Sequencing was carried out in the presence of
limiting radiolabeled dideoxynucleoside triphosphates (ddNTPs) which terminate
synthesis at specific bases. Sequencing was performed using the "Thermo
Sequenase™ Radiolabeled Terminator Cycle Sequencing Kit" supplied by United
States Biochemical (USB). Thermo Sequenase DNA polymerase was used for strand
extension. This enzyme was created by in vitro genetic manipulation and is a variant
of bacteriophage T7 DNA polymerase, without 3' or 5' exonuclease activity. The
enzyme is particularly suited to this activity as it is able to efficiently incorporate
strand terminating ddNTPs.
The reaction was performed directly using cloned cDNA as template and involved
the incorporation of one of four terminating [a-33P]ddNTPs into the sequencing
reaction products at the 3'end. In the case of PCR product, the template was pre-
treated with combination of Exonuclease I (Exol) and Shrimp Alkaline Phosphatase
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(SAP) to eliminate any primer or dNTPs which were not incorporated into the PCR
product (both enzymes were supplied by USB). Pre treatment of PCR amplification
product was carried out in a 10 pi volume containing 5 pi of PCR product
(approximately 100 ng/pl), 2 U of SAP, 10 U of Exol and made up to 10 pi with
nuclease free water (Ambion). The reaction mix was incubated at 37°C for 15 min
before denaturing at 80°C for a further 15 min.
A termination mix was prepared for each dNTP in separate 0.5 ml eppendorf tubes
each containing 1 pi of nucleotide master (7.5 pm each of dATP, dCTP dGTP and
dTTP ), 0.5 pi of the appropriate [a-33P]ddNTP (0.45 pCi/pl) (Amersham) and
made up to 2.5 pi with nuclease free water (Ambion). A reaction mixture was set up
containing 2 pi of reaction buffer (260 mM Tris-HCl, pH 9.5 65 mM MgCh), 0.15
mM of the appropriate primer, 4 U of Thermo Sequenase polymerase and made up to
20 pi with nuclease free water. The cycle termination reactions were then prepared
in four separate 0.5 pi eppendorf tubes (one for each [a-33P]ddNTP), each
containing between 100 - 200 ng ofDNA template, 4 pi of reaction mixture, 2.5 pi
of termination mix and made up to 10 pi with nuclease free water. Each termination
reaction was covered with a drop of liquid paraffin and transferred to a Techne
Genius thermal cycler for 30 cycles of 95°C for 30 sec, 55°C for 30 sec and 72°C for
30. 6 pi of each termination reaction was transferred to a fresh 0.5 ml Eppendorf
tube containing 4 pi of denaturing stop solution (95 % formamide, 20 mM EDTA,
0.05 bromophenol blue, and 0.05% xylene cyanol).
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2.2.8 ANALYSIS OF SEQUENCING PRODUCT
Sequencing products were analysed by electrophoresis through a 5% denaturing
acrylamide gel. The quality of electrophoresis gel is an important factor which limits
the extent of sequence information that can be determined from a sequencing
experiment. Consequently, electrophoresis grade reagents were used and glass plates
cleaned by swabbing with ethanol, methanol and acetone prior to pouring the gel.
The gel contained the following reagents: 21 g urea (Ana-BDH), 5% v/v Ultrapure
Sequagel concentrate (acryhbis-acryl = 19:1) (National Diagnostics) 5 ml of 10x
Sanger TBE, 0.05 g ammonium persulphate and distilled water up to 50 ml. When
all the urea had dissolved 20 pi of TEMED (N,N,N,N-tetramethylethlediamine)
(Sigma) was added and the gel solution was poured into the plate assembly.
Gels were prepared at least 2 hours prior to use and were pre-run for 15 min in 1 x
Sanger TBE electrophoresis buffer before loading the samples. Prior to loading
samples were denatured by heating at 95 °C for 5 min. Gels were run for between 1
and 3 hours, depending on the fragment size of interest. Gels were dried and
exposed overnight on BIOMAX autoradiography film (Eastman Kodak).
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2.3 TRANSCRIPTION IN VITRO
2.3.1 LINEARISATION OF PLASMID TEMPLATE
T7 and SP6 DNA dependent RNA polymerases were originally isolated from
bacteriophage infection of their respective Escherichia coli (E. coli) hosts. They are
both template dependent polymerases with distinct and highly specific promoter
requirements. Before cloned DNA can be used as a template for transcription in
vitro it must be linearised, by restriction digest downstream of the insert DNA, to
prevent the RNA polymerase reading through the insert into the vector sequence.
10 pg of purified plasmid DNA template containing either HGV/GBV-C NS5B
region or 3'UTR cDNA inserts were incubated with 5 U of Spe I restriction enzyme
(Promega), 2 pi of 10 x reaction buffer B (Promega) and made up to 20 pi with
nuclease free water. The reaction was mixed by pipetting and incubated for 3 hrs at
37°C
2.3.2 PREPARATION OF LINEAR PLASMID FOR TRANSCRIPTION IN
VITRO
The plasmid digestion mix was made up to 200 pi with DEPC-water. 200 pi of
phenol (Sigma) was added and the tube vortexed. After centrifugation at 12,000 g
for 5 min the aqueous layer was transferred to a new microcentrifuge tube,
containing 200 pi of chloroform, which was again centrifuged at 12,000 g for 5 min.
71
The aqueous layer was then transferred to a new microcentrifuge tube and
precipitated at -20°C after the addition of 2.5 volumes of 100% ethanol and 0.1
volumes of sodium acetate (3.5M, pH 8). The DNA was collected by centrifugation
at 12,000 g for 15 min. The supernatant was removed and the pellet washed by the
addition of 500 pi of 70% ethanol (nuclease free) followed by centrifugation at
12,000 g for 15 min. The supernatant was removed and the pellet dried for 5 min at
90 and then resuspended in 20 pi of nuclease free water.
2.3.3 IN VITRO TRANSCRIPTION
The transcription reaction was performed with a "T7 MEGAscript high yield
transcription kit" (Ambion), according to the manufacturers instructions. Firstly the
10 x reaction buffer and four ribonucleotides (ATP, CTP, GTP and UTP) were
vortexed and briefly centrifuged. The ribonucleotides were then stored on ice along
with the T7 RNA polymerase enzyme. The reaction was then set up in an RNase
free 0.75 ml microcentrifuge tube containing (7.5 mM) of each ribonucleotide either
1 pg of linear cloned cDNA or 0.1-0.2 pg of T7 annealed PCR product, 2 pi of 10x
reaction buffer (Ambion), 2 pi of T7 RNA polymerase enzyme mix (Ambion) and
made up to 20 pi with nuclease free water (Ambion). The reaction was then mixed
by gently flicking the tube, centrifuged briefly and incubated overnight at 37°C.
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2.3.4 PURIFICATION OF RNA
The transcribed RNA was treated with 2 U of DNase I (Ambion) for 30 minutes at
37°C in order to remove the DNA template and then made up to 200 pi with 15 pi of
5 M ammonium acetate and 164 pi of nuclease free water (Ambion). 200 pi of low
pH phenol (pH 4.5) was then added and the tube vortexed. After centrifugation at
12,000 g for 5 min the aqueous layer was transferred to a new microcentrifuge tube,
containing 200 pi of chloroform, which was again vortexed and centrifuged at
12,000 g for 5 min. The aqueous layer was transferred to a new microcentrufuge
tube and the RNA precipitated for 15 min at -20 °C after the addition of 1 equal
volume of isopropan-2-ol. The RNA was then collected by centrifugation at 12,000
g for 15 min and the pellet dried for 5 min at 90 °C. The dried pellet was
resuspended in 20 pi of nuclease free water with lpl of Anti-RNAse (Ambion).
2.3.5 ANALYSIS OF TRANSCRIPTION PRODUCT
1 pi of purified RNA was analysed by electrophoresis through a 5% acrylamide
(acryl: bis-acryl = 19:1), denaturing (7 M urea) gel in lxTAE buffer against an RNA
molecular weight marker (Century Marker Plus or Millennium Marker) (Ambion) in
order to check the size and integrity of the transcription products. 1 pi of purified
transcription product was made up to 20 pi with 14 pi of nuclease free water and 5 pi
of loading buffer (95% formamide, 0.025% xylene cyanol, 0.025% bromophenol
blue, 18 mM EDTA and 0.025% SDS) (Ambion). This was then heated to 95°C for
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2 min, in order to denature the RNA, and run on a 5% denaturing acrylamide gel for
60 min at 150 V.
The RNA was visualised by staining the gel in a tank for 1 hour under a solution of
methylene blue (0.04 % methylene blue (w/v), 0.5 M sodium acetate) and then
rinsing with distilled water. Alternatively the integrity of 1 pi of purified RNA was
assessed by visualisation under UV light after electrophoresis through a 1% (w/v)
agarose gel in lxTAE buffer with 0.07 pg/ml ethidium bromide.
2.4 TRANSMISSION ELECTRON MICROSCOPY
2.4.2 RNA ADSORPTION AND ELECTRON MICROSCOPY
Purified HGV/GBV-C NS5B, 3'UTR or complete genome transcript RNA was
diluted to 3 pg/ml in a volume of 150 pi with nuclease free water. MgCl2 and NaCl
were added to a final concentration of 10 mM to stabilise RNA secondary structures.
Approximately 1.2 xlO13 molecules of biotinylated oligonucleotides were hybridised
to specific stem loop structures (Table 1.2). The mix was then heated to 70 °C for 5
min and cooled slowly to room temperature for approximately 2 hours to allow RNA
structures to reform and overlain with 10 nm streptavidin-coated gold particles.
RNA was then adsorbed onto a carbon film and negatively stained with a solution of
uranyl acetate (2 %, w/v, pH 4.5), (Agar), (Fig. 2.1). 200 pi drops of diluted RNA,
nuclease free water and uranyl acetate were placed on individual segments of
parafilm. A 3 mm square segment of carbon covered mica was dipped into the RNA
74
Table 2.2 Biotinylated oligonucleotides used for hybridisation to RNA structures in
HGV/GBV-C.





NS5B SLNS5BIII 8710-8723 GCCAACTCCGCCCA
NS5B SLns5BIV 8560-8573 GCTGCCGGTCCGTG
3'UTR 3'SLII 9176-9190 CCCCTCAAATCACA
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droplet for 60 sec, to allow the adsorption ofRNA onto the carbon film. The carbon
covered mica was then washed in the nuclease free water for 10 sec and negatively
stained for 90 sec in the uranyl acetate droplet. The carbon film was then mounted
on a gold plated copper mesh grid (300 mesh) (Agar) and dried on blotting paper for
1 hour. Micrographs were recorded on Agfa Scientia 23D56 electron image film
electron image sheet films at calibrated magnification on a Philips CM10
transmission electron microscope operated at 100 kV.
2.5. NUCLEASE MAPPING OF RNA SECONDARY STRUCTURE
2.5.1 PARTIAL NUCLEASE DIGESTION OF RNA
4pg of HCV core gene or NS5B RNA transcript was made up to 53.4 pi with
nuclease free water and 6 pi ofRNA structural buffer (10 mM Tris pH 7, 100 mM
KC1, 10 mM) (RNA structural analysis kit, Ambion), melted at 70 °C for 5 min
and then cooled at room temperature for 45 min. After the addition of 6 pg of yeast
carrier RNA (10 pg/pl), (RNA structural analysis kit, Ambion) 9pl of the reaction
mix was aliquoted into six individual 0.75 ml microcentrifuge tubes for nuclease
digestion. 1 pi of nuclease free water was added to tube 1, 1 pi of RNA nuclease Ti
(RNA structural analysis kit, Ambion) was added to tubes 2 and 3 at 0.02 U/pl
and 0.14 U/pl respectively. The same procedure was followed for tubes 4 to 6 but
using RNA nuclease V] (RNA structural analysis kit, Ambion) at 0.005 U/pl and
0.002 U/pl. The digestion was run at room temperature for 15 min before being
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stopped by the addition of 20 pi of inactivation/precipitation solution (RNA
structural analysis kit, Ambion) followed by alcohol precipitation as described in
section 2.3.4.
2.5.2 PRIMER EXTENSION BY REVERSE TRANSCRIPTION
1 pg of resuspended RNA was made up to 10 pi with 1 pg of one of three reverse
primers for each subgenomic region (table 2.1) and nuclease free water. The RNA
was then heated to 70 °C for 5 min and cooled quickly on ice to minimise the
formation of structure and allow the hybridisation of primer to template. The reverse
transcription reaction was then set up by the addition of 12.5 mM each of dGTP,
dTTC and dCTC (Promega), limiting [a-33P]ATP (10 pCi/pl) (Amersham), 5 pi of
reaction buffer (50 mM Tris-HCl (pH 8.3 at 25°C), 75 mM KC1, 3 mM MgCl2,
5 mM DTT) (Promega), 25 U RNasin (Promega), 200 U of M-MLV reverse
transcriptase (RNase H deficient) (Promega) and made up to 25 pi with
nuclease free water. Each sample was then covered with a drop of paraffin,
incubated at 42 °C for 60 min and chased after 20 min by the addition of 12.5 mM
ofdATP.
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2.5.3 PREPERATION OF RADIOLABLED cDNA FOR ANALYSIS
In order to remove excess salt, which would decrease band resolution when the
cDNA was analysed by electrophoresis, the radiolabeled cDNA product was purified
using a QIAquick PCR Purification kit (QIAGEN) following the manufacturers
instructions and using the buffers provided.
Five volumes of buffer PB were added to 1 volume of cDNA product in order to
achieve an optimum DNA binding pH for silica-gel binding. This was then added to
a QIAquick spin column in a 2 ml collection tube and the cDNA bound to the silica
gel by centrifugation at 12,000 g for 30 sec. The flow through was discarded and
excess salt removed from the cDNA by the addition of 0.75 ml of ethanol containing
buffer PE, followed by centrifugation at 12,000 g for 30 sec. The flow through was
discarded and a final centrifugation at 12,000 g for 30 sec removed any residual
buffer. The column was placed in a clean 1.5 ml microcentrifuge tube and 30 pi of
nuclease free water was added to the centre of the QIAquick gel. After a 1 min
incubation the cDNA was eluted by centrifugation at 12,000 g for 60 sec.
2.5.3 ANALYSIS OF RADIOLABELED cDNA
Purified radiolabeled cDNA was analysed by electrophoresis through a 5 %
acrylamide gel (w/v) (acryl: bis-acryl = 19:1), denaturing (7 M urea) gel in 1 x
Sanger TBE buffer against radiolabeled cycle sequencing products of the same DNA
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sequence in order to map primer extension termination products to defined genome
regions.
4 pi of cDNA product was made up to 7 pi with denaturing loading buffer (95 %
formamide (v/v), 0.05% xylene cyanol (v/v), 0.05 % bromophenol blue (w/v), 20
mM EDTA (w/v)). This was then heated to 95 °C for 5 min, in order to denature the
cDNA and analysed on a 5 % (w/v) acrylamide gel for between 2 hrs 30min and 60
min depending on the length of the cDNA to be analysed. Gels were dried and
exposed overnight on BIOMAX autoradiography film (Eastman Kodak), (see
section 2.2.8 for full details of this procedure)
2.6. THERMODYNAMIC PREDICTION OF FOLDING FREE ENERGY
(FFE) AND RNA STRUCTURE PREDICTION
Prior to analysis all sequences were aligned by hand using the SIMMONIC
sequence editor package (Simmonds and Smith 1999). All FFE calculations were
determined using MFOLD 3.1 (http://.bioinfo.rpi.edu/~zukerm/), using the
implementation available in the program ZEPFOLD on default setting which allow
FFEs of RNA sequences to be rapidly determined (Zuker 2003). MFOLD and
ZIPFOLD provide computational speed and accuracy of structural prediction
independently of comparative sequence information required by phylogenetic
structure prediction methods. In order to calculate folding free energy differences
(FFED) the FFE of each native sequence was compared to those of 50 independent
sequence randomisations of the original sequence.
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All sequence randomisation methods were carried out using the SIMMONIC
sequence editor package. A number of sequence randomisation algorithms were
implemented including those which preserve dinucleotide frequencies and local
biases (CDR and CDS), three codon orientated randomisation methods (CLR, CLS
and COS) and a standard nucleotide randomisation method. The GenBank
Accession numbers of all sequences analysed is shown in appendix.
Specific structural predictions of RNA secondary structure were made for those
regions of the polyprotein coding regions showing suppression of synonymous
substitutions, clustering of covariant substitutions and excess FFEDs from sequence
order randomised controls. In practice this meant the core gene of HCV and the
NS5B regions of both HCV and HGV/GBV-C; predictions were also made for the
3'UTR region of HGV/GBV-C. Conservation of each structure was assessed by
parallel folding of each region in all available epidemiologically unlinked complete
genome sequences and comparison of covariant and semi-covariant substitutions.




FOLDING FREE ENERGY DIFFERENCES
3.1 INTRODUCTION
A number of previous investigations have attempted to reconstruct times of
divergence between genotypes of both HCV (Ogata et al., 1991; Okamoto et al.,
1992; Abe et al., 1992; Smith et al., 1997b), and HGV/GBV-C (Nakao et al., 1997;
Khudyakov et al., 1997), based on estimated rates of sequence change within
chronically infected individuals over time or between divergent virus genotypes.
Such studies have revealed that a number of constraints on sequence change appear
to act on the genomes of both viruses; limiting the use of such a "molecular clock"
based approach in calculating rates of divergence over time (more detail in section
1.9) (Smith and Simmonds, 1997a; Tuplin et al., 2002).
In HCV it was shown that synonymous variability, although generally presumed to
be selectively neutral, was suppressed within subgenomic regions of the virus
genome (Ina et al., 1994; Smith and Simmonds, 1997a; Tuplin et al., 2002). The
greatest constraints on synonymous variability were observed across the core gene
and NS5B region; within the 5' and 3' coding regions of the virus respectively
(Smith and Simmonds, 1997a; Tuplin et al., 2002). Even greater constraints on
sequence divergence have been observed in HGV/GBV-C (Simmonds and Smith,
1999b; Cuceanu et al., 2001). In particular, a large disparity between the short- and
long-term rates of sequence change has been noted (Simmonds and Smith, 1999b).
In contrast to HCV, constraints on variability at synonymous sites have been
observed along the length of the virus genome and were more extreme. In further
analysis, of divergent genotypes, it was noted that covariant substitutions clustered
within regions of suppressed synonymous variability within the genomes of both
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viruses, yet were again more numerous in HGV/GBV-C than HCV (Smith and
Simmonds, 1997a; Simmonds and Smith, 1999b; Cuceanu et al., 2001).
It has been suggested that these observed constraints on sequence change may
result from the presence of evolutionarily conserved RNA structure (Smith and
Simmonds, 1997a; Simmonds and Smith, 1999b). In a folded genome, sequence
change in regions that are internally base paired would require simultaneous
nucleotide substitutions on either side of stem loop structure to maintain base pairing.
It would also lead to a much lower rate of sequence change than in unpaired regions,
as sites in which substitutions would not disrupt RNA structure will quickly become
saturated. Whilst these results are consistent with the presence of conserved RNA
structure within the genomes of both viruses, the more extreme biases observed in
HGV/GBV-C are suggestive of more extensive structure than within the genome of
HCV.
In the present study, in order to investigate the extent of sequence dependent RNA
structure within the genomes of HCV and HGV/GBV-C, folding free energy (FFE)
was determined across the virus genomes and was compared to that of 50
independently generated sequence order controls for corresponding regions. The
difference between the two figures (FFED) provides an estimate of excess folding
free energy across the length of the virus genome which was shown to be indicative
of sequence dependent RNA structure.
The evolutionary conservation of potential sequence dependent RNA structures
was assessed through folding representative examples of each of the major genotypes
for both HCV (genotypes 1-6) and HGV/GBV-C (genotypes 1-4). However, the
diversity between HGV/GBV-C genotypes is much less than that observed for HCV
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(approximately 14% compared to 31-34%). Consequently GBV-A and GBV-B were
analysed as out-groups, as they have similar genome organisations to HG/GBV-C
and HCV respectively, yet show much greater divergence (approximately 40%). A
recently isolated chimpanzee homologue (HGV/GBV-Ccpz), which shows
intermediate divergence between HGV/GBV-C and GBV-A was also analysed as a
further out-group.
Prior to analysis the complete genome sequences of HCV (genotypes 1-6),
HGV/GBV-C (genotypes 1-4), GBV-A and GBV-B were aligned by hand using the
Simmonic 2000 package (Simmonds and Smith, 1999b), (See appendix for a list of
sequences examined). The virus genomes were then split into 498 base fragments
overlapping by 249 bases, in order to retain codon integrity, and 50 independent
nucleotide randomisations made (randomisation methods explained in section 3.2.1).
The FFE of each randomised sequence was then compared to that of each native
sequence in order to make an estimate of FFED.
All FFE calculations were determined using MFOLD 3.1
(http:www.bioinfo.rpi.edu/~zukerm/) using the implementation available in the
program ZIPFOLD (Zuker, 2003). MFOLD calculates the minimum FFE of a given
sequence based on the sum of the contribution of nucleotide pairings, stacking and
stem loop lengths (Rivas and Eddy, 2000; Zuker, 2000). The contribution of each
nucleotide pairing (the "nearest neighbour" rules) to the overall free energy of a
sequence is derived from experimental melting data (Mathews et ah, 1999). MFOLD
does not take into account higher order structures such as pseudoknots.
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3.2 RESULTS
In order to investigate the existence of RNA structure within the polyprotein
coding regions of HCV (genotypes 1-6) and HGV/GBV-C (genotypes 1-4) a
comparison of FFE with those of sequence order randomised controls was made
(Tuplin et al., 2002; Cuceanu et ah, 2001). As a comparison GBV-B and GBV-A
were also analysed, as they are divergent from HCV and HGV/GBV-C yet maintain
similar structural organisation (Leary et ah, 1996; Linnen et ah, 1996).
3.2.1 SEQUENCE ORDER RANDOMISATION
It has previously been proposed that local base composition heterogeneity and
biased dinucleotide distribution may result in artefactualy high FFEDs that are not
the result of a sequence that evolved to produce stable RNA structure (Workman and
Krogh, 1999; Rivas and Eddy, 2000). Consequently, in this study we developed and
used a number of the sequence order randomisation methods in order to overcome
these compounding effects (Tuplin et ah, 2002).
1. Nucleotide order randomisation (NOR): Nucleotide order was randomised
with no account of local nucleotide or codon composition. This is the standard
method used in most previous studies.
2. Codon order randomisation (COR): Codon order was randomised, thus
avoiding the disruption of sequence order within triplets.
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3. Like codon randomisation (CLR): Randomisation of codons for each specific
amino acid. Following randomisation the amino acid sequence remained the
same.
4. Like codon swap (CLS): Pairwise exchange of neighbouring codons specifying
each specific amino acid; may only be applied twice to a given native sequence.
Following randomisation the amino acid sequence remained the same and there
was little disruption of local nucleotide biases.
5. Dinucleotide randomisation (CDR): Randomisation of each set of codons with
identical first and third bases. Following randomisation the dinucleotide
sequence remained the same but the amino acid sequence was changed.
6. Dinucleotide swap (CDS): Pairwise exchange of neighbouring codons with
identical first and third bases; may only be applied twice to a given native
sequence. Following randomisation the dinucleotide sequence remained the
same, the amino acid sequence was changed and there was little disruption of
local nucleotide biases.
The difference in FFE of a native sequence to a set of randomised sequences has
been shown to approximate to a normal distribution, with mean of zero and a
standard deviation of + and -1 (Workman and Krogh, 1999; Rivas and Eddy, 2000).
Consequently, the FFED between the native and randomised sequences was
expressed as a Z-score (Workman and Krogh, 1999), which is the number of
standard deviations between the free energy on folding the native sequence and the
mean of the randomised sequences. This method took into account the range of
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values between independent randomisations as well as just the difference in folding
free energy to the native sequence. Z-scores of less than -2.33 were taken as being
statistically significant at 1% for sequence order dependent RNA structure
(Workman and Krogh, 1999). It was possible to determine Z-scores using the
randomisation methods NOR, COS, CLR and CDR, as each was able to produce a
multiple set of independent randomised sequences (Fig. 3.1). The nucleotide
swapping methods CLS and CDS only generate two randomised sequences,
preventing the calculation of a Z-score (Fig. 3.1).
3.2.2 CONTROL FOLDING FREE ENERGY INVESTIGATIONS
In order to investigate the effect of the six sequence order randomisation methods
on FFED each method was applied to a range of mammalian sequences with no
known or likely RNA secondary structure (the coding regions of mammalian
albumin, actin, HLA class II and alpha-globin genes) (Fig. 3.1) (Cuceanu et ah,
2001; Tuplin et ah, 2002). These were compared to sequences in which RNA
secondary structure had previously been demonstrated by analysis of covariant
substitutions and reduction in synonymous variability (FIGV/GBV-C coding regions
1-500 and 8001-8500 (Simmonds and Smith, 1999b; Cuceanu et ah, 2001); HCV
coding regions 1-500 and 8501-9000 (Han and Houghton, 1992; Smith and
Simmonds, 1997a; Hofacker et ah, 1998; Tuplin et ah, 2002)) (Fig. 3.1).
Each of the six randomisation methods produced comparable FFEDs between the
native and randomised sequences. None of the results for the mammalian sequences
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Figure 3.1. A: Differences in folding free energy between native mammalian
(albumin, actin, HLA class II, alphaglobin) and viral coding sequences (5' and 3'
ends of HGV/GBV-C and HCV) and those between six different randomisation
methods (NOR, COR, CLR, CLS, CDR and CDS). B: Corresponding Z-scores for
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produced a positive difference above 3% (Fig. 3.1A). For those methods from which
Z-scores could be calculated (NOR, COR, CLR and CDR), the values were limited
to above -1, indicating no significant FFEDS between the randomised and native
sequences (Fig. 3.IB). Large differences were observed between the randomised and
native sequences for both regions of FIGV/GBV-C and HCV (Fig. 3.1). For both the
5' and 3' coding regions of HGV/GBV-C analysed the FFED by each of the six
methods ranged from 10 to 17% (Fig. 3.1 A); Z-scores ranged from -3.7 to -5.1,
indicating a significant difference in folding free energy between the randomised and
native sequences (Fig. 3.IB). Similar results were obtained for the 5' and 3' coding
regions ofHCV, with difference for each of the six methods ranging from 10 to 15%
(Fig. 3.IB); Z-scores ranged from -3.4 to -6.3, again indicating a significant FFED
between the randomised and native sequences (Fig. 3.IB).
These results provide evidence for sequence order dependent RNA secondary
structure within the 5' and 3' coding regions of both HGV/GBV-C and HCV (Tuplin
et al., 2002). They are also comparable to those observed for other viruses with well
defined secondary structure such as plant viroids and the non-coding region of
hepatitis delta virus; in which free energy differences of between 15% and 20% were
observed, using the NOR method of sequence randomisation (Cuceanu et ah, 2001).
The similarity in excess folding free energy between the randomised and native
sequence (and Z-scores where calculable) using the six different methods indicated
that disruption of codon composition, dinucleotide frequencies or local differences in
base composition did not account for the differences observed in the viral sequences
(Tuplin et ah, 2002).
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3.2.3 FOLDING FREE ENERGY DIFFERENCES ALONG THE COMPLETE
HCV POLYPROTEIN CODING REGION
As each of the six methods of calculating excess FFEDs gave comparable results
the two least disruptive methods, that allowed Z-scores to be calculated, were used
(CLR and CDR) for more detailed analysis of complete virus genomes. The
polyprotein coding regions of HCV, genotypes la, 2a, 3a, 4a, 5a and 6a, were split
into 498 base fragments overlapping by 249 bases (36 fragments over an alignment
length of 9168 bases). Excess free energy on folding was compared between each
native sequence and a set of 50 independently randomised sequence replicates, using
both the CLR and CDR methods (Fig. 3.2). In each of the genotypes FFEDs
between 6.2% and 8.8% was observed across the polyprotein coding region between
the native and randomised sequences (mean values CLR: 7.8%, CDR: 6.9%; mean Z-
scores: CLR: -2.6, CDR: -2.3).
In order to localize potential sequence dependent RNA secondary structure to
defined regions of the HCV genome the mean values of each of the six genotypes
were plotted against genome position (Fig. 3.3A). The greatest FFEDs were
observed towards the 5' (fragments 1-498 and 251-749) (CLR; 9.5%, CDR: 10.5%;
mean Z-scores: CLR -4.1, CDR -3.5) and 3' (fragments 7251-7749 and onwards)
(CLR; 11.8%, CDR: 10.7%; mean Z-scores: CLR -3.5, CDR -3.9) extremes of the
polyprotein coding region.
In order to investigate possible sequence dependent secondary structure within the
replication intermediate of the HCV genome parallel testing of the reverse
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Figure 3.2: Mean differences in folding free energy of 498-base fragments spanning
viral genome of HCV genotypes la-6a, and GBV-B, using two randomisation
methods (column 1 CLR and column 2 CDR). For each sequence, columns 1 and 3
correspond to CLR; 2 and 4 to CDR. For each sequence, columns 1 and 2
correspond to native sequence; 3 and 4 to reverse compliment. Z-scores indicated by
shading.
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compliment sequence was performed. The antisense genomes showed consistently
lower FFEDs between randomised and native sequences than was observed for their
sense orientation equivalents (Figs. 3.3B). In each of the six genotypes examined
levels of FFEDs between 3.0% and 6.3% were observed across the antisense
polyprotein coding region (mean values CLR: 4.5%, CDR: 3.7%; mean Z-scores:
CLR:-1.5, CDR:-1.2). This low excess free energy on folding was observed across
all windows of the antisense genome. Values only consistently rose above 6%, in
two fragments towards the 5' (fragment 251-749) (CLR; 6.2%, CDR: 7.4%; mean Z-
scores: CLR -2.1, CDR -2.5) and 3' (fragment 8670-9168) (CLR; 8.0%, CDR: 6.3%;
mean Z-scores: CLR -2.7, CDR -2.0) ends of the antisense polyprotein coding
region. In no fragments were Z-scores for both methods within the level of statistical
significance for the HCV replication intermediate.
3.2.4 FOLDING FREE ENERGY DIFFERENCES ALONG THE COMPLETE
GBV-B POLYPROTEIN CODING REGION
GBV-B exhibited a similar levels of FFEDs between the native and randomised
sequences as that observed for HCV (Fig. 3.2 and 3.4A), with a mean excess across
the polyprotein coding region of 8.5% using the CLR method and 7.4% using CDR
(Z-scores: CLR -2.6, CDR -2.3). The greatest differences were again observed
towards the 5' (fragments 1-498 to 751-1249) (CLR; 11.1%, CDR: 9.7%; mean Z-
scores: CLR -3.8, CDR -2.9) and 3' (fragments 7001-7499 and 7751-8249) (CLR;
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13.7%, CDR: 13.4%; mean Z-scores: CLR -2.2, CDR -3.9) extremes of the
polyprotein coding region.
The reverse compliment replication intermediate of GBV-B showed much lower
levels of FFED than the positive sense sequence (Fig. 3.4B), with a mean excess of
5.1% using the CLR methods and 3.6% using CDR (Z-scores: CLR -1.5, CDR -1.1).
Low FFEDs were observed across all windows of the antisense genome, with values
only rising above 6%, for both methods, towards the 3' extreme of the sequence.
Two fragments within this region (7000-7500 and 7250-7750) consistently exhibited
both FFEDs above 8% and statistically significant Z-scores (mean Z-scores: CLR -
3.4, CDR -3.2).
3.2.5 FOLDING FREE ENERGY DIFFERENCES ALONG THE COMPLETE
HGV/GBV-C AND GBV-A POLYPROTEIN CODING REGION
The polyprotein coding regions of HGV/GBV-C, genotypes 1, 2, 3 and 4, and
GBV-A were divided into 35 and 36 fragments respectively, each measuring 498
bases in length and overlapping by 249 bases. The FFEDs of each sequence were
analysed using the CLR and CDR algorithms, following the same methodology as
previously used for HCV and GBV-B.
In each of the HGV/GBV-C genotypes FFEDs of between 9.5% and 13.2% were
observed across the polyprotein coding regions (mean values CLR: 11%, CDR:
12.1%; mean Z-scores: CLR: -3.7, CDR: -4.1) (Fig. 3.5). Differences were
consistently high across the length of the genome (Fig. 3.6A). However, the greatest
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Figure 3.5. Mean differences in folding free energy of 498-base fragments spanning
viral genome of HGV/GBV-C genotypes 1-4, and four examples of GBV-A, using
two randomisation methods (CLR and CDR). For each sequence, columns 1 and 3
correspond to CLR; 2 and 4 to CDR. For each sequence, columns 1 and 2
correspond to native sequence; 3 and 4 to reverse complement. Z-scores are
indicated by shading.
HGV 1 HGV 2 HGV 3 HGV 4 GBV-A GBV-A GBV-A GBV-A
NC_001837 U22303 AF023425 AF023424
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differences were observed towards the midpoint (fragments 3001-3499 to 4001-
4499) (CLR; 16%, CDR: 16.6%; mean Z-scores: CLR -4.9, CDR -5.2) and 3'
(fragments 7751-8249 to 8251-8749) (CLR; 19.9%, CDR: 22.3%; mean Z-scores:
CLR -5.5, CDR -6.4) regions of the polyprotein coding region.
Contrasting results were obtained for the HGV/GBV-C replication intermediate
sequences, in which low levels of FFED were again observed in all genotypes
examined, ranging from 2.1% to 3.2 % (Fig. 3.5). Differences were consistently low
along the length of the reverse compliment sequence (Fig. 3.6B). In only three
fragments were FFEDs above 5% (fragments 1-498, 3751-4249 and 8498-8754).
Fragment 8256-8754 was the only one in which a significant Z-score was observed
(CLR; 7.8%, CDR: 8.2%; mean Z-scores: CLR -2.3, CDR -2.4).
Similar results were observed for GBV-A sequences examined with FFEDs
between 12.2% and 14.6% noted across the polyprotein coding region (mean values
CLR: 13.1%, CDR: 14.1%; mean Z-scores: CLR: -4.2, CDR: -4.4) (Fig. 3.5). As
with HGV/GBV-C, levels of FFED were consistently high across the length of the
genome (Fig. 3.7A), with the greatest differences observed towards the midpoint
(fragment 4001-4498) (CLR; 18.8%, CDR: 19.8%; mean Z-scores: CLR -5.7, CDR -
5.8) and 3' (fragments 8001-8598 to 8614-9112) (mean values CLR: 20.9%, CDR:
22.4%; mean Z-scores: CLR: -6.2, CDR: -6.4) regions of the GBV-A polyprotein
coding region.
Again contrasting results were obtained for GBV-A replication intermediate
sequences, with low levels of FFEDs, ranging from 4.0% to 5.6%, along the length
of antisense sequence (Fig. 3.5 and 3.7B). However, towards the 3' extreme of the
sequence fragments with differences above 5% and significant Z-scores were
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observed (fragments 6501-6999, 6751-7249, 7501-7999, 7751-8249, 8501-8999 and
8751-9112). Fragment 8614-9112 was of note as it had an FFED above 10% and a
Z-score below -3.0 (CLR: 11.2%, CDR: 12.7%; Z-scores: CLR: -3.2, CDR: -3.1).
In summary, these results suggest that sequence dependent RNA secondary
structure is distributed throughout the genomes of HCV and HGV/GBV-C as well as
the related viruses GBV-B and GBV-A. The contrasting results observed between
the positive and negative sequence orientations suggest that RNA structure is most
relevant biologically for the virus RNA in its positive sense orientation.
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3.3 DISCUSSION
In this study we have used excess free energy on folding in order to predict the
existence of extensive sequence dependent RNA secondary structure across the
genomes of both HCV and HGV/GBV-C and the closely related viruses GBV-B and
GBV-A (Cuceanu et al., 2001; Tuplin et ah, 2002). The results concur closely with
those obtained using phylogenetic methods in which we observed a reduction in
synonymous variability and clustering of covariant substitutions within the
polyprotein coding regions of both viruses (Smith and Simmonds, 1997a; Simmonds
and Smith, 1999b; Cuceanu et ah, 2001; Tuplin et ah, 2002).
Previously published analysis of prokaryotic and eukaryotic secondary structure
using excess FFE has revealed a number of potential problems associated with the
randomisation of local nucleotide composition which may lead to artefactual results.
These include the effect of GC rich regions (GC islands) which may have a relatively
high free energy on folding when compared with the randomised controls where any
local nucleotide biases have been homogenised throughout the sequence (Rivas and
Eddy, 2000). We were able to discount local nucleotide heterogeneity as a
contributing factor in HCV as the base composition was shown to be relatively
homogenous throughout the genome with an over representation of G/C residues at
the third base position (Fig. 3.8) (Tuplin et al., 2002). We also developed a codon
swapping method (CLS) of randomisation that minimised the distance between
shuffled sites, thus maintaining local nucleotide biases. CLS gave comparable
results to the other randomisation methods, for virus sequences examined, which
further discounted sequence heterogeneity as a compounding factor.
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Figure 3.8: Scan of base composition at third codon positions across the polyprotein
coding region of HCV genotypes 1-6 (mean values), including combined values for
(G + A) and (G + C).
Nucleotide position
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A second cause of artefactualy high differences in folding free energy results from
the disruption of dinucleotide frequencies (Workman and Krogh, 1999). The main
contribution to free energy on folding an RNA molecule is associated with base
pairing. However, a second contributing factor is the two neighbouring residues to
the paired bases. For example, a C-G base pair is more thermodynamically
favourable than a G-C base pair when stacked on top of an A-U base pair (Workman
and Krogh, 1999). Consequently, a randomisation algorithm which disrupts
dinucleotide frequencies may lead to large differences in FFE, between the native
and randomised sequences, which are independent ofRNA secondary structure.
Excess FFE, utilising a dinucleotide disrupting algorithm, was used in a previous
study to predict stable RNA structure in 51 prokaryotic and eukaryotic mRNAs
(Seffens and Digby, 1999). It has since been shown by Workman and Krogh that in
the majority of the mRNAs examined the excess free energy on folding was an
artefact, due to the disruption of dinucleotide frequencies (Workman and Krogh,
1999). In this study we developed two randomisation methods that retained the
dinucleotide frequencies and codon structure of the native sequences (CDR and
CDS); CDS also retains any local differences in dinucleotide frequencies. Further
evidence that unusual dinucleotide frequencies were not responsible for the folding
free energy differences observed in HCV or HGV/GBV-C was provided by the
observation of only very limited dinucleotide frequency biases in either virus. Of
sixteen dinucleotide pairs only the frequencies of CG and UG differed from those
expected (Tuplin et al., 2002). However, these differences were not localised to
either the 5' or 3' extremes of either virus genome, in which the greatest differences
in folding free energy were observed.
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In order to determine the relationship between the six different randomisation
algorithms developed and FFEDs, each of the methods was applied to the coding
regions of a number of mammalian genes, with no known or likely RNA secondary
structure (Fig. 3.1). They were also used to examine the extreme upstream and
downstream fragments of HCV and HGV/GBV-C, in which RNA secondary
structure had previously been predicted by independent methods (Fig. 3.1). Each of
the randomisation methods gave comparable results indicating the presence of
sequence dependent RNA structure within the extreme 5' and 3' polyprotein coding
region of both viral genomes and a lack of structure in each of the mammalian
sequences examined. The folding free energies observed within the virus sequences
were comparable to those observed for plant viroids and the non-coding region of
delta virus (Cuceanu et al., 2001), in which RNA structure is known to play a
functional role during genome replication. The results were also comparable to those
obtained in a study by Workman and Krogh, where they observed that large,
functional, highly structured RNA molecules, such as rRNA, possess a high excess in
FFE which is comparable to that observed for the viruses examined in this study
(mean Z-score -7.93, using a randomisation method which maintained dinucleotide
frequencies) (Workman and Krogh, 1999). Further evidence for the veracity of the
results observed in this study is provided by the fact that no excess folding free
energies were observed within the mammalian mRNA sequences even though they
possesses a wide diversity of sequence compositions and dinucleotide biases.
Analysis of the complete coding regions of HCV, HGV/GBV-C, GBV-B and
GBV-A revealed excess FFE across the length of the genomes; with the greatest
excesses towards the 5', middle and 3' domains of the coding regions of HCV,
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HGV/GBV-C and GBV-A. In GBV-B the largest excesses were also observed
towards the 5' and 3' extremes of the coding region, yet towards the middle of the
virus genome the differences were more sporadic.
We have previously analysed sequence alignments of all available
epidemiologically unlinked HCV (Smith and Simmonds, 1997a; Tuplin et ah, 2002),
and HGV/GBV-C (Simmonds and Smith, 1999b) (Cuceanu et al., 2001), sequences
for the presence of covariant substitutions and the frequency of synonymous
substitutions. Reductions in sequence diversity at synonymous sites and the
existence of covariant substitutions may result from constraints on sequence change
imposed by RNA secondary structure. A very close concordance was observed
between fragments which possessed large FFEDs and regions in which such
constraints in sequence divergence were observed for both HCV and HGV/GBV-C
(Fig. 3.9). In HCV the greatest reductions in synonymous variability and excesses in
FFE were observed in the most extreme 5' and 3' fragments, in which the greatest
clustering of covariant substitutions were also observed. As with excess FFE,
suppression of synonymous variability and covariant substitutions were more
extreme and dispersed further across the genome of HGV/GBV-C than was the case
for HCV. However, a close agreement in position was again noted, especially
towards the 3' of the genome within the NS5 coding regions (approximately down
stream of position 7000) and towards the middle of the genome within the NS3/NS4
(4000-5000) coding regions. It has not been possible to complete such phylogenetic
analysis for GBV-A or GBV-B due to the lack of comparative sequence data and
genotypes. Agreement between these independent phylogenetic and thermodynamic
methods adds further veracity to the FFE results presented in this study, which
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Figure 3.9. A: Variability at synonymous sites across the genome ofHCV, genotypes 1-6
(mean values shown); location of covariant sites indicated by red arrows and stem loop
names labelled (chapter 4) (Smith and Simmonds 1997a; Tuplin et al 2002). B:
Synonymous variability across the genome of HGV/GBV-C genotypes 1-4 (mean values
shown); location of covariant sites indicated by a red arrow (Simmonds and Smith 1999b).
A
-500 500 1500 2500 3500 4500 5500 6500 7500 8500 9500
Nucleotide position
110
suggest that sequence dependent RNA structure is distributed throughout the genome
ofHCV, HGV/GBV-C, GBV-B and GBV-A.
In analysis of the reverse complement sequences large FFEDs were observed to be
significantly reduced from those observed within the positive sense RNA genomes
(Figs. 3.2 and 3.5). This suggests that RNA structure is more functionally relevant
for the positive sense RNA genomes examined than the antisense replication
intermediates. However, in both GBV-B and GBV-A discrete antisense fragments
were observed with significant excess FFE (Figs. 3.4B and 3.6B). In both instances
such fragments were observed within regions in which the greatest differences were
also observed for the positive sense genomes. Due to non-canonical base pairing and
different dinucleotide stacking energies the sense and antisense sequences would not
be expected to possess the same folding free energies. However, it is likely that a
sequence in which highly thermodynamically stable RNA structure were present
would also posses a residual higher then expected free energy on folding in the
opposing orientation, even though no biologically significant structure was present.
Using the same parameters we previously observed 14 covariant substitutions
within HCV, compared to 48 within HGV/GBV-C, in which lower levels of
suppression of synonymous variability were also noted (Simmonds and Smith,
1999b; Tuplin et al., 2002). It may be that the greater levels of sequence diversity
between HCV genotypes prevented detection of less well conserved stem loops
within HCV. However, the agreement between the phylogenetic and thermodynamic
evidence is consistent with the existence of less RNA structure within the HCV
genome than that ofHGV/GBV-C. The absence of phylogenetic evidence for GBV-
B and GBV-A makes it difficult to make a comparison with the other two viruses.
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Nevertheless, based purely on the thermodynamic evidence, the level of RNA
structure within GBV-B may be comparable to that observed in HCV and that of
GBV-A to HGV/GBV-C which mirrors the genome organisation and phylogenetic
relationship between the four viruses.
An even greater contrast is seen on analysis of other related viruses such as
pestiviruses in which no thermodynamic evidence for RNA secondary structure
within the polyprotein coding region was observed. Analysis of both BVDV and
CSFV showed that the polyprotein coding regions of both viruses lack significant
FFEDs when compared to randomised sequence controls (3.2% and 2.1%
respectively) (Tuplin et al., 2002). Phylogenetic analysis has also failed to show any
bias in synonymous variation or covariant substitutions (Peter Simmonds, personal
communication).
In summary, we have used excess free energy to predict the existence of extensive
sequence dependant RNA secondary structure across the polyprotein coding regions
of a number of related single stranded RNA viruses (HCV, HGV/GBV-C, GBV-B
and GBV-A). In doing so have developed a number of novel sequence




COMPUTATIONAL RNA STRUCTURE PREDICTION
4.1 INTRODUCTION
In chapter 3 large excesses in FFED were observed across the genomes of HCV
and FIGV/GBV-C, which were conserved between divergent genotypes and related
viruses (GBV-B and GBV-A) and are consistent with sequence dependent RNA
structure. Levels of FFED were comparable to those observed for viruses with well
defined secondary structure such as plant viroids and Delta virus. Although, levels
of FFED were high across the length of the genomes the greatest excesses were
observed within core gene ofHCV and the NS5B regions ofHCV and HGV/GBV-C.
A number of previous investigations have shown that these regions exhibit the
greatest suppression of synonymous variability and clustering of covariant
substitutions, which are consistent with restraints on sequence divergence due to
functionally conserved RNA structure (more detail in chapter 1.9).
Based on the concordance of the previous phylogenetic and thermodynamic
studies specific structural predictions are made in chapter 4 for the core gene and
NS5B region of HCV and the NS5B region of HGV/GBV-C. Secondary structure
predictions were also made for the 3'UTR of HGV/GBV-C as a comparison with
related viruses, such as GBV-A and HCV, suggest that this region is likely to be
highly structured.
Secondary structure predictions were made using MFOLD 3.1 with default setting
(Zuker, 2003; Mathews et al., 1999). MFOLD predicts all possible secondary
structure conformations into which an RNA molecule can fold, based on minimum
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folding free energy; which is the sum of the contribution of nucleotide pairings,
stacking energies and stem loop lengths (Rivas and Eddy, 2000; Zuker, 2000).
In order to assess the evolutionary conservation of predicted structures parallel
folding of all epidemiologically unlinked, complete genome sequences available on
GenBank was performed for both HCV (genotypes 1-6) and HGV/GBV-C
(genotypes 1-4). As the sequence divergence between HGV/GBV-B is
comparatively high (approximately 13%) the chimpanzee homologue HGV/GBV-
Ccpz was also analysed as an out-group, as it is has the same genome organisation as
HGV/GBV-C but is relatively divergent (approximately 27%). Conservation was
assessed between parallel foldings and included analysis of both covariant and semi-
covariant substitutions.
SEQUENCES ANALYSED FOR RNA SECONDARY STRUCTURE
Complete genome sequences of both HCV and HGV/GBV-C (including
HGV/GBV-Ccpz) were aligned by hand using the Simmonic 2000 package
(Simmonds and Smith, 1999b), prior to analysis with MFOLD (see appendix for
alignments and a list of GenBank accession numbers). Alignment of the HGV/GBV-
C homologous nucleotides indicated that the terminal 55 nucleotides of the 3'UTR
were missing from the chimpanzee isolate. The HCV sequence alignment was
divided into the core gene including the extreme 3' of the 5'UTR (nucleotides -23 to
516) and the NS5B region (nucleotides 8717 to 9186). The last 1000 nucleotides of
the HGV/GBV-C alignment were separated into the NS5B region and 3'UTR. The
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NS5B region of HGV/GBV-C included the whole sequence upstream of and
including the stop codon (nucleotides 8231 to 8901), whilst the 3'UTR included the
whole sequence downstream of this.
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4.2 RESULTS
Specific predictions of RNA secondary structure were made for regions of both
HCV and HGV/GBV-C in which there was a suppression of synonymous variability,
an excess free energy on folding as compared with sequence order randomised
controls and a clustering of covariant substitutions (chapter 3). The regions
investigated were the core gene and NS5B region of HCV (Tuplin et ah, 2002) and
the NS5B encoding region and 3'UTR of HGV/GBV-C (Cuceanu et al., 2001).
Secondary structure predictions were made using the program MFOLD 3.1 with
default settings (Mathews et al., 1999).
Conservation of each predicted RNA structure was assessed by parallel folding of
all epidemiologically unlinked, complete genome sequences available on GenBank
of HCV (genotypes 1-6) and HGV/GBV-C (genotypes 1-4 and HGV/GBV-Ccpz)
and the retention of structural prediction between divergent genotypes, covariant and
semi-covariant sites.
4.2.1 HCV SECONDARY STRUCTURE PREDICTION
Ten thermodynamically stable and evolutionarily conserved RNA structures were
observed within the coding region of HCV; three within the core gene and seven
within the NS5B region. The RNA structures were provisionally named according to
the position within the HCV alignment of the first nucleotide at the 5' end of the base
paired region. The core gene structures SL47, SL87 and SL443 spanned regions 47
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to 84; 87 to 167 and 443 to 475 respectively (Fig. 4.1). The seven NS5B encoding
structures SL7730, SL8376, SL8828, SL8926, SL9011, SL9061 and SL9118
spanned regions 7730 to 7777; 8376 to 8455; 8828 to 8897; 8926 to 8987; 9011 to
9058; 9061 to 9006 and 9118 to 9148 respectively (Fig. 4.2).
All the predicted RNA structures exhibited a high degree of conservation between
genotypes and both covariant and semi-covariant substitutions (Table 4.1), (Fig. 4.1
and 4.2). However, some variation in structure length, sequence conservation in
unpaired regions and predicted base pairings was observed. In predicted base-paired
regions the third base positions were most commonly aligned with the downstream
third codon position so that covariant sites were usually synonymous (in seven of the
ten predicted stem-loops). Non-synonymous covariant substitutions were observed
in SL47, SL8833, SL8926 and SL9118 resulting from base pairing between
nucleotides at different codon positions.
Predicted HCV core gene RNA structures
The core gene stem-loops SL47, SL87 and SL443 were highly conserved between
genotypes 1-6 (Fig. 4.1). However, there was variation in the length of SL47 within
and between genotypes; in -25% of sequences the first paired nucleotides were 48
and 83 as opposed to 47 and 84. A total of two covariant sites were observed within
SL47, four within SL87 and five within SL443 (Table 4.1). There were a number of
instances, in all three core gene stem loops, when a single substitution resulted in the
destabilisation of individual paired nucleotides; in the majority of cases such
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Figure 4.1. Schematic representation of HCV core gene conserved RNA structures.
Covariant sites are highlighted in grey.
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Figure 4.1: Schematic representation of HCV core gene and NS5B coding region
conserved RNA stem loops. Stem loop names are given above the structures;
positions of the upstream and downstream extent of base pairings are given below
the structures and are numbered from the start of the HCV alignment (see appendix).
Covariant sites are indicated by shading of paired nucleotides. Symbol canonical
Watson-Crick base pairing or G-U pairing. Examples of structurally different stem-
loops (SL7730 and SL8376) indicated in boxes.
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la 10 100 0 0 0 4/5
lb 81 100 0 0 0 7/8
2a 22 100 0 0 1 5/6
SL47 3a 6 100 0 0 1 5/5
4a 1 100 0 0 / /
5a 1 100 0 0 / /
6a 6 100 0 0 0 5/7
la 10 100 0 0 1 8/10
lb 81 100 0 0 0 8/9
2a 22 100 0 0 0 7/9
SL87 3a 6 100 0 0 2 7/12
4a 1 100 0 0 / /
5a 1 100 0 0 / /
6a 6 100 0 0 4 7/9
la 10 100 0 0 4 3/3
lb 81 100 0 0 1 4/5
2a 22 100 0 0 2 4/5
SL443 3a 6 100 0 0 2 5/8
4a 1 100 0 0 / /
5a 1 100 0 0 / /
6a 6 100 0 0 5 1/1
Structures were scored from + to +++ depending on the degree of similarity to the
most common structure. +++ Stem-loop structurally identical; ++ minor differences
in base pairing and/or size but the overall stem-loop conservation was maintained; +
different structure in the same region. The frequency within which single
synonymous substitutions retain or had a neutral effect on stem-loop structure is also
shown. * Number of sequences examined for a given genotype: f Number of
stabilising or neutral synonymous substitutions compared to the total number of
synonymous substitution (semi-covariance).
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la 10 100 0 0 1 5/7
lb 81 100 0 0 1 6/6
2a 22 100 0 0 0 2/3
SL7730 3a 6 100 0 0 2 5/5
4a 1 100 0 0 / /
5a 1 100 0 0 / /
6a 6 100 0 0 2 3/4
la 10 100 0 0 4 7/11
lb 81 100 0 0 0 11/19
2a 22 100 0 0 2 10/15
SL8376 3a 6 0 100 0 3 7/11
4a 1 0 100 0 / /
5a 1 0 100 0 / /
6a 6 0 100 0 3 /
la 10 90 10 0 0 13/14
lb 81 100 0 0 0 15/20
2a 22 100 0 0 1 8/12
SL8828 3a 6 100 0 0 1 11/12
4a 1 100 0 0 / /
5a 1 100 0 0 / /
6a 6 / 16.7 83.3 / /
la 10 60 40 0 2 12/17
lb 81 100 0 0 1 8/15
2a 22 100 0 0 1 6/6
SL8926 3a 6 / 100 0 0 8/12
4a 1 / 100 0 / /
5a 1 / 100 0 / /
6a 6 / 100 0 / /
la 10 100 0 0 2 5/8
lb 81 100 0 0 1 2/2
2a 22 100 0 0 3 9/9
SL9017 3a 6 100 0 0 5 4/4
4a 1 100 0 0 / /
5a 1 100 0 0 / /
6a 6 100 0 0 5 6/7
la 10 100 0 0 2 7/7
lb 81 100 0 0 1 4/4
2a 22 100 0 0 1 2/2
SL9061 3a 6 100 0 0 3 7/7
4a 1 100 0 0 / /
5a 1 100 0 0 / /
6a 6 100 0 0 2 3/3
la 10 100 0 0 1 4/4
lb 81 100 0 0 1 5/6
2a 22 100 0 0 1 9/10
SL9118 3a 6 100 0 0 0 3/3
4a 1 100 0 0 / /
5a 1 100 0 0 / /
6a 6 100 0 0 0 3/3
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Table 4.2: Structures were scored from + to +++ depending on the degree of
similarity to the most common structure. +++ Stem-loop structurally identical; ++
minor differences in base pairing and/or size but the overall stem-loop conservation
was maintained; + different structure in the same region. The frequency within
which single synonymous substitutions retain or had a neutral effect on stem-loop
structure is also shown. * Number of sequences examined for a given genotype: f
Number of stabilising or neutral synonymous substitutions compared to the total
number of synonymous substitution (semi-covariance).
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substitutions were directly adjacent to conserved single stranded bulges. However,
in no instances were substitutions observed to destabilise the RNA structures in such
a way as to cause slippage in nucleotide pairing or disrupt the overall conformation;
the majority of nucleotide changes at synonymous sites either stabilised the stem
loops or had a neutral effect (Table 4.1).
Predicted HCV NS5B RNA structures
RNA structures SL7730 and SL8376 were the most upstream of all the HCV stem
loops predicted within the NS5B region (Fig. 4.2). SL7730 was highly conserved in
all HCV genotypes exhibiting two covariant substitutions (Table 4.2). SL7730 also
included the greatest proportion of stem loop stabilising or neutral synonymous
mutations. SL8376 was highly conserved in all genotype la, lb and 2a sequences
examined. In genotypes 3a, 4a, 5a and 6a the size and shape of the RNA structure
was maintained even though there were a number of differences in predicted base
pairings and the degree of sequence conservation. Four covariant sites were
observed within SL8376.
RNA structure SL8828 was highly conserved within genotypes lb to 5a and nine
out of ten la sequences examined (Table 4.2). In a single la sequence (D50409) and
one out of six 6a sequences (JK049E1) examined there were a number of differences
in the paired and unpaired regions, although the overall shape and size of the stem
loops was maintained (Fig. 4.2). In the remaining 6a sequences examined, the
overall size and shape of the RNA structure was not maintained but a structure of
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Figure 4.2. Schematic representation of HCV NS5B region conserved RNA stem
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Figure 4.2: Schematic representation of HCV core gene and NS5B coding region
conserved RNA stem loops. Stem loop names are given above the structures;
positions of the upstream and downstream extent of base pairings are given below
the structures and are numbered from the start of the HCV alignment (see appendix).
Covariant sites are indicated by shading of paired nucleotides. Symbol canonical
Watson-Crick base pairing or G-U pairing. Examples of structurally different stem-
loops (SL7730 and SL8376) shown in boxes (genotypes of variant structures
indicated in bold).
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different conformation was present within the same region. Nucleotide substitutions
resulted in slippage of base pairings between all genotypes towards the base of the
stem loop, which in most cases was resolved by nucleotide pair 8857-8877. Two
covariant sites were observed within SL8828 (excluding genotype 6a which was too
divergent to make a comparison).
SL8926 was the least highly conserved RNA structure predicted within HCV
(Table 4.2). It was highly maintained in all genotype lb and 2a sequences and six
out often la sequences (AF011751, AF511948, AF11950, HEC278830, HPCHJ1
and HPCPLYPRE). In all other genotype sequences examined, single nucleotide
substitutions towards the base of the structure led to slippage in base pairing and the
formation of novel single stranded bulges. However, the overall shape, size and
position of the stem loop was maintained in all subtypes and two covariant sites were
observed (Fig. 4.2).
SL9011, SL9061 and SL9118 were the most down-stream RNA structures
predicted within the coding region of HCV. SL9011 was directly adjacent to
SL9061 which in turn was only twelve nucleotides upstream of the 5' nucleotide of
SL9118 (Fig. 4.2). The 3' nucleotide of SL9118 was nineteen nucleotides upstream
of the stop codon. All three RNA structures were highly conserved between
genotypes la-6a (Table 4.2). Six covariant sites were observed within SL9011, three
within SL9061 and one within SL9118. A short slippage in base pairing, within and
between genotypes, was observed between the four nucleotide pairs at the base of
SL9011 which was resolved by nucleotide pair five (9015-9054). Sequence variation
between positions 9015 and 9054 also led to the formation of unique single stranded
bugles within the main paired stem of SL9011 in genotype la but did not result in
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further slippage in nucleotide pairing. No further regions of slippage were observed
for RNA structures SL9011, SL9061 and SL9118. Of note was an eight nucleotide
unpaired bulge in SL9061 between positions 9092 and 9099; the sequence within this
unpaired region included three synonymous sites all of which are very highly
conserved.
4.2.2 HGV/GBV-C SECONDARY STRUCTURE PREDICTION
NS5B encoding region
Eight thermodynamically stable and evolutionarily conserved RNA structures were
predicted within the NS5B region of HGV/GBV-C (Fig. 4.3). The RNA structures
were provisionally named according to their position in relation to the other stem
loops and the stop codon. Structures SLns5bVIII, SLns5bVII, SLnssbVI, SLns5bV,
SLnssbIV, SLns5bIII, SLNs5bII and SLns5bI spanned regions 8250 to 8302; 8309 to
8321; 8327 to 8395; 8402 to 8500; 8551 to 8585; 8640 to 8730; 8761 to 8789 and
8802 to 8821 respectively.
All the predicted RNA structures exhibited a high level of conservation between
genotypes and in most cases with HGV/GBV-Ccpz (Table 4.3). However, variation in
structure length, sequence and paired nucleotides was observed within a number of
predicted RNA structures. Covariant sites were less frequent within HGV/GBV-C
predicted RNA structures than was the case within HCV. This may have been due to
the higher levels of nucleotide homology within the regions of HGV/GBV-C
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Figure 4.3: Schematic representation of HGV/GBV-C NS5B coding region
conserved RNA stem loops. Covariant sites are indicated by grey boxes.
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Figure 4.3 legend. Schematic representation of HGV/GBV-C conserved RNA
structures within the NS5B encoding region and 3'UTR. RNA structure names are
given below and above the stem loops. Bases are numbered from the start of the
HGV/GBV-C alignment (see appendix). Symbols: canonical Watson-Crick base
pairing or G-U pairing; intervening sequence without secondary structure.
Covariant sites are indicated by shading of paired nucleotides. HGV/GBV-Ccpz
RNA structures are shown in boxes.
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Table 4.3: Structures were scored from + to +++ depending on the degree of
similarity to the most common structure. +++ Stem-loop structurally identical; ++
minor differences in base pairing and/or size but the overall stem-loop conservation
was maintained; + different structure in the same region. The frequency within
which single synonymous substitutions retain or had a neutral effect on stem-loop
structure is also shown. * Number of sequences examined for a given genotype: f
Number of stabilising or neutral synonymous substitutions compared to the total
number of synonymous substitution (semi-covariance).
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sequence analysed as compared to HCV. However, covariant sites were observed in
seven of the eight RNA structures predicted within the NS5B encoding region of
HGV/GBV-C (SLns5bVII which only has three paired nucleotides was the
exception). As with HCV, the third base codon positions usually paired with down¬
stream third base positions and synonymous covariant sites were observed within
five of the seven stem loops with covariant substitutions (SLnssbVIII and SLnssbIII
being the exception). Non synonymous covariant sites were observed within
SLnssbVIII, SLnssbVI, SLnssbV and SLnssbIII. All the predicted RNA structures
exhibited a large excess of synonymous substitutions which either stabilised or had a
neutral effect on stem loop structure.
SLnssbVIII and SLnssbVII were most upstream of all the RNA structures
predicted within the NS5B region of HGV/GBV-C and were very highly conserved
between all the human isolate sequences examined (Table 4.3). SLns5bVII was the
smallest independent RNA structure predicted within HGV/GBV-C with only three
paired nucleotides and no observed covariant substitutions (Fig. 4.3). Four covariant
sites were observed within SLnssbVIII. No comparable structures were observed
within HGV/GBV-Ccpz-
SLnssbVI was made up of two nucleotide pair stacks branching off a basal
structure which was composed of five nucleotide pairs (Fig. 4.3). This "Y shaped"
three-way junction was unique amongst all the stem loops predicted within this study
for both HGV/GBV-C and HCV. SLns5bVI was conserved amongst all genotypes
with the exception of two out of three genotype 4 sequences examined, in which the
structure was not branched (ABO 18667 and AB021287). Three covariant
substitutions were observed; one within the basal structure and two within the
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downstream branch. SLns5bVI was not conserved within HGV/GBV-Ccpz, although
two thermodynamically stable structures were observed within the same region
between nucleotides 8313 to 8349 and 8353 and 8392.
SLNS5bV and SLnssbIII were the longest RNA structures predicted in HGV/GBV-
C. SLns5bV was thirty eight nucleotide pairs in length and SLns5bIII thirty four (Fig.
4.3). Both RNA structures were highly conserved within all HGV/GBV-C genotypes
(Table 4.3). A UUC codon insertion was observed at position 8458 within SLnssbV
in one of three genotype 1 sequences examined (U36380). This insertion was in
frame and within the single stranded pre-terminal bulge; the overall nucleotide
pairing of the stem loop was unaffected. Three covariant substitutions were observed
within SLnssbV and four within SLnssbIII. The position and length of each stem
loop was conserved within HGV/GBV-Ccpz but in both cases there was slippage in
nucleotide pairings due to sequence variation.
SLNS5bIV, SLNs5bII and SLNssbI were highly conserved between all HGV/GBV-C
genotypes and HGV/GBV-Ccpz- Two covariant substitutions were observed within
SLNS5bIV which was flanked by the much longer RNA structures SLNS5bV and
SLns5bIII (Table 4.3). Two covariant substitutions were also observed within
SLNs5bII and one within SLns5bI which were the most down-stream of all the
predicted NS5B RNA structures. Both SLNS5bIV and SLnssbII were one nucleotide
pair longer within HGV/GBV-Ccpz due to pairing of nucleotides 8550-8586 and
8760-8790 respectively at the base of each stem loop within the chimpanzee isolate
(Fig. 4.3). SLns5bI was two nucleotide pairs shorter in HGV/GBV-Ccpz due to a
single G to A substitution at position 8820 which disrupted the two nucleotide pairs
at the base of the stem-loop.
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4.2.3 HGV/GBV-C 3'UTR SECONDARY STRUCTURE
Seven thermodynamically stable evolutionarily conserved RNA structures were
predicted within the 3'UTR of HGV/GBV-C (Fig. 4.4). The RNA structures were
provisionally named according to their position in relation to the other stem loops
and the stop codon. Structures 3'SLVII, 3'SLVI, 3'SLV, 3'SLIV, 3'SLIII, 3'SLII
and 3'SLI spanned regions 8936 to 8958; 8959 to 8975; 8987 to 9025; 9074 to 9087;
9088 to 9101; 9170 to 9195 and 9199 to 9241 respectively.
The RNA structures predicted within the 3'UTR were more highly conserved
between genotypes than those of the NS5B encoding region (Table 4.4). However,
the extreme downstream region of the 3'UTR was incomplete or missing in a number
of sequences, resulting in a smaller sample size being available for examination.
Alignment with homologous HGV/GBV-C sequences also indicated that the terminal
55 nucleotides of HGV/GBV-Ccpz were missing, including the regions forming
3'SLII and 3'SLI within the human isolate sequences. Due to the high level of
sequence conservation within the 3'UTR of HGV/GBV-C the levels of stabilising,
de-stabilising and structurally neutral substitutions were much lower than within the
NS5B coding region.
3'SLVII and 3'SLVI are the most upstream of all the predicted 3'UTR RNA
structures. The 5' nucleotide at the base of 3'SLVII is twenty five nucleotides down¬
stream of the stop codon and the 3' nucleotide is directly adjacent to 3'SLVI (Fig.
4.4). 3'SLVII is highly conserved between all genotypes and six covariant sites were
observed out of eight nucleotide pairs (Table 4.4). 3'SLVII was not present within
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Figure 4.4: Schematic representation of HGV/GBV-C 3'UTR conserved RNA stem


























































Figure 4.4 legend. Schematic representation of HGV/GBV-C conserved RNA
structures within the NS5B encoding region and 3'UTR. RNA structure names are
given below and above the stem loops. Bases are numbered from the start of the
HGV/GBV-C alignment (see appendix). Symbols: canonical Watson-Crick base
pairing or G-U pairing; intervening sequence without secondary structure.
Covariant sites are indicated by shading of paired nucleotides. HGV/GBV-Ccpz
RNA structures are shown in boxes.
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l 2 100 0 0 1 0/0
3'SL
VII
2 7 100 0 0 4 0/0
3 4 100 0 0 2 0/2
4 2 100 0 0 2 0
CPZ 1 0 0 0 / /
I 2 100 0 0 0 0/0
3'SL
VI
2 7 100 0 0 0 0/0
3 4 75 0 25 0 1/1
4 2 100 0 0 0 0/0
CPZ 1 100 0 0 / /
1 2 100 0 0 0 0/0
3'SL
V
2 6 100 0 0 0 0/0
3 4 100 0 0 0 0/0
4 2 100 0 0 0 1/1
CPZ 1 100 0 0 / /
1 2 100 0 0 0 0/0
3'SL
IV
2 6 100 0 0 0 0/0
3 4 100 0 0 0 0/0
4 2 100 0 0 0 1/1
CPZ 1 100 0 0 / /
1 2 100 0 0 0 0/0
3'SL
III
2 6 83.3 16.7 0 1 1/1
3 3 0 0 100 / /
4 2 100 0 0 0 0/0
CPZ 1 0 0 0 / /
1 2 100 0 0 0 0/0
3'SL
II
2 5 100 0 0 0 0/0
3 3 100 0 0 0 0/0
4 2 100 0 0 0 2/3
CPZ 0 / / / / /
1 2 100 0 0 0 0/0
3'SL
I
2 3 100 0 0 0 1/1
3 3 100 0 0 0 0/0
4 2 100 0 0 0 2/3
CPZ 0 / / / / /
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Table 4.4: Structures were scored from + to +++ depending on the degree of
similarity to the most common structure. +++ Stem-loop structurally identical; ++
minor differences in base pairing and/or size but the overall stem-loop conservation
was maintained; + different structure in the same region. The frequency within
which single synonymous substitutions retain or had a neutral effect on stem-loop
structure is also shown. * Number of sequences examined for a given genotype: f
Number of stabilising or neutral synonymous substitutions compared to the total
number of synonymous substitution (semi-covariance).
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HGV/GBV-Ccpz due to a thirteen nucleotide deletion between positions 8946 to
8958 which overlapped with the RNA structure. Two covariant sites were observed
within 3'SLVI which was highly conserved between genotypes 1, 2, 4, HGV/GBV-
Ccpz and three out of the four genotype 3 sequences examined. In one of four
genotype 3 sequences examined (AB008342) a tri-nucleotide deletion between
positions 8961 to 8964 resulted in slippage of base pairing.
3'SLV was highly conserved between all genotypes of HGV/GBV-C and
HGV/GBV-Ccpz (Table 4.4). No covariant sites were noted within the human isolate
sequences, although one covariant site was observed between the HGV/GBV-Ccpz
and HGV/GBV-C RNA structures. Nucleotide substitutions in both the 5' and 3'
extremes of 3'SLV within HGV/GBV-Ccpz were predicted to result in slippage of
nucleotide pairings within the chimpanzee isolate. This was restricted to the basal
nucleotide pair stack and was resolved within the single stranded internal bulge at
nucleotide 8994.
3'SLIV and 3'SLIII were both short RNA structures of only five predicted
nucleotide pairs each (Fig. 4.4). The terminal downstream nucleotide of 3'SLIV was
directly adjacent to the first upstream nucleotide of 3'SLIII. 3'SLIV was highly
conserved between all human genotypes and HGV/GBV-Ccpz with one covariant site
observed between the human and chimpanzee isolates (Table 4.4). 3'SLIII was
highly conserved in all genotype 1 and 4 sequences and five of six genotype 2
sequences examined. In a single genotype 2 sequence (ABO 13501) the terminal C-G
nucleotide pair, at positions 9043 and 9048, was absent. One covariant site was
observed within the structure between genotypes 1, 2 and 4. 3'SLIII was absent
from all the genotype 3 sequences examined due to the deletion of nucleotides 9043
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and 9044. The stem-loop was also absent from HGV/GBV-Ccpz due to the deletion
of nucleotides 9044 and 9055.
3'SLII and 3'SLI were the most down-stream of all the predicted RNA structures
within the 3'UTR of HGV/GBV-C. 3'SLI formed a terminal stem loop of thirteen
paired nucleotides which incorporated the extreme 3' end of the HGV/GBV-C
sequence (Fig. 4.4). The 3' terminal nucleotide of 3'SLII (position 9195) is
separated from the 5' nucleotide of 3'SLI (position 9199) by a CCC unpaired triplet.
3'SLII is a shorter RNA structure with seven paired nucleotides and a long unpaired
terminal loop between positions 9177 and 9188. Both RNA structures were
conserved between all genotypes; unfortunately it was not possible to make a
comparison with HGV/GBV-Ccpz as the terminal 55 nucleotides were missing from
this sequence (Table 4.4).
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4.3 DISCUSSION
In this study free energy minimisation on folding, structure conservation between
genotypes, the occurrence of covariant substitutions and stabilising or neutral
synonymous substitution in nucleotide paired regions have been used to predict and
map evolutionarily conserved and thermodynamically stable RNA structures within
both HCV and HGV/GBV-C. Specific RNA structure predictions were made for the
3'UTR of HGV/GBV-C (Fig. 4.4), in which excess free energy on folding was
observed (chapter 3) (Simmonds and Smith, 1999b; Cuceanu et al., 2001). Structural
predictions were also made for the NS5B regions of both HCV and HGV/GBV-C
(Figs. 4.2 and 4.3), and the core gene of HCV (Fig. 4.1), in which reductions in
synonymous variability and clustering of covariant substitutions were observed as
well as excess free energy on folding (chapter 3) (Simmonds and Smith, 199b;
Cuceanu et al., 2001; Tuplin et al., 2002).
4.3.1 RNA STRUCTURE OF THE HGV/GBV-C 3'UTR
Predictions made in this study of seven thermodynamically stable evolutionarily
conserved RNA structures within the 3'UTR of HGV/GBV-C differ from previous
studies which analysed a very limited number of sequences and concentrated on only
the extreme downstream region of the 3'UTR. A previous model, in which only the
terminal 140 nucleotides of three sequences were analysed, proposed four terminal
RNA structures within the downstream region of the 3'UTR, (Fig. 4.5) (Okamoto et
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Figure 4.5: Schematic model of the RNA structure for the terminal 140 nucleotides
of the HGV/GBV-C 3'UTR, proposed by Okamoto et al (1997). Substitutions which
disrupt the proposed nucleotide pairings are indicated with a red triangle 'W.
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al., 1997). Analysis of the forty two sequences used in this study identified eleven
substitutions which disrupt the three downstream RNA structures predicted in this
model. For example, the proposed U-A pairing between nucleotides 9098 and 9229
is disrupted by a U to C substitution at position 9229 in genotypes 1, 2 and 3; the
proposed C-G nucleotide pairing between positions 9150 and 9189 is disrupted by a
C to G substitution in genotype 3 and a C to A substitution in genotype 4, at position
9150. Substitutions also disrupt proposed nucleotide pairings C-G between positions
9106 and 9120; G-C between positions 9107 and 9119; C-G between positions 9108
and 9118; U-A between positions 9109 and 9117; A-U between positions 9130 and
9201; G-C between positions 9140 and 9193; C-G between positions 9152 and 9187;
C-G between positions 9166 and 9179 and G-C between positions 9170 and 9175. In
addition the Okamoto model is not supported by covariant substitutions and is
limited to the terminal 140 nucleotides of the 3'UTR.
The model of 3'UTR RNA structure proposed by Okamoto and others predicts a
terminal stem loop with eleven nucleotide pairs between positions 9203 and 9228
(Fig. 4.5). A separate study in which twelve 3'UTR sequences were analysed
predicted the same stem loop at the terminal region of the 3'UTR but failed to predict
any further upstream structures (Katayama et al., 1998). Again the region of
sequence analysed was restricted to the extreme downstream region the 3'UTR. This
terminal RNA structure shows a high degree of homology with 3'SLI predicted in
this study. However, the final three nucleotides of the 3'UTR, which are predicted to
form the terminal three paired nucleotides of 3'SLI in this study, are shown as
unpaired in the previous models.
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Highly conserved RNA structures have been predicted by free energy
minimisation, phylogenetic and RNase cleavage analysis in the terminal down¬
stream regions of a number of different viruses including pestiviruses such as bovine
viral diarrhea virus (BVDV) (Yu et al., 1999; Deng and Brock, 1993), the
Picornaviridae family (Witwer et al., 2001; Mellits et al., 1998), most flaviviruses
(Proutski et al., 1997; Brinton et al., 1986; Rice et al., 1985; Rauscher et al., 1997;
Olsthoorn and Bol, 2001), GB viruses A (GBV-A) and B (GBV-B) (Sbardellati et al.,
1999) and HCV (Kolykhalov et al., 1996; Tanaka et al., 1996; Blight and Rice,
1997).
The terminal 3'UTR sequences of HCV, GBV-B and GBV-A are all predicted to
form three similarly structured adjacent stem-loops in a "cloverleaf" conformation.
The configuration of 3'SLI and 3'SLII of GBV-C closely resembles the two most
downstream RNA structures predicted for these related viruses, however there is no
evidence for a third adjacent upstream stem loop similar to that of HCV, GBV-A or
GBV-B (fig. 4.4). The predicted terminal stem loops of HCV and GBV-B are also
longer (19 and 21 nucleotide pairs respectively) than the HGV/GBV-C 3'SLI
homologue (14 nucleotide pairs) which is closer in size to the equivalent predicted
GBV-A stem-loop (11 nucleotide pairs). 3'SLII in HGV/GBV-C (7 nucleotide pairs)
more closely resembles the predicted HCV homologue (8 nucleotide pairs) than
those of either GBV-A or GBV-B (4 and 3 nucleotide pairs respectively).
The high degree of 3'UTR sequence conservation which is observed between
human HGV/GBV-C genotypes, with mean pairwise distances of between 3.87% to
6.6%, contrasts with that between human and chimpanzee isolates of between 12.8%
to 13.4% (Cuceanu et al., 2001). However, despite a relatively high level of
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sequence divergence 3'SLVI, 3'SLV and 3'SLIV were all predicted within
HGV/GBV-Ccpz, with a high level of structural conservation (Table 4.4). It was not
possible to make structural predictions for the most downstream region of the
HGV/GBV-Ccpz 3'UTR as it was shown, after alignment with human genotypes,
that the terminal 55 nucleotides were missing from the sequence.
The 3'UTR ofHCV is absolutely required for infectivity in the chimpanzee animal
model (Yanagi et al., 1999). It has also been shown to bind polypyrimidine tract-
binding protein (PTB) and NS3 (Baneijee and Dasgupta, 2001; Ito and Lai, 1997),
suggesting a role in viral replication and/or regulation of translation. Apart from this
it remains unclear what role RNA structure within the 3'UTR may play, although the
level of 3'UTR secondary structure homology between a range of virus types
suggests a high degree of functional importance. (Possible functional roles are
discussed in more detail in chapter 5).
4.3.2 RNA STRUCTURE WITHIN THE POLYPROTEIN CODING REGIONS
OF HCV AND HGV/GBV-C
The important role played by RNA stem loop structures within the polyprotein
coding regions of RNA viruses is becoming increasingly recognised. For example,
small stem loops within the coding regions of rhinovirus type 14 (McKnight and
Lemon, 1998), enteroviruses (Goodfellow et al., 2000) and cardioviruses (Lobert et
al., 1999) have all been shown to play an important role in virus replication. In this
study thermodynamic and phylogenetic methods have been used to predict three
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RNA structures within the core gene (Fig. 4.1), seven within the NS5B regions of
HCV (Fig. 4.2) and eight within the NS5B encoding region of HGV/GBV-C (Fig.
4.3) (Tuplin et al., 2002; Cuceanu et al., 2001).
A previously published model predicted two conserved RNA structures within
the core gene (between positions 47 to 84, 87 to 167) and two within the NS5B
region (between positions 9014 to 9054 and 9118 to 9148) of HCV (Smith and
Simmonds, 1997a). The core gene stem loops predicted in this model overlap the
same regions and exhibit very high levels of structural homology to SL47 and SL87.
In the Smith and Simmonds model a total of twenty six epidemiologically unlinked
sequences were analysed, including sixteen lb genotype sequences, three la and two
3a sequences and single examples of 2a and 4a sequences; no 5a or 6a sequences
were analysed. In the present study a total of one hundred and twenty one
epidemiologically unlinked sequences were analysed, including both genotype 5a
and 6a sequences. This increased data set enabled a more accurate estimate of RNA
structure conservation to be made.
SL47 exhibits almost complete structural homology to the Smith and
Simmonds model. However, nucleotide pair C-G (between positions 64 and 70),
which is adjacent to the terminal single stranded loop of SL47 is unpaired in the
previous model due to a G to U substitution at position 70. This substitution was not
observed in the current study.
The initial six and terminal fourteen nucleotide pairs of SL87 are identical to the
previous model. However, nucleotide pair U-A (positions 93 and 161) was shown as
unpaired and nucleotides 97 (G) and 159 (C) as paired in the Smith and Simmonds
model which contradicts the current study. In a number of genotypes (la, lb, 2a, 4a
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and 5a) nucleotide substitutions disrupt the previously predicted pairing between
positions 97 and 159. Nucleotides 104 (C) and 150 (G) are also predicted to pair in
the previous model but not in the current study. However, nucleotide substitutions in
genotypes la, 3a, 4a, 5a and 6a would again disrupt this previously predicted pairing.
These contradictory predictions result in a slippage in nucleotide pairings between
base pairs 87-67 (U-A) and 107-146 (G-C) in the previous model and would disrupt
a covariant substitution, between nucleotides 107 and 146, observed in the current
study.
RNA structures were also predicted in the Smith and Simmonds model between
positions 264 to 310, 337 to 394 and 443 to 475, although the structures of these
potential stem loops were not mapped. The latter region overlaps SL443 which is the
most downstream of all the in the core gene RNA structures predicted in HCV. No
evolutionarily conserved stem loops or covariant substitutions were observed
between regions 264 to 310 or 337 to 394. However, it is possible that RNA
structures exist within these regions whose function is not dependent upon a
conserved structural conformation. Such structures would be difficult to predict and
map using phylogenetic conservation methods and would require mutational analysis
of an infectious clone in a chimpanzee model, as the structural genes are missing
from the more amenable replicon system, in order to assess functionality.
A further study, in which eight sequences were analysed, has previously predicted
two evolutionarily conserved thermodynamically stable RNA structures within the
downsteam sequence of the NS5B region of HCV, between nucleotides 9015 to 9054
and 9118 to 9148 (Han and Houghton, 1992). The two stem loops predicted in the
Han and Houghton study are structurally identical with the two NS5B stem loops
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predicted in the Smith and Simmonds study. The most downstream of these RNA
structures is also identical to SL9118. The upstream structure predicted in the
previous models shows a degree of homology to SL9011, although the base of the
structure is shown to be formed by a C-G pair between positions 9054 and 9118.
This differs from the current model in which a U-A pair between positions 9011 and
9058 forms the base of the stem loop. This discrepancy in the structural prediction
of SL9011 is due to the prediction in the previous models that nucleotides 9014 (C)
and 9054 (G) form a pair at the base of the RNA structure. However, a nucleotide
substitution in genotype 1 at position 9014 (G to A) would disrupt this pairing. In
the current study nucleotide 9014 (C) is predicted to pair with 9055 (G) and
nucleotide 9054 (G) is unpaired, resulting in an extra three nucleotide pairs at the
base of the structure compared to that of the previous model. Neither the Han and
Houghton or the Smith and Simmonds models predict SL9061 and show the region
between SL9017 and SL9124 as unpaired. The discrepancies between the
conformation and presence of RNA structures predicted between the different
models may be due to the limited number of sequences previously available and the
short distance over which the sequences were analysed.
An excess free energy on folding and reduction in variability at synonymous sites
has been observed towards the 5' and 3' ends of the polyprotein reading frames of
both HCV (Smith and Simmonds, 1997a; Tuplin et al., 2002) (chapter 3) and
HGV/GBV-C (Simmonds and Smith, 1999b) (Cuceanu et al., 2001) (chapter 3).
These locations correspond to the core gene and NS5B coding regions of HCV and
the E1/E2 genes and NS5B coding region of HGV/GBV-C. Four RNA structures
have previously been predicted, by analysis of covariant substitutions, within the El
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and E2 genes of HGV/GBV-C and one between positions 265 to 309 was structurally
mapped. This RNA structure was observed to contain three covariant substitutions
and is conserved between HGV/GBV-C, HGV/GBV-Ccpz and GBV-A (Simmonds
and Smith, 1999). Given that these RNA structures and those predicted in this study
are evolutionarily conserved and thermodynamically stable it is likely that they
account for the bias in nucleotide substitutions and excess free energy on folding
observed towards the extreme ends of the polyprotein coding regions of both HCV
and HGV/GBV-C (chapter 3).
To a lesser extent free energy and nucleotide substitution biases are observed
within other regions of the HGV/GBV-C polyprotein coding regions. For example,
an excess free energy on folding and a reduction in synonymous variability occurs
between positions 6001 to 7000 (NS5A encoding region) and 4001 to 5000 (NS3
encoding region) (Simmonds and Smith, 1999) (Cuceanu et al., 2001). Although
secondary structures were not mapped within these regions, it seems likely that they
will contain RNA structures. Indeed the excess free energy on folding across the
genome of HGV/GBV-C is much higher then for HCV, in which it is more restricted
to the 5' and 3' extremes, suggesting further RNA structures throughout the genome.
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CHAPTER 5
VISUALISATION OF RNA STRUCTURE
5.1 INTRODUCTION
Fifteen evolutionary conserved RNA structures were previously predicted within
the genome of HGV/GBV-C, using both thermodynamic and phylogenetic methods
(chapters 3 and 4) (Cuceanu et al., 2001). Eight stem loops were predicted and
mapped within the NS5B region at the 3' extreme of the polyprotein coding region
and seven within the 3'UTR. Despite sequence divergence each of the predicted
RNA structures were shown to be highly conserved between all genotypes and
multiple covariant and semi-covariant substitutions were observed suggesting
functional constraint. However, the free energy minimisation algorithm used
previously does not predict higher order folding (tertiary structure), such as
pseudoknots. In order to physically investigate the position and tertiary folding
structure of the predicted stem loops, RNA transcripts of both the NS5B region and
3'UTR of HGV/GBV-C, were directly visualised under transmission electron
microscopy in chapter 5.
In chapter 3 it was shown that excess FFE is not confined to specific regions of the
HGV/GBV-C sequence but that the complete genome itselfmay be highly structured
(Cuceanu et al., 2001). This is consistent with phylogenetic results which show that
reductions in synonymous variability and covariant substitutions also occur along the
complete length of the ORF (Simmonds and Smith, 1999b; Cuceanu et al., 2001). In
order to investigate the potential of genome wide RNA folding, complete RNA
transcripts ofHGV/GBV-C were also visualised by electron microscopy in chapter 5.
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SEQUENCES ANALYSED
Subgenomic RNA transcripts were transcribed in vitro using cloned cDNA NS5B
region and 3'UTR as template. The subgenomic fragments were originally amplified
by RT-PCR from HGV/GBV-C positive serum (genotype 1), which had been
collected from a haemophilia patient. A full length infectious cDNA clone was used
as a temple for the generation of genome length RNA transcripts (genotype 1)
(GenBank Ac. No. AB013500).
152
5.2 RESULTS
In chapter 4 the secondary structure of eight stem loops in the NS5B region and
seven in the 3'UTR were predicted using a combination of thermodynamic and
phylogenetic methods. In chapter 3 the FFED results were consistent with genome
wide RNA folding. In order to physically investigate the RNA folding structure of
the NS5B region, 3'UTR and complete genome, RNA transcripts were negatively
stained and visualised under a transmission electron microscope (section 2.4).
The downstream domain of the NS5B coding region (position 8410-8894) and
3'UTR (position 8875-9231) were reverse transcribed and then amplified by PCR
from HGV/GBV-C positive human serum (genotype 1) (section 2.1); the sequences
and genotypes of both regions were confirmed by cycle sequencing of each
amplification product (section 2.2.7). The PCR products of both regions were then
cloned into pGEM-T Easy vectors, containing both T7 and SP6 RNA transcription
promoters at alternate ends of the vector ligation site (section 2.2). The ligation
products were used to transform JM109 competent cells which were then cultured
and plated out on LB selective plates. Insert orientation was assessed by single
round PCR screening of individual bacterial colonies (section 2.2.5). Primers were
designed to amplify across the insert boundary, with one primer designed to
hybridise to the vector and the other to the cDNA insert itself. The orientation of
individual inserts was then assessed through the presence or absence of an
amplification product. This was performed across both the T7 (5') and SP6 (3')
promoter boundaries so that each colony was checked twice for both a positive and
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negative PCR result. Colonies in which the insert was shown to be in a sense
orientation for the T7 RNA polymerase promoter were selected, cultured, and
plasmid DNA extracted by midi-prep (section 2.2.6). The plasmid DNA was then
linearised upstream of the cDNA insert, which was then used as a template from
which RNA was transcribed in vitro using the T7 RNA polymerase promoter
(section 2.3). Complete genome RNA transcripts were generated by transcription in
vitro from a T7 RNA polymerase promoter, using a linearised full length clone as a
template (genotype 1) (GenBank Ac. No. AB013500). RNA integrity was assessed
by electrophoresis though a 5% denaturing acrylamide gel (representative examples
are shown in Fig. 5.1).
After purification the RNA was slowly re-natured under physiological ionic
conditions, hybridized with biotinylated oligonucleotides and labelled with
streptavidin-coated colloidal gold particles (section 2.4). The RNA was then
adsorbed onto a carbon film, negatively stained with a solution of uranyl acetate and
mounted on gold plated copper grid. Micrographs of each specimen were then
recorded on a transmission electron microscope.
5.2.1 VISUALISATION OF THE NS5B CODING REGION AND 3'UTR RNA
FOLDING CONFORMATIONS
Visualisation of the NS5B coding region of HGV/GBV-C revealed a structure
folded into a cruciform-like conformation with four major stems of similar length
radiating from a central axis (Fig. 5.2). The four stems were arbitrarily labelled A,
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B, C and D, based on similarities in confirmation, size and position within four
independent micrograph images. Although the overall confirmation of the observed
structures was consistent between each micrograph there was variation in the length
of each stem. Based on micrograph images A to C (Micrograph A includes two
structures, both of which were separately analysed) the approximate mean length of
stem A was 41.7 nm (range 38-46 nm); stem B 44.7 nm (range 41-47 nm), stem C
35.3 nm (range 30-40 nm) and stem D 35.8 nm (range 34-35 nm) (Fig. 5.3). A
short side structure was consistently observed branching approximately 7 nm from
the distal end of stems A and B. The angles of rotation between stems A and B
ranged from 57° to 670 (mean 61.7°); B and C from 122° to 123° (mean 119°); C and
D 59° to 78° (mean 68°) and D and A 102° to 113° (mean 111°) (Fig. 5.3).
Gold labelling via biotinylated oligonucleotides (10 nm diameter) complimentary
to either the terminal loop of RNA structure SLNS5bIV (loop IV probe) or the single
stranded bulge towards the base of RNA structure SLnssbIII (loop III probe), were
used to confirm that the observed structures were indeed HGV/GBV-C NS5B
encoding region transcripts (complete predicted structural map shown in Fig. 4.3).
Gold labelling also enabled the identification of individual stems and an
approximation of size to be made. The streptavidin coated colloidal gold appeared as
a dense circular mass attached to individual stem structures. The loop IV gold probe
was observed hybridized towards the distal end of stem C in structure 1 of
micrograph A (Fig. 5.2A). The loop III gold probe hybridised towards the proximal
end of stem B, also overlaying slightly with stem A in (Fig. 5.2B). In micrograph C
both the loop III and IV probes were used for RNA hybridisation (Fig. 5.2C). In this
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image streptavidin coated colloidal gold was observed hybridised towards the distal
end of stem C and the central core of the structure.
The overall secondary structure of the downstream region ofNS5B encoding RNA
(8410-8894) that was visualised was also computationally predicted, using the
MFOLD free energy minimisation algorithm (Fig. 5.4). This aided in the
identification of individual stems visualised in the micrograph images and helped to
assess the accuracy of the method. The MFOLD prediction showed a high degree of
structural agreement to the micrograph images, with four stems radiating from a
central axis. As with the micrograph images stems A and B were the longest
structures and were located at opposing ends of the central axis to stems C and D.
Stem A was proportionally longer and stem B shorter in the MFOLD prediction then
the micrograph images. The structural prediction created by MFOLD is limited, as
the algorithm does not take into account tertiary structure and presents a schematic
diagram which does not offer a correct representation of the angles of rotation
between and within predicted structures. For example, stem A was visualised as
having a kink at its distal end in the micrograph images yet the computer image
shows a linear stem.
Visualisation of the F1GV/GBV-C 3'UTR RNA proved more problematic than for
the NS5B coding region. Although, a consistently linear shaped structure was
observed under the electron microscope it proved extremely difficult to resolve this
structure on a micrograph image. A single resolved micrograph image, consistent
with those observed by eye under the electron microscope, revealed a long structure
approximately 57.7 nm in length (Fig. 5.5). The two termini, either end of the
structure, were arbitrarily labelled A and B. Four short structures of approximately
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6.5 nm were observed branching from the main stem; two at terminus B and two 19
nm away from the B terminus at a 135° kink in the main stem. A further large kink
in the main stem, with an angle of rotation of 76°, was noted 20 nm from terminus A.
However, gold labelling via biotinylated oligonucleotides complimentary to the
terminal single stranded loop of RNA structure 3'SLII failed to hybridise to this
structure. Consequently, due to the lack of comparable images and the failure of
colloidal gold hybridisation it was not possible to make any predictions as to the
RNA folding structure of the 3'UTR region based on this study.
5.2.2 VISUALISATION OF THE COMPLETE VIRUS GENOME RNA
FOLDING CONFORMATION
Examination of the transcribed HGV/GBV-C complete genomic RNA revealed a
molecule consisting of four main stems radiating from a central, more clumped
region (Fig. 5.6). The four stems were arbitrarily labelled 1, 2, 3 and 4 and measured
approximately 67.5 nm, 72.5 nm, 57.5 nm and 66.25 nm respectively. A 10 nm long
side structure was also noted branching from stem 4; 15 nm from the central core of
the structure. Gold labelling via a biotinylated oligonucleotide, complementary to
the single stranded bulge in domain IVa of the IRES, was observed hybridised to
stem 3 and confirmed the identity of the object visualised in the electron
micrographs. The colloidal gold label was observed bound half way up stem 3, in
the region of a 101.5° kink in the structure.
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Two electron micrographs of the same molecule were resolved, one at x30 000
magnification (A) and a second at *60 000 magnification (B). The resolution of the
lower magnification image was the better of the two, revealing a fifth possible
structure between stems 2 and 4. However, it was not possible to accurately
visualise this potential stem at the lower magnification used in micrograph A. In
micrograph B the region was obscured due to a loss of resolution which was
observed at higher magnification. The central region of the structure appeared to be
composed of a number of discrete strands, although these were not fully resolved in
either electron micrograph and so it was not possible to accurately map this region.
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5.3 DISCUSSION
Previously, a combination of thermodynamic and phylogenetic methods were used
to predict and map stable RNA stem loop structures within both the NS5B encoding
region and 3'UTR of the HGV/GBV-C genome (chapters 3 and 4) (Cuceanu et al.,
2001; Simmonds and Smith, 1999b; Katayama et al., 1998; Okamoto et al., 1997).
We also provided evidence suggesting that the HGV/GBV-C may be more
extensively folded, across the complete length of its genome (chapter 3) (Cuceanu et
al., 2001). In this study negative staining followed by transmission electron
microscopy and gold label hybridisation has been used to directly visualise and
identify five RNA structures within the NS5B region (Fig. 5.2). These structures
were consistent with the downstream stem loops previously mapped within the NS5B
encoding region of HGV/GBV-C (SLnssbV to SLnssbI)- 3'UTR RNA transcripts
were also visualised, although it proved difficult to resolve these micrograph images
(Fig. 5.5). Visualisation of the complete virus genome transcript revealed a highly
structured molecule consistent with local and long range RNA structure along the
length of the HGV/GBV-C genome (Fig. 5.6).
Methods of RNA structure visualisation such as X-ray crystallography (Robertus
et al., 1974), cryoelectron microscopy (Gabashvili et al., 1999), and nuclear magnetic
resonance (NMR) (Lukavsky et al., 2000; Montelione et al., 2000), have previously
been used to provide very detailed, atomic level, RNA structure information.
However, all of these methods require relatively short RNA fragments or ribonuclear
protein complexes to aid crystal formation. Both the NS5B region and the complete
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genome RNA transcripts of HGV/GBV-C are relatively long, naked RNA molecules.
Consequently, it was decided that negative staining followed by transmission
electron microscopy would be used to directly visualise the structure of HGV/GBV-
C RNA transcripts, as sample length is not prohibitive with this method. Negatively
stained electron micrograph images of RNA virus IRES structures have previously
been published (Beales et al., 2001; Beales et al., 2003; Yunoki et al., 2003),
although there are no examples in the literature of this method having been used to
investigate the structure of virus coding region RNA or complete virus genomes.
Formerly direct visualisation of RNA structure by electron microscopy has relied
upon coating RNA with spermidine, or other polyamines, followed by rotary
shadow-casting with heavy metals such as platinum (Wang et al., 1994; Nakamura
et al., 1995). Spermidine has since been shown to alter the structural conformation
of a ribozyme four way junction (Walter et al., 1998), making it impractical for the
analysis of RNA folding structure. Negative staining is not believed to affect RNA
conformation in this way and also results in a smaller grain size than heavy metal
shadowing, increasing the resolution of the micrograph images (Beales et al., 2001).
5.3.1 VISUALISATION OF HGV/GBV-C NS5B REGION RNA FOLDING
STRUCTURE
The negatively stained NS5B region was observed to fold into a cruciform
conformation (Fig. 5.2), which was consistent with a computational prediction of
overall confirmation created using free energy minimisation (Fig. 5.4). Based on
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conformational similarities to the predicted structure and gold labelling of specific
stem loops it is hypothesised that stem A corresponds to SLnssbIII, B to stems
SLNs5bI and SLNS5bII, C to SLNssbIV and D to SLnssbV (complete predicted
structural map shown in Fig. 4.3). It is possible to make an estimate of the length of
a predicted stem loop based on the assumption that RNA nucleotide pair stacks adopt
an A form helix in which paired nucleotides rise at 0.273 nm per base and lateral side
chains at 2.5 nm (Dock-Bregeon et al., 1989; Beales et al., 2001). Following these
parameters the computationally mapped stem A structure was estimated to be 16.7
nm in length, B 11.82 nm, C 12.64 nm and D 9.56 nm. This compares to an average
length determined from the micrograph images of 41.7 nm, 44.7 nm, 35.3 nm and 34
nm respectively (Fig. 5.3). The underestimation in predicted stem loop length,
compared to the directly visualised structures, may be due to the presence of single
stranded bulges which are present in each of the predicted structures and are of an
indeterminate length (Beales et al., 2001).
There is close agreement in the individual stem loop angles of rotation between
separate micrograph images (Fig. 5.3). The angles between stems C to B (mean
119°) and A to D (mean 1110) were consistently greater than those between C to D
(mean 68°) and A to B (mean 61.7°). However, in micrograph C the angle of rotation
between stems A to B was larger (99°) than that between A to D (54°). The structure
in micrograph B was labelled at two separate points with colloidal gold which may
have disrupted individual angles of rotation. It has previously been proposed that
stem loop flexibility is required for pseudoknot formation in the IRES of HCV
(Nakamura et al., 1995; Beales et al., 2001). The variation in angles observed within
the NS5B encoding region of HGV/GBV-C may thus suggest a level of flexibility in
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stem loop conformation in order to allow tertiary structure formation; in which stem
flexibility would enable the interaction of unpaired nucleotides.
Hybridisation with biotinylated oligonucleotides followed by labelling with
streptavidin coated colloidal gold confirmed that the negatively stained image was
that of the NS5B encoding region RNA transcript (Fig. 5.2). Gold labelling also
confirmed the identity of stems A and C as RNA structures SLnssbUI and SLnssbIV
respectively. Comparison with a free energy minimisation predicted structure for the
NS5B encoding region also allowed the identity of stem D to be surmised as RNA
structure SLNS5bV and the two branched structures at the distal end of stem D as
RNA structures SLns5bI and SLnssbII. However, without specific probes for these
stem loops it was not possible to make a more definitive prediction or show which of
the distal branches was RNA structure SLNS5bI or SLNS5bII.
Phylogenetic and thermodynamic methods previously predicted stem loop
SLnssbIV to be only twelve nucleotide pairs in length as compared to stem loops
SLns5bV and SLnssbIII which are respectively thirty eight and thirty four nucleotides
in length. However, both SLnssbIII and SLnssbIV are observed as being longer than
SLNS5bV in the electron micrographs images. This suggest that although, the
phylogeneticaly conserved regions of the two stem loops are shorter than SLNS5bV
they are presented on a long but less sequence dependent proximal base paired stalk.
5.3.2 VISUALISATION OF THE HGV/GBV-C 3'UTR RNA FOLDING
STRUCTURE
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Resolution of a HGV/GBV-C 3'UTR electron micrograph image of RNA
transcripts proved difficult. This may have been due to the fact that less RNA
structure was predicted within the 3'UTR than the NS5B coding region, making the
RNA molecules less easy to resolve against the negatively stained background. Less
RNA structure may also have meant that the 3'UTR RNA transcripts were more
prone to digestion with contaminating ribonucleases. Although, a single micrograph
image revealed a structure approximately 58 nm in length, gold label hybridisation
failed to confirm the identity of this structure. Consequently, it was not possible to
make specific predictions concerning the RNA folding structure of the HGV/GBV-C
3'UTR based on direct imaging via electron microscopy.
5.3.3 VISUALISATION OF THE HGV/GBV-C COMPLETE GENOMIC RNA
FOLDING STRUCTURE
Direct visualisation of the HGV/GBV-C complete genome revealed four main
negatively stained stems radiating from a central core (Fig. 5.6). The central region
was less well resolved than the radiating structures but appeared to be composed of
discreet individual structures. Hybridisation with a biotinylated oligonucleotide,
specific for domain IVa of the HGV/GBV-C IRES, followed by labelling with
streptavidin-coated colloidal gold confirmed that the negatively stained image was
that of the HGV/GBV-C full length RNA transcript.
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The complete genome of HGV/GBV-C (9231 nucleotides) is approximately
twenty times the length of the NS5B encoding region visualised in this study (484
nucleotides). However, the diameter of the complete genome structure is only
approximately twice that of the NS5B encoding region. The diameter of the
observed complete genome structure was 133.75 nm across the axis of stems 1 to 4
and 138.75 nm across the axis of stems 2 to 3 (Fig. 5.6). The average diameter of the
NS5B region RNA structure was 76.7 nm across the axis of stems A to C and 79.2
nm across the axis of stems B to D (Fig. 5.3). This apparent contradiction suggests
that RNA structure may not be confined to the extreme ends of the genome, or
indeed any to any discreet region, but that the complete genome may be folded
through local or long range interactions to form a compact, highly structured, tertiary
conformation. This is consistent with the thermodynamic and phylogenetic results
presented in chapter 3 in which extensive RNA structure was predicted to exist
across the polyprotein coding region. Similar results have been noted for the
complete genome of HCV, in which three main stems are observed radiating from a
central core region (Lucy Beales, personnel communication).
5.3.4 ROLE OF SECONDARY STRUCTURE IN HGV/GBV-C
The functional role of RNA structure within the NS5B coding region and 3'UTR
of HGV/GBV-C has yet to be identified. In similar positive sense, single stranded,
RNA viruses a number of stem loops have been identified within the polyprotein
coding region which function as cA-acting replication elements (CRE). These
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structures have been shown to be essential for negative strand initiation in a number
of viruses including enteroviruses (Goodfellow et al., 2000), cardioviruses (Lobert et
al., 1999), aphthoviruses (Mason et al., 2002) and rhinoviruses (McKnight and
Lemon, 1998) (described in more detail in section 6.3). It may be that the RNA
structures identified in this study within the NS5B encoding region of HGV/GBV-C
perform a similar role in virus replication, although they are larger and more
extensive than any previously predicted in similar viruses.
RNA structures identified within the 3'UTR may have an analogous role to
similarly structured regions predicted in related virus, which play a critical role in the
initiation of both positive and negative strand replication, through specific RNA-
protein interactions. For example, stem loop structures within the 3'UTR of West
Nile virus (WNV) act as specific recognition sites for host cellular proteins such as
EF-la (Blight and Rice, 1997; Blackwell and Brinton, 1995; Shi et al., 1996). The
3'UTR of HCV has also been shown to be absolutely required for virus replication
and has been shown to bind a number of replication complex proteins such as PTB
RdRp (NS5B protein) (more detail in section 6.3) (Yanagi et al., 1999; Banerjee and
Dasgupta, 2001; Ito and Lai, 1997).
The close similarities in excess free energy on folding the complete genomes of
plant viroids, the non-coding region of delta viruses and HGV/GBV-C have
previously been noted (chapter 3) (Cuceanu et al., 2001). In viroid agents and the
non-coding region of delta virus RNA folding is essential for replication of the
genome in which specific domains catalyse RNA cleavage, editing and sequence
ligation (Branch and Robertson, 1984). The complete genome folding of
HGV/GBV-C may play a similar role or be involved in genome packaging or
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protection against ribonuclease enzymes particularly, since HGV/GBV-C does not
appear to encode a nucleocapsid protein.
In summary, negative staining followed by transmission electron microscopy has
been used to visualise the folding structure of the NS5B region and complete genome
of HGV/GBV-C. The visualised structures are consistent with phylogenetic and
thermodynamic results presented earlier in chapters 3 and 4. Whilst the function of
the RNA structures predicted within the HGV/GBV-C genome are currently not
understood in any detail these results may provide a starting point for further
functional studies using the HGV/GBV-C replicating full length transcript system
(Xiang et al., 2000).
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CHAPTER 6
RIBONUCLEASE MAPPING OF RNA STRUCTURE
6.1 INTRODUCTION
Ten evolutionary conserved stem loop structures were previously predicted within
the coding region of HCV, using both thermodynamic and phylogenetic methods
(chapters 3 and 4) (Tuplin et al. 2002). Three were predicted and mapped within the
core gene and seven within the NS5B region. Each structure was shown to be highly
conserved between divergent genotypes with multiple covariant and semi-covariant
substitutions observed in each structure, suggesting functional conservation (chapter
4).
The free energy minimisation methods used in chapter 4 do not take account of
tertiary structures, such as long range interactions, which may have a functional role
and affect stem loop stability and structure. For example, evidence from HCV IRES
driven translation in a dicistronic reporter construct, suggests that the core gene may
play a role in the modulation of virus translation (Reynolds et al 1995; Kim et al,
2003; Honda et al., 1999). It was shown that this function may be dependent upon a
long range interaction between the core gene and the 5'UTR. A potential core gene
long range interaction site was variously mapped between nucleotides 87 to 101
(Kim et al., 2003), and/or 66-588 (Honda et al, 1999). The three core gene RNA
structures predicted in chapter 4 (SL47, SL87 and SL443) fall within this region and
may thus play a role in higher order interactions affecting the regulation of
translation. However, although such tertiary interactions may affect RNA structure
they are not accounted for in free energy minimisation predictions.
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In order to examine the stem loops predicted in HCV in as natural a context as
possible the core gene and NS5B region were enzymatically mapped using a
multisite priming method which allowed the analysis of long RNA transcripts. The
use of long transcripts enabled potential tertiary interactions between secondary
structures to occur prior to cleavage. Both genotypes 1 and 2 were analysed in order
to assess the conservation of ribonuclease cleavage patterns between divergent
sequences
SEQUENCES ANALYSED
The RNA transcripts were transcribed in vitro using T7 phage promoter annealed
PCR product as a template. The core region templates corresponded to positions -23
to 516 and the NS5B regions 8180 to 8715 of full length, functional HCV infectious
clones of genotype 1 (M62321) and 2a (AF177036).
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6.2 RESULTS
Through analysis of variability at synonymous sites, analysis of covariant
substitutions, thermodynamic prediction and calculation of excess free energy on
folding we have previously obtained evidence for extensive RNA secondary
structure within the coding region ofHCV (chapters 3 and 4) (Smith and Simmonds,
1997a; Tuplin et al., 2002). Three stem loops were predicted within the core gene
and seven within the NS5B region (Figs 4.1 and 4.2).
In this study a multisite RNA transcript priming method was developed to
enzymatically map the complex and extensive predicted RNA structures in the core
and NS5B regions of the HCV (section 2.5). Long RNA transcripts (approximately
500 bases) were used as templates for ribonuclease digestion as it was essential to
allow stem loop formation to occur in as natural a context as possible and in
particular to enable potential interactions between RNA secondary structures, such as
formation of pseudoknots, to occur prior to nuclease cleavage.
RNA was generated by in vitro transcription using a MegaScript kit (Ambion)
and T7 phage polymerase promoter annealed PCR product as a template (section
2.3). The PCR product templates corresponded to positions -23 to 516 within the
core gene and 8180 to 8715 within the NS5B encoding region of full length,
functional HCV infectious clones of genotypes la and 2a (section 2.1.3). The
integrity of the RNA was determined by electrophoresis through a 1% agarose gel
(typical example is shown in Fig. 6.1). Prior to cleavage the RNA was melted and
slowly annealed under physiological ionic conditions. RNase partial digestion was
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performed with ribonucleases VI, T1 or Al, which preferentially cleave downstream
of base-pared regions, unpaired G or unpaired C and U nucleotides respectively
(section 2.5).
Three antisense primers were used for transcription (in the presence of an a-
IT ... .
[ P]ATP substrate) from multiple sites in the transcripts to analyse consecutive
regions of the RNA cleavage products of the core gene (corresponding to positions
157-176, 327-456 and 497-516) and NS5B encoding region (corresponding to
positions 8961-8981; 9061-9080 and 9161-9180). The radio-labelled cDNA
fragments were separated by electrophoresis through a 5% denaturing acrylamide
gel, dried and exposed on autoradiography film (typical examples are shown in Fig.
6.2).
Figure 6.1. Determination of RNA transcript integrity, for HCV core gene (C) and
NS5B region (N), after electrophoresis through a 1% agarose gel. RNA is stained
with 0.07 pg/ml ethidium bromide (section 2.3.5). RNA transcripts from 2
independent transcription reactions are shown for each region
N N C C
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6.2.1 HCV CORE GENE ENZYMATIC MAPPING
Three evolutionarily conserved stem loops, SL47, SL87 and SL443, were
previously predicted in the core gene region of HCV, spanning regions 47 to 84; 87
to 167 and 443 to 475 respectively (Fig. 4.1) (chapter 4) (Tuplin et al., 2002). Both
the position and structural conservation of these stem loops were consistent with the
cleavage patterns of the RNA transcripts in the present ribonuclease mapping study
(Fig 6.3). As well as locating the stem loop structures, the ribonuclease cleavage
results were consistent with the predicted lengths and positions of the base paired
stems, the location of the terminal single stranded regions and many of the single
stranded bulges found within the main paired stem structures. Furthermore, the
cleavage patterns obtained by RNAse mapping were very similar between genotype
1 a and 2a transcripts, despite the often high degree of primary sequence divergence
between the genotypes.
While the nuclease mapping data generally corresponded closely to the optimally
folded structures from MFOLD for genotypes la and 2a, there were some instances
where the two methods made discordant predictions (Fig. 6.3). For example, the
terminal loop of SL47 was previously predicted to be single stranded and the results
from ribonuclease Ti confirm this. However, the results from Vi suggest that two
out of the five bases in the terminal loop of SL47_la are paired (positions 65 and
67). Within the same stem loop a single stranded bulge is predicted by
computational analysis, between positions 57 to 59 and 73 to 74, V] enzymatic
cleavage indicated that positions 57 and 58, within genotypes la and 2a respectively,
are paired. Positions 452 and 460 within SL443 (genotype la) also highlight
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Figure 6.3. Representative ribonuclease cleavage results alongside schematic representations of stem loops indicating
enzymatic cleavage positions within the core gene of HCV (genotypes la and 2a indicated by bold type. Cleavage sites
by the nucleases V,, A, and T, are indicated by solid, hollow and outline arrows respectively (see Figure key). Each RNA
transcript was cleaved with two different concentrations of each RNAse, and a no nuclease control to detect non-specific
cleavage or transcription pausing during strand extension (blocks 1, 2 and 3 respectively). Fragments were sized by
comparison wilth a cycle sequencing reaction of a DNA template of the same sequence (block Seq).
Cleavage sites: —►Y T > A
111
Predictions: (u)double stranded: Single stranded: Discordant prediction
SL47 la SL87 la SL47 2a SL87 2a
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instances in which the cleavage results contradict the computational predictions; both
nucleotides lie within predicted single stranded regions yet V] cleavage results
suggest that they are paired. Interestingly position 460 also maps as single stranded
with ribonuclease TV It has been suggested that this region of the core gene
modulates translation through the formation of local higher order structures and a
transient long range pseudoknot structure with the upstream IRES (Kim et ah, 2003;
Rijnbrand et al., 2001; Honda et al., 1999). Such interactions may account for these
apparent contradictions between the computational and ribonuclease cleavage results,
as most computational methods are unable to predict higher order structures such as
pseudoknots.
The results also indicate that paired nucleotides adjacent to a single stranded
region may map enzymatically as both single stranded and paired. This is the case
for nucleotide 69 (in both genotypes la and 2a) which is directly adjacent to the
terminal single stranded loop in SL47 and nucleotide 67 within SL443 (genotype la).
However, these results are consistent with the known dynamic instability of stacked
base pairs adjacent to unpaired regions (Zuker, 2000).
6.2.2 HCV NS5B REGION ENZYMATIC MAPPING
Ribonuclease cleavage patterns were also consistent with the structure and position
of stem loops SL8828; SL8926; SL9011; SL9061 and SL9118 spanning positions
8828 to 8897; 8926 to 8987; 9011 to 9059; 9061 to 9106 and 9118 to 9148
respectively within the NS5B protein encoding region (Fig. 6.4). All five stem loops
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exhibit a high degree of structural conservation between genotypes la and 2a,
following both the thermodynamic/phylogenetic methods of prediction and
ribonuclease cleavage patterns.
Intriguingly, as with the core gene, there are a number of instances when the two
predictive methods appear to contradict each other. For example, nucleotides 8837,
8954, 9047, 9081 and 9031 within stem loops SL8828 (genotype la), SL8926
(genotype 2a), SL9011 (genotype la), SL9061 (genotype la) and SL9118 (genotype
2a) respectively were observed in stranded domains with both computational and
ribonuclease (Ti and/or Ai) cleavage results. However, all five positions also
mapped as paired in ribonuclease V) cleavage results. This may be due to some of
the apparently unpaired bulges within the stem loops forming pseudoknot like
interactions with other structures or with completely unpaired regions of the virus
genome. Evidence for this, may be the high degree of sequence conservation in
unpaired regions, which was observed even at synonymous sites such as in the
terminal stem loop of SL9061.
Paired bases 8858 -8876 and 8864 - 8870 within SL8828 (genotype la); 8842 -
8885, 8852 - 8877 and 8891 - 8872 within SL8828 (genotype 2a); 8926 - 8987,
8939 - 8973 and 8947 - 8965 within SL8926 (genotype la); 9012 - 9058 and 9028 -
9041 within SL9011 (genotype la); 9011 - 9059 within SL9011 (genotype la) and
9068 - 9091 within SL9061 (genotypes la and 2a); were all part of stacked base
pairs adjacent to single stranded regions which mapped by ribonuclease cleavage as
unpaired or as both paired and unpaired. This is in marked contrast to contradictory
results towards the middle of base pair stacks, which was only observed once within
the NS5B region, at paired nucleotides 8831 - 8894 in SL8828 (genotype la). These
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results provided further evidence for increased instability of stacked base pairs
adjacent to single stranded regions. Instances when the results from the various
methods appear to contradict each other within base paired stacks may be evidence
that the RNA stem loop, or a particular domain within it, is inherently unstable and
able to adopt multiple conformations (Goodfellow et al 2003).
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6.3 DISCUSSION
Although extensive stable stem loop structures have been predicted within the 5'
and 3' untranslated regions (5' and 3' UTRs) of single stranded RNA viruses, very
little is known about possible structures within the coding region of HCV and related
viruses. In this study, ribonuclease cleavage followed by multisite transcript priming
was used to investigate the presence and elucidate the structure of a large number of
stable stem loops within the coding region of HCV. Physical mapping also enabled
the validation of both thermodynamic and phylogenetic predictive methods which
were previously used (chapter 4) (Tuplin et al. 2002; Smith and Simmonds 1997b).
In chapter 4 a variety of both thermodynamic and phylogenetic methods were used
to predict ten evolutionarily conserved stable stem loops within the positive sense
RNA genome of HCV. Ribonuclease cleavage mapping of regions of predicted
structure within HCV formed an important part of this study as it allowed the
validation of these computational methods. Enzymatic mapping also supplied
additional information which was not highlighted by computational predictions. For
example, a number of single stranded regions within stem loops were observed to
base-pair, potentially indicating the formation of long range RNA-RNA interactions
or higher order structures such as pseudoknots. The dynamic nature of some stem
loops, in which bases may be either paired or unpaired, was also highlighted. This
was shown to be more common towards the extremes of stacked regions such as
adjacent to unpaired bulges or the base of a structure.
A number of other physical mapping methods could have been employed to
validate the computational methods used in chapter 4. These include nuclear
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magnetic resonance spectroscopy (NMR spectroscopy) and direct visualisation by
transmission electron microscopy; this was used in chapter 3 when analysing the
higher order structure of HGV/GBV-C. Direct mapping by ribonuclease cleavage
followed by multisite primer extension holds a number of advantages over these
techniques for the purposes of this study.
The regions ofRNA analysed here by enzymatic cleavage were approximately 500
nucleotides in length. The fragment length required for NMR spectroscopy (100 -
200 bases) would not have been suitable in this regard, as the shorter fragment length
would not have allowed the formation of large structures or potential interactions
between structures to occur. The use of shorter fragments would also have given a
self determining aspect to the results. For example, if regions 1 to 100 or 8900 to
9000 were analysed it is likely that both SL47 and SL8926 would have formed,
however this would not have been evidence for their existence within the longer
fragments (Tuplin et al. 2002). This could also be true for the enzymatic cleavage
method applied here; although the potential is minimised as a results of using much
longer RNA fragments, which allow potential long range interactions between
structures to occur.
Transmission electron microscopy could have been used to directly visualise the
folding pattern of the complete virus genome. Unfortunately, the lower resolution of
this method determines that shorter stem loops would be very difficult to visualise.
The two dimensional nature of the electron micrograph image may also have meant
that individual stem loops would have been obscured (chapter 5).
Translation of the HCV polyprotein is directed by an internal ribosome entry site
(IRES) which is located within the 5' UTR of the virus genome and is composed of
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four major structural domains (Tsukiyama Kohara et al. 1992; Wang et al. 1993;
Brown et al. 1992; Smith et al. 1995). It has been suggested that the activity of the
IRES is modulated by a long range RNA-RNA interaction between nucleotides 87 to
101 within the core gene and -317 to -302 within the 5'UTR (referred to as long
range interaction sites) (Kim et al. 2003). Mutations within nucleotides -317 to -302,
which have been observed to destabilise the long range interaction, significantly
enhance IRES mediated translation within a dicistronic reporter system (Kim et al.
2003). It has also been shown that a deletion between nucleotides -309 to -304 of the
5'UTR enhances IRES driven translation but only when nucleotides 66 to 588 of the
core gene are included in the construct (Honda et al. 1999). Further analysis, with
frame shift mutations, has shown that the nucleotide sequence of the core gene and
not the amino acid sequence of the translation product is responsible for modulating
IRES efficiency (Honda et al. 1999).
Intriguingly SL47, SL87 and SL443 all fall within nucleotides 66 and 588, which
have been shown to modulate IRES translational activity (Kim et al. 2003; Honda et
al. 1999). The 3' terminus of SL47, at nucleotide 84, directly precedes the 5'
boundary of the predicted long range interaction site within the core gene
(nucleotides 87 to 101), which also overlaps with the first 15 nucleotides of SL87.
The close proximity of SL47 to the long range interaction site suggests that this stem
loop may play a role in the formation of a higher order structure, between the core
gene and the extreme 5' end of the virus genome. This could occur through SL47
exposing or presenting the long range interaction site within SL87, facilitating an
interaction between the core gene and the extreme 5' end of the virus genome. The
ribonuclease cleavage results presented here provide evidence that nucleotides within
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the single stranded bulge of SL47 (genotypes la and 2a) and the single stranded
terminal loop of genotype la also form paired structures, which is consistent with
SL47 taking part in further tertiary interactions.
It has been proposed that differences in RNA structure between virus genotypes
may confer differing phenotypes (Honda et al. 1999). The 5'UTR ofHCV genotype
la directs cap-independent translation with approximately twice the efficiency of
genotype lb (Honda et al. 1996). It has been suggested that this is due to a 9
nucleotide sequence difference within the 5'UTR which stabilises a long range RNA-
RNA interaction (in genotype lb) between the 5'UTR and nucleotides 67 to 588 of
the core gene, down regulating IRES function (Honda et al. 1999). Ribonuclease
cleavage analysis highlights a number of differences between the stem loops of
genotypes la and 2a. For example, the single stranded terminal loops of structures
SL47 and SL443 in genotype la show evidence of transient base pairing, which is
not the case for genotype 2a. It is possible that such differences may be evidence of
differing long range interactions which could affect virus phenotype.
An important aspect of the HCV replication cycle is that RNA transcription is
confined to the virus genome and does not results in the amplification of cellular
messenger RNAs (McKnight and Lemon 1998). For many positive-sense single
stranded RNA viruses, such as rhinovirus type 14, specificity is believed to be a
result of unique interactions between the replication complex proteins, RNA
structures within the 5' and 3' UTRs and cA-acting replicating elements (CRE)
within the coding sequence of the virus (McKnight and Lemon 1998). A number of
cA-acting elements have been described in positive-sense RNA viruses including
enteroviruses (Goodfellow et al. 2000), cardioviruses (Lobert et al. 1999),
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aphthoviruses (Mason et al. 2002) as well as rhinoviruses (McKnight and Lemon
1998).
Electrophoretic mobility shift and competition assays have revealed that
recombinant NS5B protein (RdRp) preferentially binds the 3' end of the NS5B
protein coding region, between positions 8916 and 9115 (Cheng et al. 1999). This
region includes stem loop structures SL8926, SL9011 and SL906. It has yet to be
elucidated whether these stem loops are specifically involved in the binding the
NS5B protein, or the replication complex. However, their presence within this
region and high degree of conservation between divergent genotypes is suggestive
that they may be involved in strand initiation in the same way as the picornavirus
CREs template strand extension from the 3' end of the genome.
The 3'UTR ofHCV has been shown to be absolutely required for virus infectivity
in the chimpanzee animal model (Yanagi et al. 1999). It has also been shown that
the helicase domain of NS3 and polpyrimidine tract-binding protein (PTB) bind to
stem loop structures within this region (Banerjee and Dasgupta 2001) (Ito and Lai
1997). NS3 forms a complex with NS5B and is required to unwind paired RNA and
PTB binds both the 5' and 3' UTRs circularising the full length RNA; suggesting
that RNA structures within the 3'UTR may play a role in viral replication and/or
regulation of translation. The 5' boundary of the RNA structures within the 3'UTR
has yet to be defined. Consequently it is possible that the binding of the helicase
domain of NS3 and the PTB protein to stem loop structures in the 3'UTR (Banerjee
and Dasgupta 2001; Ito and Lai 1997), may involve additional interactions with
adjacent RNA structures in the NS5B region.
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The stem loop structures predicted in this study would be amenable to functional
investigation through mutational analysis of replicating clones of HCV.
Unfortunately, the only animal model available for HCV infection and replication is
currently the chimpanzee and its use is limited for ethical reasons, its scarcity and
high cost ofmaintenance. Further more, no cell culture system for HCV has yet been
described in which the virus replicates to a sufficiently titre or level of
reproducibility to allow detailed in vitro analysis of its molecular biology.
A subgenomic replicon system, in which the structural protein coding regions have
been removed, has recently been developed which replicates to high titre in the
human hepatoma cell line Huh-7 (Lohmann et al. 1999). The replicon system would
allow mutational analysis of the stem loop structures within the NS5B region.
Unfortunately the stem loops predicted towards the 5' of the coding region fall
within the core gene which has been removed from the replicon. The lack of
structural region may also disrupt potential long range RNA-RNA interactions
making the system less realistic. It would be possible to investigate potential
interactions between the RNA structures and viral or cellular proteins with a
Saccharomyses cerevisiae three-hybrid system (SenGupta et al. 1996). This has
recently been used to study the interactions between the 3'X region of HCV and
human ribosomal proteins (Wood et al. 2001).
In summary, ribonuclease cleavage analysis has been used to physically identify
the position and structure of eight stable stem loop structures within the HCV coding
region. The role of these stem loops has yet to be established but evidence presented
in this study of their conservation between diverse genotypes, close proximity to the
highly structured 5' and 3' UTRs and possible long range RNA-RNA interactions is
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Recently a number of observations have suggested the existence of constraints on
the sequence divergence of HCV, HGV/GBV-C and related viruses. Various lines of
evidence, including the geographical spread of the virus and infection of old and new
world primates, suggest that HGV/GBV-C has always infected the human population
through co-speciation. However, the lack of sequence diversity and high rate of
nucleotide substitution observed in the virus suggests a relatively recent time of
infection and diversity in the human population. This apparent contradiction has
been accounted for with the observation of reduced variability at synonymous sites
and clustering of covariant substitutions which suggest constraints on sequence
divergence, out with those normally imposed by the requirement to encode
functional protein translation products. It has been proposed that such constraints are
due to the presence of evolutionarily conserved RNA structure within the coding
region of the virus genome. The genome of HCV exhibits greater diversity than
HGV/GBV-C, although constraints on sequence change at synonymous sites and
clustering of covariant substitutions are observed, in particular towards the 5' and 3'
regions of the genome. It has been suggested that these biases in sequence
divergence are due to the presence of evolutionarily conserved RNA structure, in
which the requirement to maintain nucleotide pairing constrains the potential for
nucleotide substitutions.
In order to fully investigate potential RNA structure in the coding regions ofHCV
and HGV/GBV-C the genomes of both viruses were analysed for regions of excess
folding free energy (FFEs), which was shown as being indicative of sequence
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dependant RNA structure (chapter 3). Previously published analysis of RNA
structure in eukaryotic and prokaryotic genomes reveals a number of potential causes
of artefactual results such as the disruption of regional differences in nucleotide and
dinucleotide composition in the calculation of FFE differences, between native and
randomised sequences. In order to overcome this, a number of sequence
randomisation methods where developed and assessed, which maintain local
sequence heterogeneity during analysis. Each method gave comparable results,
indicating that figures of FFE presented in this study are not due to the
homogenisation of composition biases within the sequences analysed.
Large excesses in FFE were observed across the genomes of both HCV and
HGV/GBV-C. The results were comparable to those of known highly structured
RNA genomes, such as plant viroids and the non-coding region of hepatitis delta
virus and are suggestive of extensive sequence dependent RNA structure across the
coding regions of HCV and HGV/GBV-C. The greatest FFE differences were
observed within the core gene and NS5B coding region ofHCV and NS5B region of
HGV/GBV-C which is in close concordance with regions of reduced synonymous
variability and clustering of covariant substitutions.
These observations of large differences in FFE across the coding regions of HCV
and HGV/GBV-C suggests that sequence dependent RNA structure is distributed
throughout the virus genomes and is not restricted to the 5' and 3' UTRs. Such
structure would account for the biases observed in nucleotide substitutions within
HCV and HGV/GBV-V and the lack of sequence diversity observed in HGV/GBV-C
and related viruses.
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Specific predictions of RNA secondary structure were made for the NS5B
regions of both viruses as well as the core gene of HCV (chapter 4). Predictions
were made using a combination of thermodynamic and phylogenetic methods
including free energy minimisation on folding, structure conservation between
genotypes and the occurrence of both covariant and semi-covariant substitutions.
Combining these methods, the computational data presented in this thesis
demonstrates and predicts the existence and structure of at least ten evolutionarily
conserved stem loops in the core gene and NS5B region of HCV (Tuplin et al.,
2002). The structure of a further eight stem loops was demonstrated in the NS5B
region and seven in the 3'UTR of HGV/GBV-C (Cuceanu et al., 2001). High
frequencies of covariant and semi-covariant substitutions were noted within all but
the terminal two structures within the 3'UTR of HGV/GBV-C, in which extreme
conservation of nucleotide sequence was observed.
These predictions confirm the existence of a number of structures predicted
independently by simple sequence inspection (Han and Houghton, 1992; Smith and
Simmonds, 1997), or by a comparative RNA-folding algorithm that identified
covariant sites through the comparison of phylogenetically conserved RNA
structures (Hofacker et al., 1998). The former two studies predicted the existence of
SL9011 and SL9118; the latter SL7729 and the terminal seven out of twenty four
paired nucleotides in SL8828. However, with the exception of SL9118, there are a
number of discrepancies between the conformation of previously predicted structures
and those presented in this thesis. These differences may be explained by the
expanded data set used in this study, which included all epidemiologically unlinked
HCV and HGV/GBV-C complete genome sequences available on GenBank, and the
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shorter distances over which the sequences were previously analysed which may
have limited the potential for RNA folding.
Free energy minimisation and RNase cleavage experiments have previously
demonstrated the existence of stable secondary structure towards the distal part of the
3'UTR of number of different flaviviruses (Proutski et ah, 1997; Brinton et ah, 1986;
Rice et ah, 1985), HCV (Kolykhalov et ah, 1996; Tanaka et ah, 1996; Blight and
Rice, 1997), GBV-A and GBV-B (Sbardellati et ah, 1999), pestiviruses (Yu et ah,
1999; Deng and Brock, 1993) and the Picornaviridae family (Witwer et ah, 2001;
Mellits et ah, 1998). Further studies have provided evidence of specific interactions
between these regions and both viral and cellular proteins involved in virus
replication (Banerjee and Dasgupta, 2001; Ito and Lai, 1997) and determined which
regions of the HCV 3'UTR are critical for replication of HCV in a chimpanzee
model (Yanagi et ah, 1999). The terminal two structures predicted in this study in
the extreme down-stream region of the HGV/GBV-C 3'UTR closely resemble those
predicted in HCV, GBV-A and GBV-B. However, there is no evidence for a
conserved third stem loop in HGV/GBV-C which forms a characteristic cloverleaf
conformation in HCV, GBV-A and GBV-B. Further, the terminal loop of
HGV/GBV-C is shorter (14 nucleotide pairs) than those previously predicted in HCV
(19 nucleotide pairs) and GBV-B (21 nucleotide pairs).
A multisite RNA transcript priming method was used to enzymatically map the
extensive predicted RNA structures in the core gene and NS5B region of HCV
(Chapter 6). The use of long RNA transcripts for nuclease digestion was essential to
allow stem loop formation to occur in as natural a context as possible, and in
particular to enable potential interactions between RNA secondary structures, such as
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the formation of pseudoknots, to occur prior to nuclease cleavage. Whilst the
nuclease mapping data generally corresponds to the predicted structures for
genotypes la and 2a, there were some instances where the two methods make
discordant predictions. Such discrepancies included the observation of Vi (paired
nucleotides) cleavage at one or two out of the five bases in the single stranded
terminal loop of SL47 and the predicted single stranded bulge within the base paired
stem. This and similar observations, including apparently both single stranded and
paired residues, in a number of stem loops provide evidence for additional base
pairing; suggesting the formation of higher order structures such as pseudoknots
between adjacent secondary structures.
Experimental data on the function of RNA structures in the genome of RNA
viruses is far from complete, particularly for those in the genomes of HCV and
HGV/GBV-C described here. However, evidence for a role ofRNA structure within
the core gene of HCV in translation has been provided by the observation of
enhanced translation of a dicistronic reporter system, when a predicted long range
interaction between nucleotides -317 to -302 was disrupted (Kim et al., 2003). It has
also been shown that a deletion between nucleotides -317 to -302 of the 5'UTR
enhances translation but only when nucleotides 66-588 of the core gene are included
in the construct (Honda et al., 1999). Three RNA structures SL47, SL87 and SL443
fall within this region and may thus play functional roles in regulation of translation.
At the other end of the genome and perhaps functionally analogous to the CRE
structures found in the coding regions of picornaviruses, the NS5B protein (RdRp) of
HCV has been shown to preferentially bind to the NS5B RNA sequence 8922-9121,
a region which includes SL8933, SL9017 and SL9067. Consequently these
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structures may be involved in strand initiation in a similar way to picornavirus CRE
initiated strand extension from the 3' end of the genome. The upstream limit of the
functional structures mapped in the 3'UTR of HCV has yet to be fully defined.
Therefore, it is possible that the binding of the helicase domain ofNS3 and the PTB
protein to stem loop structures in the 3'UTR may involve further interactions with
adjacent structures within the NS5B region.
Negative staining followed by transmission electron microscopy and gold label
hybridisation was used to directly visualise the folding conformation of the NS5B
coding region and 3'UTR of HGV/GBV-C (chapter 5). The NS5B coding region
was observed to fold onto a cruciform conformation which was consistent with
computational predictions of overall RNA folding conformation, based on free
energy minimisation. Even though electron microscopy provided information on the
identity and presence of a number of stem loop structures, within the NS5B coding
region of HGV/GBV-C, it proved less useful than ribonuclease mapping in providing
detailed information on discrete stem loop structures. In particular definitive
visualisation of the 3'UTR of HGV/GBV-C was not successful. This may have been
due to the fact that less RNA folding and shorter structures were predicted in this
region, which were not large enough to resolve against the negatively stained
background.
Electron microscopy proved more useful in visualisation of the genome wide RNA
folding structure of HGV/GBV-C; predicted to exist by excess FFE in HCV and to a
greater extent HGV/GBV-C. The genome ofHGV/GBV-C was observed to fold into
four main negatively stained structures radiating from a central core. The IRES (as
confirmed by specific gold label hybridisation) was presented at a kink
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approximately half was along a radiating stem. The observed genome wide folding
of HGV/GBV-C was similar to that previously observed of HCV (Lucy Beales,
personal communication).
In summary, a combination of thermodynamic, phylogenetic and physical methods
have been used in this thesis to computationally and physically identify and confirm
a number of conserved RNA structures in the coding regions of both HCV and
HGV/GBV-C. Excess folding free energies have also indicated that genome wide
RNA folding may exist in both viruses, although it is not clear why this might be
more extensive for HGV/GBV-C than HCV. However the degree of structural
conservation between diverse genotypes is consistent with roles for the predicted
structures in one or more aspects of virus replication and/or interaction with the cell.
Whilst these are currently not understood in any detail, the downstream HCV
structures predicted in this thesis are providing a starting point for such functional
studies using HCV replicons.
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APPENDIX
2.1 POLYMERASE CHAIN REACTION
2.1.1 EXTRACTION OF VIRAL RNA FROM SERUM SAMPLES




1 mg/ml Proteinase K
40 jig/ml polyadenylic acid
Phenol (Rathburn Chemical Ltd)
Chloroform
Isoamyalcohol (BDH)
Sodium acetate (pH 5.2)
100% ethanol
2.1.2 REVERSE TRANSCRIPTION OF VIRAL RNA






Nucleotide triphosphate mix (100 mM stock solution; diluted to 4 mM; Promega)
RNasin (Ribonuclease inhibitor 20 U/pl; Promega)
Avian Myeoblastosis Virus Reverse Transcriptase (AMV; Promega; 1 U/pl)
2.1.3 and 2.2.5 PCR AMPLIFICATION




Nucleotide triphosphate mix (100 mM stock solution; diluted to 3 mM; Promega)
Taq polymerase (5 U/pl; Promega)
2.1.4 ANALYSIS OF PCR PRODUCT
1 % agarose gel: 1.5g agarose (Flowgen)
150 ml 1 x TAE
0.07 pg/ml ethidium bromide (Sigma)
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50 x TAE: 242g Tris base (Sigma)
57.1 ml glacial acetic acid (BDH)
37.2g EDTA (Sigma)
Make up to 1L with distilled water
1 x TBE used as electrophoresis buffer in gel tank
2.2 CLONING OF PCR PRODUCT
Luria Broth (LB) medium: 10 g Bacto-tryptone (GIBCO-BRL)
5 g Bacto-yeast extract (GIBCO-BRL)
lOgNaCl
Make up to 1L with distilled water sterilize by autoclaving
Make up to 1L with distilled water: Add 15 g of agar (GIBCO-BRL) to 1 litre ofwater
and sterilise by autoclaving. Allow to cool before adding 0.5 nM IPTG: 80pg/ml X-
Gal and 100 pg/ml ampicillin.
2.2.7 DNA SEQUENCING
Termination mix: 7.5 pM each of dATP, dCTP dGTP and dTTP
0.5 pi [<x-33P] ddATP, ddCTP ddGTP or ddTTP (0.45 pCi/pl)
(Amersham)
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Reaction mixture: 260 mM Tris-HCl, pH 9.5
65 mM MgCl2
0.15 mM antisense primer
4 U of Thermo Sequenase polymerase 4 U/pl (USB)




5% denaturing acrylamide gel: 21 g urea (Ana-BDH)
5% v/v Ultrapure Sequagel concentrate (acryhbis-acryl
= 19:1) (National Diagnostics)
5 ml of 10* Sanger TBE
0.05 g ammonium persulphate
20 pi ofTEMED (N,N,N,Ntetramethylethlediamine)
(Sigma)
Make up to 20 pi with distilled water
10 x TBE: 324g Tris base
85 g Boric acid
19 g EDTA
Make up to 2L with distilled water
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2.6. THERMODYNAMIC PREDICTION OF FOLDING FREE ENERGY (FFE)
AND STRUCTURAL PREDICTION
Sequences analysed for comparative structural predictions (chapter 4): Sequences
analysed for FFED are shown underlined (chapter 3).
HCV (genotype la): AF011751, AF064490, AF511948, AF511950, AY051292,
D50409, HEC278830, HPCCGS, HPCHCJ1, HPCPLYPRE.
HCV (genotype lb): AB049087, AB049088, AB049089, AB049090, AB049091,
AB049092, AB049093, AB049094, AB049095, AB049096, AB049097, AB049098,
AB049099, AB049100, AB049101, AB080299, AF139594, AF165045, AF165047,
AF165049, AF165051, AF165053, AF165055, AF165057, AF165059, AF165061,
AF165063, AF207752, AF207753, AF207754, AF207756, AF207757, AF207758,
AF207759, AF207760, AF207761, AF207762, AF207763, AF207764, AF207765,
AF207766, AF207767, AF207768, AF207769, AF207770, AF207771, AF207772,
AF207773, AF207774, AF208024, AF313916, AF333324, AF356827, AF483269,
AF511949, AY045702, D85516, D89815, D89872, HCJ238799, HCU01214,
HCU45476, HCV132996, HCVJK1G, HCVPOLYP, HPCCGENOM, HPCGENANTI,
HPCHUMR, HPCJ491, HPCJCG, HPCJRNA, HPCJTA, HPCK1R1, HPCK1R2,
HPCK1R3, HPCPP, HPCRNA, HPCUNKCDS, HPVHCVN,
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HCV (genotype 2a): AB030907, AB031663, AB047639, AB047640, AB047641,
AB047642, AB047643, AB047644, AB047645, AF169002, AF169003, AF169004,
AF169005, AF177036. AF238481, AF238482, AF238483, AF238484, AF238485,
AF238486, HPCJ8G, HPCPOLP,
HCV (genotype 3a): AF046866, HCVCENS1, HPCEGS. HPCFG, HPCJK046E2,
HPCK3A,
HCV (genotype 4a): HCV4APOLY.
HCV (genotype 5a): HCV1480.
HCV (genotype 6a): D84262, D84263, D84264, D84265, HCV12083. HPCJK049E1
HGV/GBV-C (genotype 1): U36380. AB013500, AB003291
HGV/GBV-C (genotype 2): AB013501, AF031829, D90600, D87255, AF104403,
U63715, U44402. AB003289, U45966
HGV/GBV-C (genotype 3): D90601. D87263, AB008342, AB003288, AB003293,
AF006500, AB003290, U94695
HGV/GBV-C (genotype 4): ABQ18667. AB021287, AB003292,
246
HGV/GBV-Ccpz: AF070476
GBV-A: NC 001837. U22303. AF023425. AF023424
GBV-B: NC-001655
The coding regions of the following mammalian sequences were used as FFED
negative controls (chapter 3):
Actin: BCQ15695
Albumin: AF116645. X84842. Y17729. AB006197. XY4045. M90463. U01222;
Alphaglobin: V00493. XQ5289. M12158. X02008. M17083.
HLA DRwl2 beta 1-chain
The following sequences were used as FFED positive controls (chapter 3):
Plant viroid: X53715. U23058. AJ247123. L78463. X76846
Delta virus: AF098261. AJ000558. M31012. D01075. M28267
247
Sequencesalignmentscr at dforompa ativestructuralp di tions(cha er4)(genotyplbi tshowntHCVsequence alignment): HCV:Coregene -2099 1 AF011751GGTCTCGTAGACCG GCACC TGAG ACGAT ACTCAAA ACAA TA C CCG C AC T AGT G TGGATT T A AF06449.AC..T AF511948 AF511950 AY051292TC... D50409TA.AC..T..C HEC278830T HPCCGST... HPCHCJ1T... HPCPLYPREA AB030907...C.A AB031663.AC.T..C AB047639.AG.TC. AB047640C.ATC. AB047641.C.ATC. AB047642C.AGT G...T AB047643.ATC. AB047644T.AC.G. AB047645.ATC. AF169002.ATC. AF169003T.AC..A... AF169004T..A.A.T..TC. . AF169005.AGTC... AF177036.ATC. AF238481T.AC. AF238482.A..T..TTC. . AF238483.ATC. AF238484T.AC. AF238485.ATC. AF238486T.A.G.ACC. HPCJ8GTA.AC. HPCPOLPA.AT. AF046866CT.AT HCVCENS1AT.AT HPCEGSACT.AT HPCFGATC..A..ACT..CATG HPCJK046E2TA.A.TG HPCK3AT.ATC.AAG ...TA .TG... HCV4APOLYATT..C.. HCV1480A.A.T D84262ACT.A D84263TACT...AG..A.C..A.A D84264ACT...A.ATT D84265TACT...A.AAT HCV12083TA T...A.AT. HPCJK049E1TA T.AC..G.C 248
AF011751 AF06449 AF511948 AF511950 AY051292 D50409 HEC278830 HPCCGS HPCHCJ1 HPCPLYPRE AB030907 AB031663 AB047639 AB047640 ABO47641 AB047642 AB047643 AB04764 AB047645 AF169002 AF169003 AF169004 AF169005 AF177036 AF238481 AF238482 AF238483 AF238484 AF238485 AF238486 HPCJ8G HPCPOLP AF046866 HCVCENS1 HPCEGS HPCFG HPCJK046E2 HPCK3A HCV4APOLY HCV1480 D84262 D84263 D84264 D84265 HCV12083 HPCJK049E1
100
■)
GTTTACTTGTTGCCGCGCAGG G C TA AG T TGCC ACGAA AC CAGCGG CGCGG GT AG GA..TC..AC .T .AC.G
219
■)
CCTATCCCCAAGGCA GTCGGCC GA GGC G..C.AA G










































































































































































































































..A...G..A .AA .C. T ..AC CA. AC. TA..C.
.T..AGT.C.C
C. T.
.C..T.. .CA .CA .CA .A .CA
TA.
AC.G. A AC.G.
.G. ..G. .G. C.G. C.G. .G.
.AA. ,C..A .C. .C.A .C.
T A .C..A..A. .C..A..A. .C..A.A. A..A. .C
.AG...A. A







AF011751 AF06449 AF511948 AF511950 AY051292 D50409 HEC278830 HPCCGS HPCHCJ1 HPCPLYPRE AB030907 AB031663 AB047639 AB047640 AB047641 AB047642 AB047643 AB047644 AB047645 AF169002 AF169003 AF169004 AF169005 AF177036 AF238481 AF238482 AF238483 AF238484 AF238485 AF238486 HPCJ8G HPCPOLP AF046866 HCVCENS1 HPCEGS HPCFG HPCJK046E2 HPCK3A HCV4APOLY HCV1480 D84262 D84263 D84264 D84265 HCV12083 HPCJK049E1




...GGAA.ACCT. TT..A .T. C..T..CTCA.
A.T. A.T.
.T.
...GAA.A..A.. .GAAGA.A. .G.A.A.A.AC .GAA.A.A.C .GAAA .GAA.A.A.C .GAACA.A.
.G. .A. .A. .A. .A. .A. .A.
GCT..CA.TT .CTCT. ACT...CA..T .C. .TCT. GCT..CA.TT .CTCT. GCT...CA..T .C..T..CTCT. ACT...CA..T ..T.CTCT. ACT...CA..T ...T..CTCT.
.T .AT .AT •AT. .AT .T .T .AT
.TCT
A.TGAACA..A.CT.. C A.T. A.T. AAT. A.T. A.T. A.T. A.T. A.TGAA A..A..C.CG..C. A.TGAA..A.... CA. CC.TG. A.TGAA.... C..A. CCT.G. AATGA .A..A.CCGCT ....T .C. T..CTCT. C..TTA G..G..CT..ATCTAT C..TT CA G..G.. ATCTAA A . C..TT..CA G... T..ATCA AT C..T.G. T..TAT C C. .....GAA.AACACT.. C..GA..Y .T.CTCT. ....GAA.AACACT.. C..GA..TT . ....GAA.AA.CA..C.GCT . CA..T .T.CTCT. ....GAA.AACA..CGCTCA T .T.CTCT. ....GAA.AACACT . C..T T.CTCT. ....GAA.AACACT.. CA..T ..T..CTCT. ....GAA.A.ACACT.T C..T T.CTCT. ACT..C.TT .CTCT.
..T .T .AT .AT .T .T .T .AT
.CATT .CTC
.C.AA.AT
C.TGGT.A.. ..A.CGA.AC. C..T.. ...T.. C..T.. C. C.T... C..CA..CT .A.. G..A GT. .AT T.C .T. T.T.TCA..G... C..T..A.AT..C.. .AT .T..T..C.TACGTCTA.AT ....T..C.CA.CT..G. G.. ..CAA GCA..CTAC.. TCTA. C C..G...AT..C..GCAT.A T..CCA..G
.T..C.A.
C.T.GG...ATA.AT. ...CAAT..T.GC..A..C TA . C..TAGG....CC..AT G.
.AT .A.AT .AT .A.AT
250
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.A C C c C.A..G. C..T.A. C ..A..C.
,C..G ,CTGC. ,CTGC. ,CTGC. CA.C.









CA. CA. CA. CA. CA. CA. CA. CA. .A. CA. CA. .A. CA. .A. CA. CA. CA. .A, .A. .A. CA. .A. .A, .A, AA. GA. •A. .A. .A. CA. .A.
G.A G.TG GTT. GTT. GTTT GTT. GTTT GCT. GTT. GCTG GTT. GTTT GCT. GTT. GTT. GTTT GCT. GTTT GTT. G.A G..A GTT. GTT. GTTT GTT. GTAT GTA. G.A GCA. GTAT GTTT GTA. GTA. GTA. GG.A GTT
.CAGC.AA...C .CAGC.A.. C .CAGC.A...TC .CAGC.A.. C .CAGC.A.. C .CAGC.A.. C .CAGC.A.. C .CAGC.A... C .CAGC.A...CC ..AGC.A.. CC .CAGC.A.. C .CAGC.A.. TC .CAGC.A...TC .CAGC.A.. C .CAGC.A...CC .CAGC.A...CC .CAGC.AA.. C .CAGC.A...CC .CAGC.A.. C .CAGC.A.AC .CAGC.AA...C .CAGC.A...CC .CAGC A .CAGC.AA .CAGC.A .CAGC.AA..AC CA...TC .CAGC A .CAGC.A.A. .CAGC.A...CC
..TC.. .GTCT. ...C.. .GTC.. .GTC.. .GGC.. .GGC.. .GGC.. .GTC.. ..GC.. .G.C.. .G.C.. .G.C.. ...C.. .G.C.. .GGC.. ..TC.. .G.C.. .G.C.. ..TC.. .TC. .G.C.. CTC.G. CCC.G. CCC.G. TCC.A. ..TC..
C.AA ...A..CC TCC .?CC C.A..AC
.CAGC.A..AC
CCC.G. .CCTT. .GC.A. ..TCA. .GTCA. .CTA. .GCT.. ..TCA. .GC...
T..A T..TA T..A G..A G.A G.A A..A G.A G.A G.A G.A G.A A.A G.A G.A G.A G.A T..A G.A T..A
A
G.A TG.. T..T. T..T. T..T.
GC.T GC.T AC.T GC.T GC.T GC.C GC.T GC.T GC.T GC.T GC.T GC.T GC.T




.A. .A. .C. .C. .C. .C. .T. .C. .C. .C. .C. .C. ..C. .C. .C. ..C. .C. .C. .C. .A. .C.
T..C. A..C. T..C.
.T. G.C.
.T .A .G .G .G .G .G .G .G .G .G .G .G .G .G ..G .A .G .G .T ..G
T..A T..A T..A
.CT. .G. .G. .G. .G. .G. .G. .G. .G. .G. .G. .G. .G. .G. .G. .G. .G. .G. .G. .TT. .TT. .G. .TT. .T. .T. .CT. .C.
T..C.
.A. .C. T..C.
C..T.. C..C.. A..C. T..C. C..C.. C..C.. C..C.. T..C. c..c.. c..c.. c..c.. C..T.. C..C.. C..C.. C..T.. C..C.. C..C.. C..T.. C..C.. C..T..C C..C..C T..C... .C.T..C .C.T..C .C.T..C .C.T..C CC.C..G .C.T..C




T..A ..G.G... .TG.G..A .TG.A..A ..GCA..A
.TA. .A. .A. .A. •A. .AA •A.A..A. .A. .A. .A.








,G ,C..T. ,C ,C ,C ,C











.A. G.A. .C. T..T.
.G .G T..G T..G
C..T..C C..C.. CC.C..A .C.C..C AC.C...
TCTG.


























.AT TAA.. .AA. .AT
.C.C.
G..C..C..T G.CA CA..A G..C..C..T G
.C G..CCAA..C G...CA...A .CCA .CCA .CCA ...CCA...A .CCA .CCA .CCA .CCA .CCA .CCA ..CCA .CCA .CCA .CCA .CCA .CCA ..CCA G..CCAA..T G..CCAA..T G..CCA GAC..C





















T.TT... .TT...G ..TA..G .TA.G .TA.G .TA.G ..TA..G .TA.G ..TA..G .TA.G ..TA..G ..T...G ..TA..G .TTA..G .TA.G .TA.G ..TA... ..TA..G .TA.G T.TC... ..TT... .TTA..G .ACA.G .ACA.G .ACA..G .ACC... •AT..G .ACA.G .AC...C TTTA..CT A.A...G G.AA.. TGA AACC..C A.A...C AAA
A...AA.. ...CAAG. ...CAAG. T..CAAG. ...CAAG. T..CAA.. AC.CAAG. T..CAA.. T..CAAG. T..CAAG. T..CAAG. T...AAG. T..CAAG. T...AA.. T..CAAG. AAG. T...AAG. T..CAAG. T..CAA.. A...AAG. G...AAG. AAG. TGCGAAC. TGCGAAG. TGCAAAG. .A.CA... T...AAG. TGCGA.G. .ATCA.G. A.. G...A.G. G..CA... .C TG. .CAG .ACCAA..








G..A G.A G.A G..A
A
G..A G.A G.A G.A G.A .A .A .A ..C. .C. AAC. G.T. T..C.
.C. G.C.. .AA. CAACA CAA.. ..C. C..CT CAACA C..A
GTA..TCCT.. GT..CTCCT.G. GTT.CGCC...A ATT.CGCC...GG GTT.CGCC...A GTT.CGCC...A GTT.CGCC...A GTT.CACCT..A GTA.CGCC...A GTT.CGCC...A GTT.CACC...A GTT.CGCC...A GTT.CGCCT. ATC.CGCC...AG GTT.CACC...A GTT.CGCC...A GTT.CGCC...A GTT.CGCC...A GTT.CGCC...A ATCCT.G. GTCCTGT ..T.G. ATT.CGCC...AG
.GCCGA.T.T. T. .G.A..CCGGA.T.T..T. .G.A..CCGGA.T.T..T. .A.AA..CCGTTT.C..T. .A.AA...TTGT.G. .G.A..CCGGA.T.T..T. GAGAT..T.G. ..GGC.C..G.
.A
A.AA.T.TTG A.ATTG ACCA..ATG ACA..T.ATG ATG A.A..TCCAT.AT.C..T.
.G. .T.G. .T.G. .T.G. .T.G.
.C A..CT A..C A..C A..C A..C A..CT A..C A..C A..C A..C A..C A..CT .C A..C A..C A..C A..CT
A. A.
A..CT C..C..A..T C..C..A..T C..C..A..T CA. C..C..A... C..C..A..T T..C..T..T AT.. A..C..A..T C..C..A.. C..C..A.. C..C..A... ...C..A..T C..C..A...
..C.G..T. .CA .CA G G..T. G..T. G..T. G..T. G..T. G G G..T. G..T. G..T. G..T. G..T. G..T. G..TA G..T. ..C.G ..C.G G..T. .TC.G .TC .T..G .T..G..G. •T..G..G. .TC.G ..C.T..G. .TC.G..G. ..C.T..G.
A.
.T..G..T. G..G. G
.CCG. .CCA. .CCA. .CCA. .CCA. .CCA. .CCG. .CCA. .CCA. .CCA. .CCA. .CCG.
CA..
.CCA. .CCA. .CCA. .CCA. .CCA. .CCA. .CCA. .CCA. •CA.. .GG.GGCC.. .GG.GGC... .GG.GGC... .G..A.C... .CC .GG.GGCC.. .C...GC... CC. .C..T .C..T.CC.. .C..TGC... .CG.AAC... .C..T .A..TGC...
AATG ACTG ACTG ACTG ACTG ACTG AC.G ACTG ACTG ACTG
GAC..C GAT..C G...TGC..T G...TT GAT..C G..C.AC..C G..CCA G..C..C..C G.AT G..C..C..A
T..A
GT..C GA.
ACTG AA.G AA.G AC.G ...G.T... ...G.C... ...G.T... .GA ...TC ...G.T... .AG ACA..C..A ..A ...GCC... .T ..GA.C...
A
A..G.T




AFO11751TTCACGGAGGCTATGACCAGG CTCCGCCCC CC GG GA CA AA A TACGA TT CTAT TT CCT T AGGAG C T A AF064490.TT..TG . ..GT..T C ..T..C.ACGTT.C . ..C AF511948TCG AF511950CT AY051292G..A.TCTG G D50409TC..T..T..CA.G•GT..A .G..GTTA..CCGCGA..C HEC278830TGT HPCCGSG..ATT .T.. HPCHCJ1TGT...A HPCPLYPRET AB030907T....TT..CAG.. GCA .G..A..G.TG..TCTC .. AB031663..T..T..TCAG..A.T..A..T.TT A.CAGCA...T ABO47639CT..T..T..TAG.. G..CT.G..GTTG.GCCGC . AB047640T..T..T..TCAG...G.CT .G..A.TT.GCC CA .. AB047641T..T..T..CCAG...GGT T.T.G..GTTG.GCCACAA. AB047642..T..TTCAG...GCGT.A..G.TT.G.CCACAA. AB047643T..G..TCAG.G.CT. .T.A..G.TG.GCCACAG.. AB047644T..T..T..T.CAG.GGT .T.G..A.T..GCC CAG. AB047645T..T..T..TCAG.G..CGT T.G..A.T..GCCGCAG. AF169002T..T..T..TCAG...G.CT .T.G..G.TG.G.CCGCAG.. AF169003T..TTCAG.G..CG.AT.G..A.GG..CCACAG.. AF169004T..TTCAG.G...CGA.T.G..A.GG...CCACAG. AF169005T..T..T..TCAG...GCG. ..T..A..C.G. ART..GCC CA . AF177036T..T..T..TCAG...G..G..TTCG.G .G.TG.G.CCACAA.. AF238481T..T..T..TCAG...GCGT.G..A.T..GCC CAG.. AF238482T..T..T.CAG...CGT. T.GCA.TTG.G. CACAA.. AF238483T..T..T..T.CAG..G.CGT .TC .G.G.TGA.CCACTG. AF238484T..T..T..TCAG.GG.T.GTTG.GCCACA .. AF238485T..T..TCAG.G..CG. .T.G..A.T..G.CTACAG. AF238486T....TT..CAGCA..G..A..G TG.CCTCG. HPCJ8GT....TT..CAG.GA. .A..G.TG...TCTC G. HPCPOLPT..T..T..TCAG.G...CG.T.G.GT .CCACAA..C AF046866T..T..T..AG C CCC. .C. ..G..A GG...A.AAG..G HCVCENS1T..T..AA TGG CACC.T. ..A..A.TG...A AAG..G HPCEGST..T..T..AA G.TGG.CACTC. .C.G..A.GG..A.AAG. HPCFGCA..T..T..TT. A.G CACC.. ..ATGA .G . HPCJK046E2..TG G.T.. ..A.GAA..G..C..G TAA..C.GA A C. HPCK3AT..T..T..AA TG.TG CACCC. .C ..G..A.GG...ATAAG. HCV4APOLYG..A. T.. ..G.T..G... .CAT .ATGA .T HCV1480TG..T..TGT.. .C .. CGT. T A..C D84262..T..A..CT..AAG.GG..CACC.T ..AT . . . D84263A..AT .GA...G..G..G..G .T...C.CAC .C.A .T..T D84264A..T.T..T..C.GAA.TC .G..C. C..GA D84265T..A..GAA..TGAG..CC T CAGT..T. ..GT..A.A C HCV12083TA..T..A..G.T..GTACG. .. C CGT..TA.. A .G HPCJK049E1AT..A..CG..T...CACT.A. T.AG G 255




ACTACCTTACCCGTGACCCTA CCTCGCGAG GC C..G..CCCA GTA..G.T
CGCGTGGGAGACA CAA C T..T.A..
8649
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.CT •C.CA..G CT. .CT
T..T...
CGCC CG.C CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC CGCC
•G .G








.A.A. .A.A. AA.A. .A.A.
..C..T..AA .GC..T..A. ..C..T..A.




.A.A. .A.A. .A.A. .A.A. .A.A. .A.A.
..C..TT.AA ..C..T..AA ..C..T..AA ..C..T..AA ..C..T..AA G.C..T..AA ..C..T..AY ..C..T..AA ..C..T..AA ..C..T..A.
.T..CC.G. CC.G. CC.G.
T..C.. T..C.. T..C.. T..C..





















T..C. T..C. T..C. T..C.
.A .A .A .A
.TT .TC .TC .TT
.T.C..C. .TTC..T. .TTC..T. .T.C..T.
.A. .A. .A.
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T..C. T..C. T..C. T..T.
.A .A .A .A
.TT .TC .TT .T























.C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A •C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .C...CA..A .CA •CA .CA
.A..CC.G. .G..CC.T. .G...C... .TAG.
T..T. G.T. T.TA. T








TTGAT ..C..A..A. GTCA. ..T..T..A. GAG
,T...C... ,GT.TC.G. GT.AC... ,GG.
T..T. T..C. T G
..C.G. .CC.C.
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.TCC .TC .TTC .TTC .TC .TTC .TTC .TTC .TTC .TTC .TTC .TTC .TKC .TC .TTC .TTC .TC .TC .TCC .TCC.. .TCC.. ..TCC. .T.CC.
G.CA. ,C...G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C..
AC CA..C A.C
A..C A.C A. A..C A..C
..G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C.. ..G.C.. .G.CA. .G.CA. ..G.C.. .G..A
.A.C .A.C .A.C .A.C .A.C .A.C .A. .A.C .A.C
AC AT..C
A..C
.TC .TC .TCC .TC









T..CTC.A T..CTC.. ...CTC.A ...CTC.A ...CTC.A TC.A ..A.TC.A ...CTC.A ...CTC.A T.ACTC.A ...CTC.A ...CTC.A ...CTC.A ...CTC.A ...CTC.A ...CTC.A ...CTC.A T..CTC.A T..CTC.A TC.A ...CTC.A ...CTC.A T..CTC.A T..CTC.A T..CTC.A TC.A G.GA T..CTC.A T..CTCAA T..C
.A.AC.G. A..G.. TG.T ,TG.
G.
TG. T..G.. T..T..G..
.T..T..G.. ,TG. ...G.. ...G.. ...G.. ...G.. ...G.. ...G.. ...G.. ...G..,T. T. T. T. ,T. T. T. T.
,C...G.C.. .TGT .T...G.G.. .T...G ,T...G.T.. ,C...G.GA.
AT. C
CTC.A GCAA CCAAA CAAA .T..CTC.A .T..CTC.A
.A..AT.G.. .A.AT.G. .TG .A..CA.T. .A...CA.T. .A.CA.T. .A.GCA. .A...CAGC. .A.CA.T. .A.C GAG ,T..ACAGAG CA.TG .A..CA.T .A...CA.. .A...CA.. CAGT .A.GCA.
.CA. .CA. .CAA. .CA. .CAA. .CAA. .CAA. .CAA. TCAA. .CAA. .CAA. .CAA. TCAA. TCAA. .CAA. .CAA. TCAA. .CAA. .CAA. .CA. .CA. .CAA. .CA. .CA. .CA. .CA. TCAA. .CA. .CA. .CA. .CA. .CA. GCA.. ACA.. GCAA. TCA..
.C. .CACT .AACC .CACC .CACC .CACT .CACC .CACC .CACC .CACC .CACC .CACC .CACC .CACC .CAC. .CACT .CACC .CACC .CACC .CACT .CACT .CACT .ACT .GATA .GATA .GATA .G. .G. .GATA .AGCC .A.
.GA. .G.
C..A T..A. C.A C.A C..A C.A C..A C.A C.A C..A C..A C..A C..A C..A C.A C..A C.A C..A
.G. .GA. .GA. •G.
,G.. .AATA G.A ,GACT A..A G.A
.G.. T.G. .CC. .A. T.A.. T.G. .A..
C.AA C..AA C..A T.GAC T.GAC T.GCC .AGA. CA.A. T.GAC GA.A. .AA GGC.. TA.A. TA TAG.. GA.A. .A.A.
AG.
.C...G. .C..CG. A...C.. AC..A.. AC..C.. AC AC..C.. AC..C.. GC AC..C.. AC..C.. AC AC..C.. AC..C.. AC..C.. AC..C.. AC AC..C.. A...C.. A...C.. AC A...C.. A...C.. AC..C.. •C...G. .C...G. .C...G.













.T ..T T.T T.T T.T
•G. .G.T
T.T
.T .T .T .T
C..A.
.A. ..A.






.G .G..AGTA. AGTG. ..T.AGTA. ..T.GGTG. GGTG. ..T.GGTG. GGTG. ..T.GGTG. ..T.GGTG. GGTG. ..T.GGTG. ..T.GGTG. .GK.GGT.. GGTG. ..T.GGTG. ..T.AGTG. ..T.GGTG. ..T.GGTG. ..T.GGTG. .G..AGTA. .G..AGTA. GGTG. .G...ACT. .G...ACT. .G...ACT. .G..TAC.. .G.T.ACG. .G...ACT. ...T.AC..
GG
.T..TG
G G G G
AG












.A...G...T TG..AG...T •A...G...T .AT.CG...T .C..CG...T
C..C. C..T. C..C.
.C. C
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ABSTRACT
The existence and functional importance of RNA secondary structure in the replication of positive-stranded RNA
viruses is increasingly recognized. We applied several computational methods to detect RNA secondary structure in
the coding region of hepatitis C virus (HCV), including thermodynamic prediction, calculation of free energy on
folding, and a newly developed method to scan sequences for covariant sites and associated secondary structures
using a parsimony-based algorithm. Each of the prediction methods provided evidence for complex RNA folding in
the core- and NS5B-encoding regions of the genome. The positioning of covariant sites and associated predicted
stem-loop structures coincided with thermodynamic predictions of RNA base pairing, and localized precisely in parts
of the genome with marked suppression of variability at synonymous sites. Combined, there was evidence for a total
of six evolutionarily conserved stem-loop structures in the NS5B-encoding region and two in the core gene. The virus
most closely related to HCV, GB virus-B (GBV-B) also showed evidence for similar internal base pairing in its coding
region, although predictions of secondary structures were limited by the absence of comparative sequence data for
this virus. While the role(s) of stem-loops in the coding region of HCV and GBV-B are currently unknown, the structure
predictions in this study could provide the starting point for functional investigations using recently developed
self-replicating clones of HCV.
Keywords: coding; covariant; GBV-B; stem-loop; synonymous; thermodynamic
INTRODUCTION
Infection with hepatitis C virus (HCV) has been identi¬
fied as the principal cause of posttransfusion non-A,
non-B hepatitis (Choo et al., 1989; Kuo et al., 1989). It
is also a major cause of chronic hepatitis, cirrhosis, and
hepatocellular carcinoma throughout the world. HCV
has been classified as a member of the flaviviridae,
with a plus-sense RNA genome containing a single
open reading frame (ORF). Details of the replication of
HCV are currently poorly understood, principally be¬
cause of the lack of a method for its in vitro culture.
Recently a subgenomic RNA of HCV genotype 1 b lack¬
ing the region encoding the core, E1, and E2 proteins
was shown to be capable of self-replication in the hu¬
man hepatoma cell line, HuH-7 (Lohmann et al., 1999;
Reprint requests to: Peter Simmonds, Laboratory for Clinical and
Molecular Virology, University of Edinburgh, Summerhall, Edinburgh,
EH9 1QH, Scotland; e-mail: Peter.Simmonds@ed.ac.uk.
Blight et al., 2000), although without structural proteins
it lacked the ability to produce infectious virus.
The genome of HCV forms RNA secondary struc¬
tures in the 5' and 3' untranslated regions (UTRs) that
are likely to play a role in initiation of RNA replication,
and in the 5' UTR, for ribosomal binding associated
with its IRES function (Tsukiyama Kohara et al., 1992;
Reynolds et al., 1996). Unusually, efficient functioning
of the HCV IRES is dependent on sequences in the
downstream coding sequence (Honda et al., 1996a;
Reynolds et al., 1996), suggesting that RNA secondary
structures in the core gene may contribute to IRES
structure. Little attention has hitherto been paid to the
existence and functional importance of RNA second¬
ary structure in other parts of the genome. Through
analysis of variability at synonymous sites, and by analy¬
sis of covariance to determine sites of internal base
pairing, we obtained evidence for extensive RNA sec¬
ondary structure formation in the coding region of a
flavivirus related to HCV, described as hepatitis G virus
824
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(HGV) or GB virus-C (GBV-C; Simmonds & Smith, 1999;
Cuceanu et al., 2001). The essential role that a rela¬
tively small stem-loop in the middle of the coding re¬
gion of poliovirus (Goodfellow et al., 2000) plays in its
replication (Rieder et al., 2000) suggests that the struc¬
tures found in HGV/GBV-C may have equally signifi¬
cant roles in its life cycle. It is similarly possible that
RNA folding may represent functional components of a
much wider range of flaviviruses and other positive-
stranded RNA viruses.
In this study, we have therefore applied a number of
separate phylogenetic and thermodynamic prediction
methods to investigate the extent to which the HCV
genome may also be folded by internal base pairing.
Predictions of secondary structure that we have made
are amenable to future functional study through muta¬
tional analysis of replicating clones of HCV.
RESULTS
Suppression of synonymous variability
Reduction in the sequence diversity of synonymous
sites may result from constraints on sequence change
that arise from the formation of stem-loop structures
that influence virus phenotype (Simmonds & Smith,
1999). HCV sequences of different genotypes are highly
divergent in sequence, particularly at synonymous sites
(Smith et al., 1997). We therefore developed a method
to score synonymous variability that depends on the
overall phylogeny of the HCV sequences and recon¬
struction of the nucleotide sequence of each codon at
each ancestral node (Fig. 1). This method is more ca¬
pable of detecting multiple substitutions at each site
than simple pairwise comparison. It also correctly scores
Mean pairwise distance - 0.75 (90/120) Mean pairwise distance = 0.75 (90/120)
Parsimony distance = 0.13 (4 / 30) Parsimony distance = 0.33 {10 / 30)
FIGURE 1. Examples of the calculation of parsimony distances through reconstruction of sequence substitutions at two
separate nucleotide positions A and B. For the 16 sequences analyzed (1-16), the overall phylogeny and sequences of
ancestral nodes were estimated by a standard parsimony program (DNAPARS). At the two nucleotide positions shown
(A, B), nucleotides in each sequence and those reconstructed for each immediately ancestral node were compared to
estimate minimum number of sequence changes to produce observed pattern of sequence diversity. Position A: Nucleotide
site where variability is congruent with overall phylogeny and where 4 nucleotide changes can be reconstructed to produce
a parsimony distance of 0.13 (4 nucleotide changes in 30 comparisons). Position B: Site where variability is noncongruent
with phylogeny and where a minimum of 10 nucleotide changes are required (parsimony distance 0.33). By contrast,
conventional measurement of pairwise distances at the both sites A and B produce values of 0.75, representing saturation.
The measurement of pairwise distances at nucleotide position A is an overestimate because it treated every difference
between sequences 1-16 as phylogenetically independent.
POSITION A POSITION B
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individual substitutions that may occur deep in the phy-
logeny of a particular clade, and therefore avoids the
multiple scoring associated with averaging matrices of
pairwise distances.
Synonymous variability between HCV sequences of
different genotypes showed considerable differences
across the coding region of the HCV genome (Fig. 2A).
Consistent with the above analysis, heterogeneity in
synonymous variability was more apparent using par¬
simony than equivalent analyzes using pairwise dis¬
tances (data not shown). Suppression of synonymous
variability relative to the rest of the genome was ob¬
served between nt 1 and 530, with particularly marked
dips at the start of the coding sequence and at position
364. In the E1-, E2-, NS2-, and NS3-encoding regions,
mean variability over 50 codon windows ranged from
0.27 to 0.34. Beyond position 4900, there was a trend
for a consistent reduction in mean synonymous vari¬
ability with particularly marked dips at the 5' and 3'
ends of the NS5B-encoding region (7768 and 9091).
The degree of suppression of synonymous variability
at the end of the NS5B-encoding region was compa¬
rable to that observed in the core gene (Fig. 2A).
The availability of a large number of epidemiologi-
cally unlinked complete genome sequences of type 1b
allowed a separate analysis of intrasubtype variability
(Fig. 2B). HCV genotype 1b sequences are thought to
have arisen from a common ancestor approximately
60-70 years ago (Smith et al., 1997), a time span over
which covariant substitutions are unlikely to have ac¬
cumulated (Simmonds & Smith, 1999). This compari¬
son may therefore provide a more sensitive indication
1000 2000 3000 4000 5000 6000 7000 8000
Nucleotide position
0
0 1000 2000 3000 4000 5000 6000 7000 8000 9000
Nucleotide position
Nucleotide position Nucleotide position
FIGURE 2. Variability at synonymous sites estimated by parsimony between coding regions of (A) single examples of HCV
genotypes and subtypes; location of covariant sites (Fig. 5) indicated by arrows. The approximate sites for cleavage of
structural (core, E1, E2) and nonstructural proteins (NS2-NS5B) indicated in upper panel (B) 65 epidemiologically unlinked
genotype 1b sequences, (C) pestivirus genotypes 1-4, and (D) human enteroviruses (poliovirus, Coxsackieviruses A and
B, echoviruses).
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of the regions where sequence change is constrained.
There was an overall similarity with the previous com¬
parison between HCV genotypes in the regions where
synonymous variability was suppressed (compare
Fig. 2A with 2B). However, there was much greater
variability between different parts of the coding region.
For example, the degree of synonymous variability at
the start of the core gene between type 1b sequences
was greater than 10-fold lower than the mean values
for E1 and E2, a larger differential than observed be¬
tween HCV genotypes (approximately 3.5-fold; Fig. 2A).
Much more pronounced dips in variability were ob¬
served elsewhere in the genome, not only in the NS5B-
encoding region but also in NS3- and NS4A/B-encoding
regions (Fig. 2B). To investigate whether regions where
variability was suppressed were shared between all
type 1 b sequences, the set of 65 sequences were ran¬
domly assigned to three separate groups and synony¬
mous variability was independently measured in each
group. There was a strong correlation between synon¬
ymous variability in the three independent samplings of
type 1b sequences, and an absence of any sites with
discrepant synonymous variability values (data not
shown). These observations provide evidence for sim¬
ilar sequence constraints on type 1 b sequences in each
of the three samplings.
To investigate whether the observed suppression in
synonymous variability at the ends of the HCV genome
resulted from biased codon usage in these regions,
base composition at third codon positions was calcu¬
lated for HCV genotypes 1-6 (Fig. 3A). Base compo¬
sition (including G + C and purine content) was similar
over the length of the genome, with no evidence for
different codon usage in regions where synonymous
variability was suppressed compared with more vari¬
able regions. Similarly, there was little variability in the
base composition at first and second codon positions
in different parts of the HCV genome (data not shown).
Suppression of synonymous variability might also orig¬
inate from biased dinucleotide frequencies that limit
codon choice. However, 14 of the 16 dinucleotides
showed little or no differences from their expected fre¬
quencies calculated from their base composition at each
of the three codon positions (i.e., dinucleotides at first
and second codon positions, at second plus third, and
third plus one; note only the latter two are subject to
selection independently of coding capacity; Fig. 4). The
CG dinucleotide was underrepresented at all three co¬
don positions (0.67,0.66, and 0.73; mean 0.72), whereas
UG was slightly overrepresented (1.31, 1.18, and 1.21;
mean 1.23). However, there was no correlation be¬
tween the observed differences in synonymous vari¬
ability in the HCV genome with frequencies of the CG
and UG dinucleotides (Fig. 3B), nor with any of the
other 14 dinucleotides (data not shown).
Analysis of the distribution of synonymous variability
was extended to sequences from pestiviruses (Fig. 2C)
and enteroviruses (Fig. 2D). In contrast to HCV, there
was no suppression of variability at the ends of the
pestivirus genomes, nor was there evidence for more
restricted regions of suppression in the genes corre¬
sponding to NS5A or the 5' end of NS5B (Fig. 2C).
Enterovirus sequences showed great variability at syn¬
onymous sites (Fig. 2D), and similarities in the pattern
of diversity with HCV. In particular there was an overall
reduction in variability in the 3' end of the genome, with
marked areas of suppression at positions 3841, 5339,
6467, and the extreme 3' terminus of the genome. The
dip at position 3841 occurred in a region of RNA sec¬
ondary structure (Goodfellow et al., 2000) with a role in
the initiation of RNA transcription (Rieder et al., 2000).
Enterovirus sequences, however, did not show the ex¬
treme suppression of synonymous variability at the 3'
terminus, and showed no reduction in variability at the
5' end (corresponding to the start of the genome cod¬
ing for the nucleocapsid).
Thermodynamic prediction of RNA
secondary structure
The existence of RNA secondary structure in the cod¬
ing region of HCV was independently investigated by
comparison of free energy on folding of overlapping
500-base-coding-sequence fragments with those of
sequence-order-randomized controls. In this study, we
have developed a number of methods to randomize
the sequence order of the HCV coding sequence to
determine its contribution to RNA folding. Many of these
were developed to prevent the randomization process
altering other sequence attributes, such as regional dif¬
ferences in base composition and biased dinucleotide
frequencies, that may have a compounding effect on
free energy calculation. The methods used were as
follows:
1. Nucleotide order randomization (NOR): Randomiza¬
tion of nucleotide sequence order. This is the stan¬
dard method used in most previous studies.
2. Codon order randomization (COS): Randomization
of codon order, therefore avoiding disruption of se¬
quence order within triplets.
3. Like-codon randomization (CLR): Randomization of
the order of codons specifying each amino acid. Fol¬
lowing randomization, the encoded amino acid se¬
quence remains unaltered.
4. Like-codon swap (CLS): Pairwise exchange of like
codons (e.g., the first glycine codon in the sequence
is exchanged with the second, the third with the
fourth, etc.). Alternatively, the second is exchanged
with the third, the fourth with the fifth, etc.).
5. Dinucleotide randomization (CDR): Randomization
of each set of codons with identical first and third
bases (i.e., the 16 sets with the sequences AnA,
AnT, AnG,... TnG,TnT). The randomized sequence
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FIGURE 3. A: Scan of base composition at third codon positions in coding sequences of HCV genotypes 1-6 (mean values
shown), including combined values for purine (G + A) and G + C. B: Scan of CG and UG dinucleotide frequencies across
HCV genome (mean of genotypes 1-6, all three codon position).
will have an identical dinucleotide composition (but
different encoded amino acid sequence) from the
native sequence.
6. Dinucleotide swap (CDS): Pairwise exchange (as
CLS) of each of the 16 sets of codons with identical
first and third bases.
Methods NOR, COS, CLR, and CDR can be applied
multiple times to a native sequence. The difference in
free energy of folding between the native sequence
and each randomized sequence approximates to a nor¬
mal distribution (Rivas & Eddy, 2000), providing an em¬
pirical statistical test for the significance of the observed
differences. Accordingly, differences in free energy be¬
tween native and randomized sequences can be ex¬
pressed as a Z-score (Workman & Krogh, 1999), which
is the number of standard deviations by which the pre¬
dicted free energy of the native sequence is lower than
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1.6
1.4
AA AC AG AT CA CC CG CT GA GC GG GT TA TC TG TT
Dinucleotide
FIGURE 4. Dinucleotide frequencies of HCV and three mammalian genes (albumin, alphaglobin and actin), expressed as
ratios to expected value calculated from base composition. For each dinucleotide: columns 1-3 (unfilled): dinucleotide ratios
of HCV for each codon position (first and second base position, second/third, and third/first); column 4 (filled): mean for all
three positions; columns 5-7: mean values for all three codon positions for coding sequences of albumin (descending
diagonal stripes), alphaglobin (ascending diagonal stripes), and actin (horizontal stripes).
the mean of the randomized sequences. This measure
therefore takes into the account the differences in free
energy as well as the range of values between inde¬
pendent randomizations. The randomization methods
that exchange like-coding or like-dinucleotide codons
generate only two randomized sequences, preventing
the calculation of a Z-score.
Applying the methods CLR and CLS to HCV coding
sequences retains their encoded amino acid sequences,
and in contrast to the NOR method, retains the base
composition at first, second, and third codon posi¬
tions. Method CLS minimizes the distance over which
codons can be exchanged to pairwise swaps and there¬
fore has the advantage of retaining any nonhomoge-
neities in base composition that may exist in sequence.
Methods CDR and CDS are similarly codon orientated,
retain dinucleotide composition, codon composition, but
not codon order, and, in the case of CDS, also pre¬
serve local differences in base composition.
To investigate the relationship between nucleotide
sequence order and folding free energy, we used each
of the six methods to randomize sequences with no
known or likely RNA secondary structure (the coding
sequences in the mammalian albumin, actin, HLA
class II, and alphaglobin genes), and parts of the
coding region of HGV/GBV-C (5' and 3' ends with pre¬
viously demonstrated RNA secondary structure; Sim-
monds & Smith, 1999; Cuceanu et al., 2001; Fig. 5A,
B). Each of the six sequence order randomization meth¬
ods produced comparable differences in folding free
energy from native sequences. In the case of mamma¬
lian sequences, none of the methods produced a pos¬
itive differences in free energy of greater than 3% in
any of the sequences (Fig. 5A); similarly, Z-scores were
limited to values of greater than -1 for each of four
methods where this statistic could be calculated (NOR,
COR, CLR, and CDR), indicating no significant dif¬
ference in folding free energy between native and
randomized sequences (Fig. 5B). In contrast, large dif¬
ferences in folding free energy were observed be¬
tween native HGV/GBV-C 5' and 3' sequences and
those randomized by each of the six methods (10-
17%); Z-scores ranging from -3.7 to -5.1 indicated
that each of these differences was statistically signifi¬
cant (p < 0.01; Workman & Krogh, 1999; Rivas & Eddy,
2000). Each of the six methods also provided evidence
for sequence-order-dependent secondary structure in
the corresponding positions in the HCV genome (free
energy differences 10-15%, Z-scores 3.4-6.3).
Because of the close concordance of free energy
differences (and Z-scores where calculable) between
the different scrambling methods, it is unlikely that un-
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FIGURE 5. A: Differences in folding free energy between native mammalian (albumin, actin, HLA class II, alphaglobin) and
viral coding sequences (5' and 3' ends of HGV/GBV-C and HCV) and those randomized by six different scrambling methods
(NOR, COR, CLR, CLS, CDR, CDS). B: Corresponding Z-scores for NOR, COR, CLR, and CDR.
wanted effects of sequence order randomization, such
as disruption of codon composition, dinucleotide fre¬
quencies, or regional differences in base composition,
accounted for the observed excess of free energy in
native viral sequences. HCV actually lacks the extreme
composition biases that are found in mammalian se¬
quences used as controls. The mean G + C content of
HCV ranged from 0.50 to 0.62 at the three codon po-
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sitions, well within the range of G + C compositions of
albumin (mean 45.4%; 34.2% at third base positions)
and alphaglobin (mean 62.0%; 83.0% at third base po¬
sitions). Additionally, the self-complementary dinucleo-
tides (GC, CG, AU, and UA) that potentially increase
free energy on folding were not overrepresented in HCV
(Fig. 4); indeed, the CG dinucleotide occurred at a lower
than expected frequency (mean 0.72). As with base
composition, biases in HCV dinucleotide frequencies
were less marked than those found in mammalian
genes. For example, coding sequences of human al¬
phaglobin, actin, and albumin showed similar or greater
underrepresentation of CG, much greater suppression
of UA dinucleotides (0.38-0.56), and there was much
greater overrepresentation of UG (1.34-1.63).
For more detailed analysis of RNA structure in the
HCV genome, we used the two least disruptive ran¬
domization methods that allowed Z-scores to be cal¬
culated (CLR and CDR). Coding sequences of HCV
genotypes 1a, 2a, 3a, 4a, 5a, and 6a were divided into
500-base fragments, overlapping by 250 bases (36 frag¬
ments over an alignment length of 9,168 nt). Folding
free energies were compared with those of 50 repli¬
cates of each fragment randomized in sequence using
the CLR and CDR methods (Fig. 6). Each of the six
genotypes showed between 6.2 and 8.8% difference in
folding free energy between native and scrambled se¬
quences over the length of the genome (mean values:
CLR: 7.8%, CDR: 6.9%; mean Z-scores: CLR; -2.58;
CDR: -2.32). To localize potential secondary struc¬
ture, mean values of each of the six genotypes were
plotted against genome position (Fig. 7). The greatest
differences in free energy were observed at the ex¬
treme 5' end of the genome (fragments 1-500, 250-
750) and at the 3' end (fragments 7251-7750 and
onwards), with good concordance between the two ran¬
domization methods. Free energy differences showed
a close, inverse correlation with suppression of synon¬
ymous variability (Figs. 2A, B, and 7A).
Parallel testing of native sequences in reverse,
complement orientation showed consistently lower
differences on folding from (reverse complemented)
sequence-order-randomized controls (Figs. 6, 7B). This
reduction in folding energy difference was observed in
all HCV genotypes using both randomization methods
(Figs. 6, 7). It was also consistently observed through¬
out the coding region of the HCV genome, with values
rarely exceeding 6%, and Z-scores invariably below
—3, and generally below -2. These observations indi¬
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FIGURE 6. Mean difference in folding free energy of 500-base fragments spanning viral genome of HCV genotypes 1a-6a,
and GBV-B, using two scrambling methods (CLR, CDR). For each sequence, columns 1,2: native sequence; columns 3, 4:
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out the HCV genome, but is probably the most relevant
biologically for HCV RNA in its positive sense orientation.
Covariance scanning
The existence of paired covariant sites associated with
adjacent regions of potential base pairing provides in¬
dependent evidence for the location of regions of sec¬
ondary structure. The problem of phylogenetic structure
and nonindependence of substitutions among mem¬
bers of different HCV clades previously encountered in
the analysis of synonymous variability also presented
difficulties with scoring covariant substitutions. Accord¬
ingly, covariant changes at paired base positions were
only scored between each sequence or node and their
immediate ancestors reconstructed by parsimony. As a
result, the covariant score reflects the minimum num¬
ber of evolutionary steps underlying the observed sub¬
stitutions. Compared with HGV/GBV-C (Simmonds &
Smith, 1999), fewer covariant sites were detected among
the HCV sequences analyzed using equivalent input
settings (Fig. 8). Using a variety of scanning param¬
eters, a total of 14 covariant sites in eight potential
stem-loop structures were detected in the coding re¬
gion of the HCV genome, located in the core and NS5B
regions. This compares with 48 sites in 23 potential
stem-loops in the coding region of HGV/GBV-C (data
not shown). The greater number of covariant sites in
HGV/GBV-C may indicate more extensive secondary
structure, or a lack of conservation of stem-loops be¬
tween genotypes of HCV (see Discussion).
HCV stem-loop structures formed by covariant base
pairings were located precisely in regions where syn¬






































































































































FIGURE 8. Covariant sites in HCV genome identified by parsimony. Stem-loop (SL) numbers and positions of upstream
and downstream paired bases are shown above sequences. Covariant sites occurring in the same stem-loop are indicated
by grouping into boxes. Genotype (1-6) of each sequence indicated on left. Covariant (CV) scores represent number of
independent substitutions at covariant site (G <-> C/U covariant changes not scored).
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ularly remarkable was the concentration of covariant
sites at the 3' end of the NS5B gene that showed the
most precipitous decline in synonymous variability.
Prediction of HCV RNA secondary structure
The combination of synonymous variability, differences
in free energy, and identification of paired nucleotides
by covariance scanning identified a number of discrete
regions in the coding sequence of the HCV genome
where secondary structure formation was likely to oc¬
cur. Accordingly, thermodynamic secondary structure
predictions of genome segments of genotypes 1-6 from
the core- and NS5B-encoding regions were created
using the program MFOLD using standard parameters
(Fig. 9). Secondary structure predictions were made
for stem-loop structures showing covariance (SL47,
SL443, SL7730, SL8376, SL8828, SL8926, SL9011,
and SL9118). Between genotypes, the structures var¬
ied in length, in the degree of sequence conservation























































FIGURE 9. Predicted stem-loop (SL) structures conserved between HCV genotypes 1-6 containing the covariant sites
shown in Figure 8. Stem-loop numbers and positions of upstream and downstream extents of base pairing shown above and
below sequences. Covariant sites are indicated by shading of paired nucleotides. Example of structurally different stem-
loops (SL7730 and SL8376) indicated in boxes.
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of the unpaired regions, and in some cases, the pre¬
dicted base pairings (Fig. 10). In the predicted base-
pairing regions, third codon positions were most
commonly aligned with downstream third codon posi¬
tions, so that covariant changes were usually synony¬
mous at both sites (in four from the seven predicted
loops). However, nonsynonymous covariant substitu¬
tions were observed in SL8828, SL8926, and SL9118,
resulting from base pairing between nucleotides at dif¬
ferent codon positions.
Secondary structure prediction for GBV-B
Methods to analyze the secondary structure of the vi¬
rus most closely related to HCV, GBV-B, are limited by
the absence of comparative sequence data from inde¬
pendent isolates or genotypes of the virus (Simons et al.,
1995). However it was possible to analyze the sin¬
gle complete genome sequence available thermo-
dynamically (Fig. 6). The coding region of the GBV-B
sequence showed differences in free energy from
sequence-order-randomized controls similar to those
observed for HCV, with comparable differences be¬
tween sense and antisense sequences. Folding free
energy differences showed a similar genome distribu¬
tion to that of HCV, with the largest values and Z-scores
at the 3' and 5' ends of the genome (data not shown).
DISCUSSION
The informationally complex HCV genome can essen¬
tially be regarded as functioning at three levels. The
single-stranded, plus-sense RNA molecule is trans¬
lated in the cytoplasm to yield viral proteins; it is used
as a template for negative-strand synthesis; and it in¬
teracts with viral structural components to yield prog¬
eny viral particles. These three processes may all rely
on secondary (and in some cases tertiary) RNA struc¬
tures that reside within the HCV genome. Although such
structure has been demonstrated within the HCV 5'
and 3' untranslated regions, little progress has been
made toward the identification and characterization of
structures residing within the HCV coding sequence. In
this study, we identified such regions of genotypically
conserved secondary structure in the viral genomic
RNA using a combination of established thermodynamic
prediction models and newly developed phylogenetic
methods that exploit the vast amount of comparative
sequence data for HCV.
Detection of RNA secondary structure
A variety of physical and computational methods have
been developed to determine RNA secondary struc¬
ture in viruses and other organisms. In this investiga¬
tion, the length of the HCV genomic sequence (9,400
bases) prevented the use of physical methods such as
nuclear magnetic resonance spectroscopy, enzymatic
cleavage, or chemical degradation. Although it would
have been possible to separately analyze subgenomic
fragments of HCV sequence by RNAse mapping or
other probing techniques, the likely complexity of the
RNA secondary structure and the possible depen¬
dence on long-range interactions for folding would
largely invalidate attempts to build up an overall struc¬
ture from the sum of those determined from short and
arbitrarily truncated HCV RNA transcripts. For exam¬
ple, short fragments of RNA suitable for RNAse map¬
ping (100-200 bases) that contained nt 47 to 84 or
8376 to 8455 would inevitably fold to form the stem-
loops SL47 and SL8376, but that would not constitute
evidence that they existed in full-length genomic RNA.
Stem loops
+++ □ ++ □ + n -
FIGURE 10. Structure conservation of
predicted stem-loops in the core and
NS5B regions between representative
sequences of HCV genotypes 1-6. Struc¬
tures were scored from - to + + + de¬
pending on the degree of similarity to the
most common structure as follows: + + +:
Stem-loop structurally identical; + + : mi¬
nor differences in base pairing but con¬
servation of overall size and shape of
stem-loop; +; different structure in the
same region; no secondary structure
detected.
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In contrast, many of the methods used in computa¬
tional analysis of RNA structure, such as covariance
detection and measurement of synonymous variability,
were not impeded by sequence length. Indeed, the analy¬
sis of HCV was aided considerably by the availability of
the large amount of comparative sequence information
of different HCV genotypes and variants within geno¬
types or subtypes. This allowed us to incorporate phy-
logenetic information into the predictions of base pairing,
and, in particular, to apply a covariance scanning al¬
gorithm to alignments of HCV genome sequences. For
sequences with a marked phylogenetic structure such
as HCV, the program represents a substantial improve¬
ment over that used previously to analyze HGV/GBV-C
sequences (Simmonds & Smith, 1999) because it is
better able to reconstruct the evolutionary history of
highly variable sites through the use of parsimony.
The data set of published HCV sequences also al¬
lowed analyses of variability at synonymous sites in the
HCV coding region. Synonymous variability cannot al¬
ter the virus phenotype through changes in the en¬
coded proteins, and it had generally been considered
that variability is selectively neutral, subject to relatively
minor constraints arising from biased codon choice and
base composition differences. The observed differ¬
ences in synonymous sequence heterogeneity in the
regions of the respective ORFs of HCV, HGV/GBV-C,
and picornaviruses are therefore likely to indicate se¬
lection pressures unrelated to their coding function. In
the case of HGV/GBV-C, we previously found that sup¬
pression of synonymous variability acted as a signa¬
ture for extensive RNA secondary structure formation
in the coding part of the genome that was predicted
by independent computational methods (Simmonds &
Smith, 1999). As another example of this association,
the marked dip in synonymous variability observed on
comparing enterovirus coding sequences (Fig. 2D) lo¬
calized precisely to the c/'s-acting element necessary
for strand initiation in poliovirus replication (Goodfellow
et al., 2000; Rieder et al., 2000).
We supplemented the standard thermodynamic
predictions of RNA secondary structure by comparison
of free energies on folding with sequence-order-
randomized controls (Fig. 5). Previously published analy¬
ses of eukaryotic and prokaryotic gene sequences has
revealed a number of potential causes of artefactual
results from such methods. These include the effect of
regional differences in base composition (such as GC
islands) on the calculation of folding free energy differ¬
ences between native and sequence-order-randomized
controls (Rivas & Eddy, 2000). This was ruled out as a
cause for the observed free energy differences ob¬
served in HCV sequences for two reasons. First, base
composition was relatively homogeneous throughout
the HCV genome, with a relatively constant moderate
overrepresentation of G/C residues at third base posi¬
tions (Fig. 3A). Second, we developed codon-swapping
methods for sequence randomization that minimized
the distance between sites that were shuffled, and there¬
fore prevented any local base composition differences
from being disturbed (CLS). Such methods produced
similar folding free energy differences from methods
which fully randomized codon order (COR, CLR; Fig. 5).
A second cause for artefactual folding free energy
differences arises from the disruption of dinucleotide
pairs by standard sequence scrambling methods (Work¬
man & Krogh, 1999). In this study, we developed two
sequence randomization methods that retained the di¬
nucleotide frequencies as well as codon structure
in the native sequence, and additionally in the case of
CDS, any regional differences there might be in dinu¬
cleotide composition. As described above, these latter
methods produced free energy differences remarkably
similar to those produced by methods that disrupted
dinucleotides (Fig. 5). Further evidence that disruption
of dinucleotide frequencies was not responsible for the
folding free energy differences in HCV (and HGV/
GBV-C) sequences was provided by the observation
for relatively limited biases in dinucleotide frequencies
in HCV sequences; only the CG and UG dinucleotide
frequencies were different from those expected from
the local base composition. Furthermore, these biases
were distributed throughout the HCV genome (Fig. 3B),
and did not localize specifically to the 5' and 3' ends
where the largest folding free energy differences were
observed (Fig. 2A, B).
Folding free energy differences observed for HCV
were comparable to those observed for viral sequences
with well-defined RNA secondary structure, such as
the noncoding region of hepatitis delta virus and plant
viroids, where free energy differences of between 15-
25% have been previously reported using the NOR
method for sequence scrambling (Cuceanu et al., 2001).
Further evidence for the veracity of the HCV results is
provided by the consistent absence of folding free en¬
ergy differences of four different mammalian coding
sequences with any of the scrambling methods (Fig. 5).
Indeed, the observation that these sequences show a
wide range of base composition differences and more
extreme biases in dinucleotide frequencies provided
further evidence that these factors have no significant
influence on the folding free energies determined in the
current study.
The observation of folding free energy differences
throughout the HCV genome therefore leads to the re¬
markable conclusion that RNAsecondary structure may
be distributed throughout the viral coding sequence.
Indeed, the observation that folding free energy differ¬
ences of reverse complemented sequences were con¬
sistently lower than those from the plus strand of RNA
indicates a greater likelihood that the RNA structure is
more relevant functionally for viral RNA sequences rather
than (antisense) replication intermediates. Rather than
invalidating our own study, the previous observations
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that folding free energy differences are generally inca¬
pable of detecting structured RNA elements in eukary-
otic and prokaryotic genome sequences (Workman &
Krogh, 1999; Rivas & Eddy, 2000) likely provides a pre¬
liminary indication of the great organizational difference
in RNA sequences of HCV (and HGV/GBV-C) viral RNA
from mRNAs and other RNA elements in their host
cells.
Location of RNA structure in HCV
This study is the first comprehensive evaluation of sec¬
ondary structure in the coding region of HCV using a
number of independent computational methods. Co-
variance scanning, thermodynamic predictions, and
synonymous variability concurred in the prediction of
conserved folded RNA structure elements in the core-
and NS5B-encoding regions of the genome. The re¬
sults confirm the existence of a number of structures
predicted independently either by simple sequence in¬
spection (Han & Houghton, 1992; Smith & Simmonds,
1997), or by a comparative RNA-folding algorithm that
identified covariant sites through the comparison of
phylogenetically conserved RNA structures (Hofacker
et al., 1998). The latter study predicted the existence of
SL7729 and the terminal region of SL8828.
Predictions of stem-loops by covariance scanning and
suppression of synonymous variability detected sec¬
ondary structures conserved between HCV genotypes
(Figs. 6, 7, and 8). However, comparison of individual
structures indicated some differences in the extent of
folding, and, in some cases, in the identity of the actual
bases involved in pairing interactions in the predicted
stems (Fig. 10). Similar structural differences have pre¬
viously between observed between human and chim¬
panzee HGV/GBV-C sequences (Cuceanu et al., 2001),
and suggest some flexibility in whatever functional
requirement there may be for such structures (see be¬
low). Although it is possible that many other, noncon-
served structures exist elsewhere in the HCV coding
region, the trend for the greatest differences in free
energy to be found at the ends of the genome (Fig. 7)
suggest that most folding is concentrated in regions
where conserved structures are found.
Comparison with other RNA viruses
The distribution of synonymous variability between
genotypes or serotypes of other positive-stranded RNA
viruses showed remarkable contrasts to HCV. Using a
similar range of thermodynamic and phylogenetic pre¬
diction methods, we previously found that HGV/GBV-C
showed extensive, conserved RNA structural elements
(Simmonds & Smith, 1999; Cuceanu et al., 2001). Al¬
though it is possible that the much greater sequence
diversity of HCV genotypes prevented the detection of
nonconserved stem-loop structures by phylogenetic
methods, HCV sequences also showed less difference
in free energy on folding than sequence-order-
randomized controls (see above). Why HCV second¬
ary structure formation should be less extensive than
in HGV/GBV-C is currently unclear.
An even greater contrast is found on analysis of pesti-
virus sequences. Despite their similarity in genome
organization to HCV, there was no evidence for sup¬
pression of synonymous variability in any region of the
latter's coding sequences. A lack of secondary struc¬
ture in pestiviruses was also indicated by the much lower
difference in free energy on folding BVDV or CSFV
sequences with sequence-order-randomized controls
(mean values over coding part of the genome: 3.2% and
2.1%; A. Tuplin & R Simmonds, unpubl. data). Finally, co-
variance scanning failed to predict any covariant sites
between variants of BVDV, BDV, or CSFV sequences
(data not shown). The lack of evidence of secondary
structure is possibly reflected in the recent finding that
IRES-driven translation of BVDV coding sequences is
strongly inhibited by base pairing downstream of the me¬
thionine initiating codon, for example, by placing the
IRES upstream from the GC-rich NS3 sequence of
BVDV (Myers et al., 2001). This finding is different from
the requirement for structured RNA sequences in the
core region of HCV for efficient translation (Reynolds
et al., 1995; Honda et al., 1996b; Lu & Wimmer, 1996).
It could be argued that some degree of secondary
structure is required to generate the compactness of
the RNA genome to assist viral packaging or other
replicative steps. The existence of sequence-order-
dependent structures in HCV and HGV/GBV-C may
therefore compensate for a particular base compo¬
sition that prevents tight packing of RNA. However, if
GC content is a guide to the likelihood on internal
base pairing, then the converse appears to be true;
The GC content of pestiviruses is only 46%-47%, com¬
pared with 58% and 59% for HCV and HGV/GBV-C,
respectively.
Role of RNA secondary structure
A total of eight RNA structures were identified in this
study. These predictions add to the list of structural
elements residing in the coding sequences of other
positive-sense RNA viruses. These include the cis-
acting replicating elements in poliovirus (Goodfellow
et al., 2000), in the cardioviruses Theiler's murine en¬
cephalomyelitis virus and Mengo virus (Lobert et al.,
1999), in human rhinovirus type 14 (HRV-14; McKnight
& Lemon, 1998), and in mouse hepatitis virus strain
JHM (Kim & Makino, 1995). These c/s-acting elements
have been characterized and shown to be involved in
viral replication (Kim & Makino, 1995; McKnight &
Lemon, 1998; Lobert et al., 1999; Goodfellow et al.,
2000). Although the function of the RNA structures we
have identified within the HCV genome remains to be
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elucidated, their possible involvement/requirement for
translation and/or replication can now be investigated
using the recently developed HCV subgenomic RNA-
replicon system (Lohmann et al., 1999; Blight et al.,
2000). However, a role of the predicted structures in en-
capsidation of HCV RNA during virion assembly would
require the development of a packaging assay or a rep¬
licating HCV clone that produced virus particles.
The RNA structures identified prior to the stop codon
in the NS5B sequence (SL9011 and SL9118) possibly
represent a 5' extension to the wealth of structure con¬
tained within the 3' UTR. Because this 5' boundary to
the 3' terminal RNA structures of the HCV genome en¬
croaches into the C-terminus of the polyprotein, the con¬
cept that the structure and function of the 3' terminus of
the virus genome is solely contained within the 3' UTR
could perhaps now be considered outmoded. The iden¬
tification of such structure within this region could also
facilitate the elucidation of the 3' terminus function, which
is currently poorly understood. Besides a role in trans-
lational regulation (Ito et al., 1998; Ito & Lai, 1999), the
3' UTR is absolutely required for infectivity in the chim¬
panzee animal model (Yanagi et al., 1999), and has re¬
cently been shown to bind the helicase domain of NS3
(Banerjee & Dasgupta, 2001), and is thus presumed to
be involved in viral replication. Of the two RNA struc¬
tures identified in the core coding sequence (SL47 and
SL443), it is interesting to note that SL443 lies 5' of a
pyrimidine-rich domain and putative PTB-binding site
previously implicated in HCV translational regulation (Ito
& Lai, 1999). Additionally, SL443 may also be involved
in translational regulation through a long-range RNA-
RNA interaction with sequences at the 5' end of the ge¬
nome (Honda et al., 1999).
Apart from secondary structure, suppression of syn¬
onymous variability at synonymous sites may occur in
sequences translated in alternative reading frames; sev¬
eral investigators have proposed that core gene of HCV
may encode a second protein in the +1 reading frame
(Ina et al., 1994; Walewski et al., 2001; Xu et al., 2001).
Proteins translated from HCV RNA in vitro included a
polypeptide of approximately 160 amino acids, contain¬
ing the first 11 codons of the core gene, and the re¬
maining amino acids encoded by the +1 reading frame
(Xu et al., 2001). The authors identified a "slippery"
homopolymeric tract of A residues upstream from the
proposed -2 ribosomal frameshift site. Frameshifting
generally requires the presence of downstream RNA
secondary structure, often in the form of a pseudoknot,
to pause translation and facilitate transfer of reading
frame (Brierley et al., 1992; Matsufuji et al., 1996;
Giedroc et al., 2000). Although the authors do not iden¬
tify an RNA structure in the HCV core gene, an obvious
candidate would be SL47, which lies in an appropriate
position in relation to the homopolymeric tract (5 nt down¬
stream) to promote frameshifting (Xu et al., 2001). How¬
ever, assigning a functional role to the product of the +1
reading frame (the F protein) is made problematic by the
lack of evolutionary conservation of the coding sequence
(Smith & Simmonds, 1997). Approximately half of the
published sequences of different HCV genotypes con¬
tain premature stop codons at a range of different nu¬
cleotide positions in the core sequence (e.g., at 377,419,
431, and 464), and would therefore produce a hetero¬
geneous range of F proteins, truncated at various po¬
sitions at the carboxyl terminus of the protein. Much
shorter potential coding sequences are found in the
sequences HPCHK6 (genotype 3a) and VN405 (geno¬
type 8b); stop codons at positions 86 and 37 would
encode polypeptides with predicted lengths of only 29
and 22 amino acids, respectively. As the proposed F pro¬
tein is clearly dispensable in HPCHK6 and VN405, there
is little likelihood that selection pressure to maintain the
reading frame in other HCV variants underlies the ob¬
served suppression in synonymous variability in the part
of the HCV genome.
Beyond RNA-RNA interactions, association of any of
the eight RNA structures with viral or cellular proteins is
also likely. Identification of such factors is possible
through techniques such as yeast three-hybrid screen¬
ing (SenGupta et al., 1996), as recently reported for the
HCV 3'X (Wood et al., 2001), or using proteomic analy¬
sis in conjunction with cells stably expressing HCV rep-
licons. The exact structures of the RNA stem-loops
identified in this study could be equivocally established
using chemical and enzymatic cleavage analysis, al¬
though the improvement in RNA secondary structure
prediction algorithms combined with the fact that these
stem-loops are small and discrete probably mean that
there would be little discrepancy between actual and
predicted structure.
In summary, we have identified eight genotypically
conserved RNA structures that reside within the HCV
coding sequence. The role of RNA secondary and ter¬
tiary structure in governing essential viral processes is
becoming increasingly obvious. The identification of
these RNA structures in conjunction with structures
known to exist within the HCV untranslated regions may
facilitate further understanding of HCV translation, rep¬
lication, and packaging, or at least may provide an in¬
sight into a previously unapparent level of functional and




Epidemiologically unlinked complete genome sequences of
HCV analyzed in the study were as follows (GenBank acces¬
sion number in parentheses if different from entry name):
HPCPLYPRE (M62321), H77 (AF011751), HC-J1 (D10749),
HEC278830 (AJ278830), HC-J4 (AF054247), BK (AF33324),
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HPCGENANTI (M84754), HPCCGENOM (L02836),
HCU01214 (U01214), HCV-J (NC_001433), HD-1 (U45476),
HPCRNA (D10934), HCVJK1G (X61596), JTB (D11355),
HPVHCVN (D63857), PP (D30613), HCV-N (S62220), HP-
CUNKCDS (M96362), HC-G9 (D14853), HC-J6 (AF177036),
NDM228 (AF169002), G2aK1 (AF169003), G2aK3
(AF169004), NDM59 (AF169005), HC-J8 (D10988, D01221),
BEBE1 (D50409), HPCK3A (D28917), HPCEGS (D17763),
HPCFG (D49374), JK049 (D63821), HCV4APOLY (Y11604),
AF064490, HCV1480 (Y13184), HCV12083 (Y12083), Th580
(D84262), VN235 (D84263), VN405 (D84264), VN004
(D84265), and JK046 (D63822). Underlined sequences (of
genotypes 1a, 2a, 3a, 4a, 5a, and 6a) were use for free
energy predictions. For the extended analysis of type 1b se¬
quences, the following additional sequences were compared:
AB049087, AB049088, AB049089, AB049091, AB049092,
AB049093, AB049094, AB049095, AB049096, AB049098,
AB049099, AB049100, AB049101, AF165046, AF165048,
AF165050, AF165052, AF165054, AF165056, AF165058,
AF165060, AF165062, AF165064, AF176573, AF207752,
AF207753, AF207754, AF207756, AF207758, AF207760,
AF207761, AF207762, AF207763, AF207764, AF207765,
AF207766, AF207767, AF207768, AF207771, AF207772,
AF208024, D85516, D89815, D89872, HCJ238800
(AJ238800), HCV132997 (AJ132997), HCVPOLYP
(AJ000009), HPC1B4 (D50484), HPC1B5 (D50485),
HPCJRNA (D14484, D001173), and HPCY1B6 (D50480).
For comparison, the following sequences of GBV-B, pesti-
viruses, and enteroviruses were analyzed: GBV-B: NC001655;
pestiviruses: BVDCG (M31182), BVDPOLYPRO (M96751),
AF091605, BVDPP (M96687), PTU86600 (U86600),
NC_002514, AF037405, BDU70263 (U70263), AF002227,
HCVPOLYPR (Z46258), AF091507, HCVPOLYP2 (D49533),
AF091661, HCVPOLYP1 (D49532), HCU45478 (U45478),
HCVSEQB (L49347), A16790, HCVCG3PE (M31768),
NC_002657, AF099102, and AF092448; enteroviruses:
NC_002058, NC_002029, POL2LAN (M12197), NC_001428,
NC_001429, NC_001342, NC_002485, AF231765,
NC_000881, NC_000873, NC_002003, NC_001657,
NC_001656, NC_001360, NC_001472, NC_002601,
NC_001612, AF304459, NC_002347, NC_000945, and
NC_001430.
Coding regions from the following mammalian sequences
were used as negative controls: actin (BC015695); albumin
(AF116645); FILA DRw12 beta 1-chain; and alphaglobin
(V00493).
Analysis of synonymous sequence
variability
Synonymous sequence variability was determined by parsi¬
mony for each codon in alignments of HCV, HGV/GBV-C,
pestivirus, and enterovirus complete genome sequences. The
phylogeny and sequences of ancestral nodes for each se¬
quence alignment were determined by the program DNA-
PARS in the PHYLIP package (Felsenstein, 1993). Variability
at each codon was expressed as the proportion of compar¬
isons between each sequence or node with the reconstructed
codon of its immediate ancestor showing synonymous differ¬
ences. This method was chosen over simple pairwise com¬
parison at each codon position (Simmonds & Smith, 1999),
as information on phylogeny is more effective at reconstruct¬
ing the likely multiple substitution events found in the highly
divergent HCV, pestivirus, and enterovirus sequences. Vari¬
ability at each codon was normalized to allow differences in
variability at saturation at codon comparisons with two-, three-,
four-, and sixfold degeneracy. Variability was calculated only
at codon positions where 40% or greater of sequence/ancestor
comparisons were synonymous. Variability at each codon
position was averaged over a sliding window of 50 codons.
Detection of covariance
An alignment of the coding regions of 41 complete genome
sequences of HCV was analyzed for covariant changes. The
method used for scoring covariance was modified from that
previously used to analyze HGV/GBV-C sequences (Sim¬
monds & Smith, 1999) to allow for the tree structure of HCV,
and in particular, the nonindependence of covariant changes
found in members of individual clades. Before scanning, the
phylogeny and ancestral sequences were determined by DNA-
PARS. To score covariance, each sequence or node was
compared with its immediate ancestor to determine the num¬
ber of evolutionary events at each paired site. This approach
avoids the problem of multiply scoring the same covariant
substitution found in members of the descendant clade. This
was identified as a particular problem with the analysis of
HCV sequences, which show several tiers of sequence vari¬
ability (genotype, subtype, isolate).
Free energy calculations
Coding regions of aligned HCV sequences of genotypes 1a
(HPCPLYPRE), 1b (HC-J1), 2a (HC-J6), 3a (HPCEGS), 4a
(HCV4APO), 5a (HCV1480), 6a (HCV12083), and of GBV-B
(NC_001655) were split into 500-base fragments overlapping
by 250 bases. The free energy of folding was calculated
using the program MFOLD (Mathews et al„ 1999) using de¬
fault settings. The contribution of nucleotide order to free
energy of folding was estimated by comparison of free en¬
ergy with the mean value of sequences generated by se¬
quence order randomizations. Six different methods were used
to randomize coding sequence order as described in Results
[nucleotide order randomization (NOR), codon order random¬
ization (COR), like-codon randomization (CLR), like-codon
swap (CLS), dinucleotide randomization (CDR), and dinucle-
otide swap (CDS)]. Free energy results were expressed as
the ratio of free energy on folding native sequences to that of
the sequence randomized by one of the six methods. For
methods NOR, COR, CLR, and CDR, differences in free en¬
ergy between native and randomized sequences were also
be expressed as a Z-score, as previously described (Work¬
man & Krogh, 1999). Z-scores are the number of standard
deviations by which the predicted free energy of the native
sequence is lower than the mean of the randomized
sequences.
Specific predictions of RNA secondary structure were made
for regions of the HCV genome showing suppression of syn¬
onymous substitutions, covariant sites associated with stem-
loop structure, and excess free energy on folding compared
with sequence-order-randomized controls. In practice, this
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included the core- and NS5B-encoding regions of HCV. Con¬
servation of each predicted structure was assessed by par¬
allel folding of sequences of different HCV genotypes, and by
retention of specific structure within the different structural
predictions using different free energy parameters. RNA stem-
loop structures have been referred to provisionally in this
study by the base position in the HCV alignment of the first
base at the 5' end of the base-paired region. The labeling
does not constitute a specific proposal for their future
nomenclature.
Sequence software
All free energy calculations and secondary structure predic¬
tions were made using the program MFOLD with default set¬
tings. Sequence alignments, measurement of synonymous
variability, sequence order randomization, measurement of
base composition and dinucleotide frequencies, and covari-
ance scanning by parsimony were performed with the Sim-
monic 2000 package (Simmonds & Smith, 1999), which is
available from the authors.
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Evolutionarily conserved RNA secondary structures in coding
and non-coding sequences at the 3' end of the hepatitis G
virus/GB-virus C genome
N. M. Cuceanu.t A. Tuplin and P. Simmonds
Laboratory for Clinical and Molecular Virology, University of Edinburgh, Summerhall, Edinburgh EH9 1QH, UK
Hepatitis G virus (HGV)/GB virus C (GBV-C) causes persistent, non-pathogenic infection in a large
proportion of the human population. Epidemiological and genetic evidence indicates a long-term
association between HGV/GBV-C and related viruses and a range of primate species, and the co-
speciation of these viruses with their hosts during primate evolution. Using a combination of
covariance scanning and analysis of variability at synonymous sites, we previously demonstrated
that the coding regions of HGV/GBV-C may contain extensive secondary structure of undefined
function (Simmonds & Smith, Journal of Virology 73, 5787-5794, 1999). In this study we have
carried out a detailed comparison of the structure of the 3'untranslated region (3 UTR) of
HGV/GBV-C with that of the upstream NS5B coding sequence. By investigation of free energies on
folding, secondary structure predictive algorithms and analysis of covariance between HGV/GBV-
C genotypes 1-4 and the more distantly related HGV/GBV-C chimpanzee variant, we obtained
evidence for extensive RNA secondary structure formation in both regions. In particular, the NS5B
region contained long stem-loop structures of up to 38 internally paired nucleotides which were
evolutionarily conserved between human and chimpanzee HGV/GBV-C variants. The prediction of
similar structures in the same region of hepatitis C virus may allow the functions of these structures
to be determined with a more tractable experimental model.
Introduction
A new member of the flavivirus family, variously described
as hepatitis G virus (HGV) or GB virus C (GBV-C) has recently
been characterized (Linnen et ai, 1996; Leary et al, 1996).
HGV/GBV-C is widely distributed in human populations,
with frequencies of active or past infection ranging from 5 to
15%. Infection is frequently persistent and associated with
high levels of circulating viraemia, although there is currently
no evidence to link HGV/GBV-C infection to any identifiable
hepatic or non-hepatic disease. HGV/GBV-C shows limited
genetic heterogeneity, but with marked geographical dif¬
ferences in distribution of the four or five currently classified
genotypes. It has been suggested that the presence and
subsequent diversification of HGV/GBV-C in humans as they
migrated out of Africa 100000 years ago accounts for the
current association of different HGV/GBV-C genotypes with
particular racial groups (Gonzalez-Perez et al., 1997; Tanaka et
al., 1998; Katayama et al., 1997). Supporting this conjecture,
sequences from the Far East are almost invariably genotype 3,
and this genotype is otherwise only found in native inhabitants
of North and South America. In contrast, Caucasian and other
populations from India westwards including those of Northern
Africa are infected with genotype 2. Genotype 1 is confined to
sub-Saharan Africa, and shows the greatest overall sequence
diversity (Smith et al., 1997; Muerhoff et al., 1997). As further
evidence for a very long-term association of this virus with
humans and other primates, viruses closely related to HGV/
GBV-C have been found in a variety of Old and New World
monkey species, and their phylogenetic relationships mirror
those of their hosts. Variants of HGV/GBV-C more divergent
than human genotypes can be detected in wild-caught
chimpanzees from Central and West Africa (Birkenmeyer et al.,
1998; Adams et al., 1998). Even more distantly related viruses,
collectively described as GBV-A, have been recovered from
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AG/b* AG/bsct % diff. AG/b* AG/bsc+ % diff.
U36380 1 -1-44 -1-19 17-33 -1-58 -1-33 15-91
AB013500 1 -1-51 -1-21 19-87 -1-55 -1-30 16-13
AB013501 2 -1-62 -1-22 24-95 -1-56 -1-29 13-21
U63715 2 -1-54 -1-22 20-78 -1-58 -1-26 20-25
U44402 2 -1-41 -1-20 14-89 -1-50 -1-27 15-33
AB008342 3 -1-41 -1-19 15-60 -1-52 -1-29 15-13
D90601 3 -1-51 -1-20 20-44 -1-51 -1-29 12-81
D87263 3 -1-51 -1-21 19-87 -1-56 -1-33 14-74
AB021287 4 -1-43 -1-17 18-82 -1-48 -1-20 18-92
AB018667 4 -1-43 -1-14 20-28 -1-52 -1-21 20-39
Meant -1-48 + 0 07 - 1-20 ±0 04 18-85 + 3-37 -1-54 + 0 03 —126 + 0 07 17-25 + 3-98
AF070476 CPZ -1-47 -1-12 23-80 -1-29 -1-10 14-73
U22303 GBV-A -1-46 -1-14 21-92 -1-46 -1-26 13-70
* Free energy on folding indicated in kj/mol per base.
t sc, Sequence order-randomized control sequences (50 for sequences U36380, AB013501, D9060X, three for other sequences analysed; mean
value shown).
t Mean and standard deviation of free energy on folding (kj/mol per base) or difference from sequence order-randomized controls.
several species of NewWorld monkeys (Bukh & Apgar, 1997;
Erker et al., 1998; Leary et al., 1997).
The great genetic stability of HGV/GBV-C and related
viruses implied by the evidence for co-evolution with primates
is difficult to reconcile with their observed rapid sequence
change in individuals over short observation periods (Nakao et
al., 1997). We have previously found evidence for constraints
on sequence change at many sites in the coding sequence, even
at those where substitutions would be synonymous (Simmonds
& Smith, 1999). Evidence that RNA secondary structure
formation through internal base-pairing limits sequence varia¬
bility at these sites was provided by the finding of multiple
covariant sites spatially associated with potential stem—loop
structures amongst HGV/GBV-C sequences of different
genotypes. Furthermore, these occurred at positions in the
genome that showed reductions in synonymous variability. In
that study we excluded non-random nucleotide composition
and biased codon usage as compounding factors in the use of
RNA folding prediction algorithms and calculation of free
energies.
In the current study we have used a variety of phylogenetic
and free energy-based predictive algorithms to compare the
extent and conservation ofRNA secondary structure formation
in the 3' untranslated region (3'UTR) with upstream coding
sequences from NS5B, a region encoding the viral RNA
polymerase. Our findings indicate that the part of the RNA
genome containing the coding sequences is more extensively
structured than the 3'UTR, and shows better conservation
between variants of HGV/GBV-C infecting different primates.
These findings imply an important functional role(s) for the
observed secondary structure.
Methods
■ Sequences. Currently available complete genomic sequences of
HGV/GBV-C genotypes 1—4 (GenBank/EMBL accession numbers in
parentheses) which included full-length or near full-length 3'UTR
sequences were the genotype 1 sequences GBV-C (U36380) and
AB013500; type 2a sequences PNF2161 (U44402), T55875 (AF031827),
HGV-1517 (AF31828), HGV-1539 (AF031829), AF121950, HGV-Iw
(D87255) and GT110 (D90600); the type 2b sequence GBV-C(EA)
(U63715); type 3 sequences GT230 (D90601), HGV-IM71 (AB008342),
GSI85 (D87262), D87708-D87714 (Katayama et al., 1998); and type 4
sequences AB018667 and AB021287. Sequences were numbered from
the start of the coding region after alignment. The chimpanzee
homologue, HGV/GBV-Ccpz, and GBV-A from the NewWorld primate
Sanguinis mystax, bore the accession numbers AF70476 and U22303.
Sequences from the NS5 region of hepatitis C virus (HCV) were obtained
from the following published sequences: genotype la (M62321), 2a
(D00944), 3a (D17763), 4a (Y11604), 5a (Y13184) and 6a (Y12083).
Viroid sequences analysed were citrus exocortis viroid (accession no.
X53715), potato spindle tuber viroid (U23058), chrysanthemum chlorotic
mottle viroid (AJ247123), Mexican papita viroid (L78463) and potato
spindle tuber viroid (X76846). Delta virus sequences of different
genotypes were obtained from the following entries: AF098261,
AJ000558, M21012, D01075 and M28267. Coding sequences of serum
albumin were obtained from the following mammalian species: cat
(X84842), cow (Y17729), gerbil (AB006197), horse (X74045), macaque
(M90463) and rat (U01222). a-globin coding sequences were obtained
from the following mammalian species: baboon (X05289), orang-utan
(M12158), duck (X02008), marsupial cat (M17083) and human (V00493).
■ Additional HGV/GBV-C 3'UTR sequences. 3'UTR sequences
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Fig. 1. Free energy on folding consecutive 1000 base fragments of FIGV/GBV-C (AB013500), HGV/GBV-Ccpz (AF070476)
and GBV-A (U22303) expressed as percentage differences from sequence order-randomized controls. Bars show 95%
confidence intervals calculated from multiple sequence randomizations. Bases numbered from start of genome.
Table 2. Free energy on folding of RNA sequences with defined secondary structure and
controls
Sequence n* AG/bt AG/bsc4 % diff.
HGV/GBV-C 5'UTR 4 -1-42 ±0-05 -1-27+ 0-05 10-27 + 2-36
Delta virus 5 -1-61 + 0-04 -1-29 + 0-01 19-95 +1-93
Plant viroid 5 -1-45 + 0-03 -1-17+ 0-04 19-47 + 2-37
a-Globin 5 -1-05 + 0-14 -1-09 + 0-12 -2-94 + 3-22
Albumin 6 -0-80 + 0-03 -0-82 + 0-04 -2-30 + 3-87
HCV NS5B 6 -1-33 + 0-08 -1-02 + 0-06 22-55 + 6-44
* No. of sequences analysed.
+ Mean and standard deviation of free energy on folding (kj/mol per base).
4 sc, Sequence order-randomized controls (three randomizations per sequence analysed).
were obtained from 17 samples whose genotype had been deduced from
sequence comparisons of the 5'UTR and E2 regions (Smith et al., 1997,
2000). RNA was extracted using proteinase K—SDS and phenol-
chloroform as described previously (Jarvis et al., 1994). Purified RNA was
then reverse-transcribed and amplified by hemi-nested RT—PCR using
primers derived from conserved regions of the HGV/GBV-C genome at
the carboxyl end of the NS5B gene and the extreme 3'-end: Z3580 -
outer sense (positions 8829-8848, 5' GGTGGTNCATCAATTGGATT
3', where N = A, C, G, T); Z3581 - inner sense (positions 8881-8900,
5' GGTTCTTAGCCCTGCTCATC 3'); and Z3582 - outer and inner
antisense (positions 9212—9231, 5' AGTAGAACCCGGCCTTTGGG
3'). Reverse transcription was carried out at 42 °C for 30 min using avian
myeloblastosis virus reverse transcriptase (Promega). The conditions for
the first round of PCR were hot start at 80 °C for 2 min followed by 30
cycles of 94 °C for 18 s, 58 °C for 21 s and 72 °C for 90 s. At the end of
the last cycle, samples were heated to 72 °C for 5 min to allow
termination of incomplete strands. The second round of PCR was
performed using 1 pi of the primary PCR product for the same number of
cycles and conditions. The amplified PCR products were cloned into
pGEM-T vector (Promega), and sequenced with both sense and antisense
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Fig. 2. For legend see facing page.
SLNSSB V SLNS5B III
plasmid primers using T7 DNA polymerase (Sequenase, USB). The
consensus sequence of one to three clones for each sample was used for
phylogenetic analysis.
■ Free energy on RNA folding. The last 1000 bases of aligned
HGV/GBV-C complete genome sequences were split into NS5B and
3'UTR regions. The NS5B sequence included the whole sequence
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Fig. 2. Predicted secondary structure of (A) the NS5B region and (B) the 3'UTR of HGV/GBV-C. Bases numbered from start of
the sequence AB01 3500. Variable sites between HGV/GBV-C genotypes 1-4 shown in grey boxes. Symbols: canonical
Watson-Crick base pairing or GU pairing; '//', intervening sequence without secondary structure (not shown). Stem-loops
formed by HGV/GBV-Ccpz that differ in structure shown in boxes.
upstream of and including the stop codon (670 bases in the sequence
U363S0), while the 3'UTR included the '.'/hole sequence downstream
from this position (321 bases). The free energy of folding was calculated
with the programs RNADraw vl.l or MFOLD using default settings.
The contribution of nucleotide order to free energy of folding was
estimated by comparison of free energywith the mean value of sequences
generated by independent sequence order randomizations. The variability
in free energy on folding 50 sequence order randomizations of three
representative HGV/GBV-C sequences of genotype 1 (U36380), 2
(AB013501) and 3 (D90601) was comparable to the combined variability
shown by three sequence order randomizations of the seven HGV/GBV-
C sequences shown in Table 1 [NS5 region: ±0-044 (±2-7%), ±0'041
(±2-8%) and ±0-040 (±2-8%); 3'UTR: ±0-043 (±4-0%), ±0*041
(±4-3%) and ±0-04 (±3-7%) for the three sequences with 50
randomizations].
This method was also used to analyse whole virus genomes of
HGV/GBV-C, HGV/GBV-Ccpz and GBV-A using a sliding window of
1000 bases. The free energies on folding each fragment of IIGV/GBV-
C, HGV/GBV-Ccpz and GBV-A sequences were compared with those of
15 sequence order randomizations. Variability in the free energies of
folding the latter sequences was used to calculate a standard error for the
free energy difference estimate.
Free energies in the HGV/GBV-C NS5B and 3'UTR were compared
with the mean values of sets of four 5'UTR sequences (U44402, U63715,
AB008335 and D87263), five plant viroid sequences, five delta virus
sequences, and five albumin and five a-globin sequences from a range of
vertebrate species.
■ Sequence software. All randomization, free energy calculations
and secondary structure predictions were made with the programs
RNADraw vl.l and MFOLD using default settings. Sequence alignments
and distance measurements were performed with the Simmonic 2000
package, which is available from the authors.
Results
Free energy on RNA folding
The free energy of folding in different parts of the
HGV/GBV-C genome was measured in consecutive 1000 base
fragments spanning the genome (Fig. 1). Free energy of folding
of the HGV/GBV-C sequence was compared with that of
independently generated control sequences whose nucleotide
sequence order had been randomized. Although each segment
of the HGV/GBV-C genome showed a greater free energy
than the control sequences, the difference was most marked at
the 3' end of the genome, with the fragments from 7000—8000,
8000—9000 and 9000-end showing differences ranging from
16 to 18%. To investigate whether the effect of sequence
ordering on free energy was conserved amongst viruses
related to HCV/CBV C, similar analyses were carried out on
sequences from HGV/GBV-Ccpz and GBV-A. Although these
viruses display only 75% and ~ 40% sequence similarity to
HGV/GBV-C, they both showed remarkably similar free
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No sequence data
Fig. 3. Structure conservation of
predicted stem-loops in the NS5B region
P'-ns5B'—■SLNS5BV") aRd 3 dTR
(3'SLI—3'SLVII) between representative
sequences of HGV/GBV-C genotypes
depending on the degree of similarity to
the most common structure in HGV/GBV-
C sequences as follows: ' + + + ',
stem-loop structurally identical
minor differences in base-pairing but
conservation of overall size and shape of
stem-loop; ' + different structure in the
same region; no secondary structure
detected.■ +++ □ ++ J + □ " 1
energy profiles, with particularly large differences in the 3'-
terminal regions. The large free energies on folding and hence
the possibility of secondary structure formation in genomic
RNA are therefore a conserved evolutionary feature of this
subgenus of viruses.
In this study we have concentrated our analysis on the 3'
terminal region of HGV/GBV-C (Table 1). Fragments of the
coding NS5B gene sequences, and the non-coding 3'UTR of
different HGV/GBV-C genotypes, showed differences in free
energy of 15—23% (mean 18'9 + 3-4%) and 15—20% (mean
17-3 + 4-0%) from sequence order-randomized controls. The
significance of these free energy differences is indicated by a
comparison with sequences of other viruses or virus-like
agents with previously documented RNA secondary structure
(Table 2). Firstly, the 5'UTR of HGV/GBV-C, whose con¬
served secondary structure is believed to function as an
internal ribosomal entry site (Simons et«/., 1996), shows a free
energy on folding of 1-4 kj/base, 10% higher than randomized
controls. Secondly, plant viroids contain covalently closed
single-stranded RNA genomes with extensive stem-loop
structures required for various RNA-catalysed replicative
functions. These sequences showed a mean free energy on
folding of —+17 kj/base (range — 1T0 to —+20), and a
difference in free energy of 19-5 % (16—23 %). Finally, the non-
coding region of the single-stranded RNA delta virus genome
also contains a well-characterized RNA structure, in which
RNA is folded into a ribosome-like domain. The mean free
energies on folding [1-29 kj/base (range —1-27 to —1-32),
20-0% difference from controls (range 15—23 %)] of five delta
virus variants were also remarkably similar to those calculated
for the NS5B region of HGV/GBV-C (Table 2). As negative
controls, sequences of the coding regions of several different
mammalian and non-mammalian a-globin and albumin genes
(which would not be expected to form secondary structures)
showed no significant differences in free energy on folding
from sequence order-randomized controls. These sequences
showed markedly different codon biases; albumin shows a low
G f C content (15-4% C I C overall, 3 4-2% C I Cat 3rd base
positions), while a-globin has a high G + C content (62-0%
overall, 83'0% at 3rd base positions). Since these sequences
show no difference from randomized controls in free energy on
folding, it is unlikely that biased codon usage per se would
influence the values calculated for HGV/GBV-C, as its G + C
content lies within these two extremes (63-3% overall, 65-7%
at 3rd base positions).
Prediction of RNA secondary structure
Two RNA structure prediction methods (RNADraw and
MFOLD) were used to compare the folding of different
variants of HGV/GBV-C and the more divergent HGV/GBV-
CCPZ (Fig. 2). Results from the two methods were equivalent.
Both predicted seven potential stem—loops formed by RNA
folding in the 3'UTR (provisionally assigned as 3'SLI—3'SLVII),
and eight in the NS5B region (labelled SLNS5BI—SLNS5BVIII).
Most of the loops in both regions were conserved between all
HGV/GBV-C genotypes, and many were also found in
HGV/GBV-Ccpz. A scoring system was adopted to indicate
the degree of structure conservation between RNA sequences
(Fig. 3), differentiating between identity of RNA structure
(+ + +), similar folding but with minor differences in the
positions of bulges and/or minor slippage ( + + ) and folding
the same region but with a different structure ( I ). (Examples
of structural differences scored as + + and + between human
and chimpanzee HGV/GBV-C secondary structures are shown
718
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. .u. Fig. 4. Covariant substitutions in
stem-loops 3'SLVII and 3'SLIII in the
3'UTR between variants of HGV/GBV-C.
Bases identical to that of GBV-C indicated
as '.Proposed base pairings in
stem-loops indicated underneath
alignment.
in Fig. 2). By these comparisons, substantial structural similarity
was found between all sequences in the NS5B region, with
similar or identical stem—loops SLNS5BI to SLNS5BV being
predicted for both human and chimpanzee HGV/GBV-C
sequences. In contrast, only stem-loop 3'SLIII was completely
conserved in the 3'UTR, the predicted structure of the
HGV/GBV-Ccpz sequence differing considerably elsewhere in
this region. The different prediction for this variant may,
however, have resulted at least in part from the likely
incompleteness of the published HGV/GBV-Ccpz sequence.
Alignment of homologous bases indicated that the terminal 55
bases were missing, including the regions forming stem—loops
3'SLII and 3'SLI.
Analysis of covariance
A large number of fully covariant and semi-covariant (C <-»
U opposite G, A<->G opposite U, and G<->U opposite A)
sites were identified in predicted base-paired regions, par¬
ticularly between human and chimpanzee sequences (Fig. 2).
These accommodated the sequence variability between geno
types in structurally conserved regions. Although sequence
variability between HGV/GBV-C genotypes was distributed
throughout thp NS5B and 3'UTR regions, a lower frequency of
substitutions were found in regions predicted to be base-paired
(18 from 273 sites in NS5B, 2 from 116 sites in the 3'UTR) than
in regions predicted to be non-base-paired (57/267 and
21/188; P < 10"' and P = < 0-002 respectively by Fisher's
Exact Test).
One of the problems of verifying structure predictions for
the 3'UTR using covariance was lack of comparative sequence
information of two of the four HGV/GBV-C genotypes. In
GenBank, there are currently only 25 complete or near-
complete 3'UTR sequences of which only two are from type 1
and two of type 4. We obtained additional 3'UTR sequences of
genotypes 1—4 from HGV/GBV-C-infected individuals from
various geographical locations. Sequence variability in the
3'UTR was largely confined to the predicted stem—loop
3'SLVII (Fig. 4), which demonstrated a large number of
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covariant substitutions both between and within genotypes.
Covariant sites, and in genotype 3 a paired deletion, were also
found in stem-loop 3'SLI1I. The remaining predicted structures
were in regions of the 3'UTR invariant between HGV/GBV-
C genotypes, although covariant changes and some structural
differences with the HGV/GBV-Ccpz sequence were detected
in loops 3'SLVI and 3'SLIV (data not shown).
Sequence variation in the NS5B region was also marked
by multiple covariant sites, generally between paired, usually
synonymous, 3rd codon positions in predicted stem loops
(data not shown). There are also examples of minor structural
differences between HGV/GBV-C genotypes, such as the
terminal region of stem—loop SLNS5BIII. The existence of
multiple covariant sites in each of the predicted stem—loops,
and their conservation of the majority of structures in the more
divergent HGV/GBV-CCPZ sequence, provides strong sup¬
porting evidence for the secondary structure predicted by free
energy calculations.
Discussion
Structure of the 3 UTR
The secondary structure of the 3'UTR was inferred by
folding algorithms based on calculations of free energy,
structural conservation between HCV/CBV C genotypes and
the occurrence of covariant changes in base-paired regions.
Our prediction differs from that of a previous study which was
based on an analysis of the last 140 nucleotides of the 3'UTR
from three HGV/GBV-C sequences (Okamoto et al., 1997).
The more extensive analysis of 42 sequences in this study
identified several substitutions that disrupted the previously
proposed base pairings. For example, the proposed pairing of
positions 9098 (U) and 9229 (A) would be disrupted in the
majority of sequences because of U —> C substitution at
position 9098, and in one group 2 sequence (SC034) because
of a U —► G substitution; another U—A pair between 9109 and
9117 is affected in three sequences (SC034, PNG29, PNG48)
because of a U —► C substitution. Other positions at which
substitutions produce mismatches in regions predicted to be
base-paired by Okamoto et al. are: C—C at positions 9140 and
9193 in four group 3 and two unassigned sequences; G-G at
positions 9150 and 9189 in three genotype 3 and two
genotype 4 sequences; A-G at positions 9130 and 9201 in one
genotype 2 sequence. In addition, the Okamoto ct al. model is
not supported by any covariant substitutions and docs not
include the fragment upstream of position 9092 in which other
structures were found.
Computer-predicted folding patterns and RNase cleavage
experiments have previously demonstrated the existence of a
long stable hairpin structure (3'-LSH) within the distal part of
the 3'UTR of several different flaviviruses (Proutski et al.,
1997; Brinton et al., 1986; Rice et al., 1985), some positive-
strand RNA plant viruses (Strauss & Strauss, 1983), HCV
(Blight & Rice, 1997; Kolykhalov et al., 1996), GBV-B
(Rijnbrand ct al., 2000) and pestiviruscs (Yu ct al., 1999; Deng
& Brock, 1993). Other studies have provided evidence for a
specific interaction between the 3'LSH of flaviviruses and host
cellular proteins, components of the virus replication complex
or have demonstrated a specific binding of cellular proteins to
the 3'-terminal 98 nucleotides of the HCV RNA (Ito & Lai,
1997) and determined which regions of the HCV 3'-UTR are
critical for in vivo virus replication (Lefrere et al., 1999).
The configurations of the predicted terminal loops 3'SLII
and 3'SLI in the 3'UTR of HCV/CBV C (Fig. 2) closely
resemble those predicted for HCV (Tanaka et al., 1996;
Kolykhalov et al., 1996) and GBV-B (Rijnbrand et al., 2000).
However, there was no evidence for a conserved third loop
(3'SLIII) nor primary sequence similarity between HGV/GBV
C and HCV or CBV B. Additionally, the terminal loop is
shorter than the HCV and GBV-B homologues (14 base pairs
in the stem instead of 19 or 20), although the predicted free
energy for formation of the terminal loop (— 73 kj, — 2-2 kj/b)
is similar to that of HCV (— 110 kj, — 2-4 kj/b), and indicates
a high probability of its formation in vivo.
The 3'UTR sequences of human HGV/GBV-C genotypes
were highly conserved, with mean pairwise distances between
genotypes ranging from 3-8 to 6-6%, compared with 12'8 to
13-4% over the rest of the genome. The HGV/GBV-Ccpz
sequence, however, did not display the same differential in
divergence, with 23—26% sequence divergence from human
genotypes in the 3'UTR, only slightly lower than observed
upon comparison of coding sequences (30%). Structurally,
only loop 3'SLV was found in both human and chimpanzee
variants, although the alignment indicated that the region
containing the two terminal loops was missing from the
published HCV/CBV Ccpz sequence. The lack of structural
conservation between HGV/GBV-C sequences is not un¬
expected, given the lack of similarity between other members
of the hepaciviruses and pestiviruses in this region. For
example, only the terminal three loops are conserved between
HCV and GBV-B, and there is also considerable sequence
variability between HCV genotypes in non-coding regions 5'
to this, including the great variability in length of the poly(U)
tract. Clearly there are varying constraints on sequence change
between different regions of the 3'UTR. However, apart from
the involvement of the terminal loops in transcription initiation
of HCV (Lohmann et al., 1999) and potentially other hepaci-
viruscs, it remains unclear what other functional roles sec
ondary structure in the 3'UTR may play.
Secondary structure in NS5B
The prediction methods used to determine the structure of
the 3'UTR were also used to analyse the coding sequence of
NS5B. Surprisingly, this region showed even greater free
energy on folding than the 3'UTR, several large stem—loops
such as those numbered SLNS5BIII and SLNS5BV and, in
contrast to the 3'UTR, substantial structural similarity between
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human and chimpanzee HGV/GBV-C variants. Generally,
secondary structures were either identical between HCV/
GBV-C variants or, particularly on comparison with the
HGV/GBV C,jpZ sequence, showed some differences in the
identity of the bases involved in base-pairing, but retained
conservation of the overall shape and size of the stem-loop.
The finding of secondary structure in this region and
differences in free energy with sequence order-randomized
sequences throughout the genome (Fig. 1) confirms and
extends our previous predictions for extensive structure of the
HGV/GBV-C genome based on a novel method of covariance
scanning and analysis of the distribution of variability at
synonymous sites (Simmonds St Smith, 1999). The involve
ment of such a high proportion of bases in internal base-pairing
in the NS5B region, and by implication elsewhere in the
genome, suggests that the RNA molecule may be extensively
folded through local and possible longer-range interactions to
form a 'tertiary' RNA structure.
The conservation in structure and the large number of
covariant substitutions suggest a functional role(s) for the
RNA structures. Particularly striking was the similarity in free
energy on folding the NS5B sequences with the free energies
observed for plant viroids and the non-coding region of delta
viruses. For these agents, the secondary structure is essential
for the replication of the genome, where specific domains may
catalyse RNA cleavage, ligation and editing of the genomic
RNA sequence. Fui IIGV/GBV-C, amongst several possi¬
bilities, RNA folding may be required for packaging of the
HGV/GBV-C genome into virus particles, or to protect the
genome from RNA-degrading enzymes, particularly as HGV/
GBV-C and related viruses do not appear to encode a
conventional nucleocapsid protein. In other RNA viruses,
secondary structures such as the ds-acting replication element
in picornaviruses may play a role in initiation of RNA synthesis
through long-range interactions with thp ^'-terminal region of
the genome (Goodfellow et al., 2000; McKnight & Lemon,
1998). The interactions between different genomic regions
implied by these observations suggest that HGV/GBV-C
might also have an organized overall structure of the RNA
genome, in which stem—loop structures may play a role in virus
replication.
Enzymatic and chemical methods have been used to provide
evidence of secondary structures independently of sequence
analysis. While we have considered this approach for the
further investigation of the HGV/GBV-C described in this and
our previous study (Simmonds & Smith, 1999), the problem
with the analysis of sequences such as the NSSB is that they are
too long to be easily resolvable by conventional methods.
Although it may be possible to separately analyse shorter
lengths of sequence in this region, splitting sequences in this
way could disrupt the longer-range interactions such as the
base-pairing in the base of stem—loops SLNS5BIII and V. Direct
visualization by electron microscopy of RNA folded in
physiological conditions is potentially a better method to
determine secondary structure of longer sequences of RNA,
particularly if combined with hybridization with gold labelled
probes to identify specific sequences within the observed
structures. We are currently carrying out this analysis with
RNA transcripts from the two regions analysed in this study.
Additionally, experimental manipulation of the recently de¬
scribed infectious clone of HGV/GBV-C and methods to
culture the virus in vitro (Xiang et al., 2000) may allow a direct
investigation of the functional significance of RNA folding in
this region of the genome.
Using methods described in this and our previous study,
we have also commenced secondary structure analyses of
other members of the flavivirus family. HCV shows an even
greater excess of free energy on folding the NS5B region
(23%, Table 2), several stem—loop structures conserved
between HCV genotypes (which are much more divergent
in nucleotide sequence than between the HGV/GBV-C
sequences analysed in this study), and the occurrence of
multiple covariant sites in each of the predicted stem- loops
(data not shown). The availability of a replicating clone of
HCV (Lohmann et al., 1999) may allow the role of such
structures to be experimentally investigated.
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